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ABSTRACT 
 
 
Discovering the basis for the unique properties of the human brain is a major goal 
of modern science. Yet, many fundamental gaps remain in our knowledge of the human 
brain development and evolution.  
  In this study we analyzed the transcriptome from sixteen human brain regions, 
comprising the cerebellar cortex, mediodorsal nucleus of the thalamus, striatum, 
amygdala, hippocampus, and eleven areas of the neocortex, throughout the entire 
prenatal development and postnatal life. Approximately 86% of genes were found to be 
expressed, and over 90% of these were differentially expressed across regions and/or 
time. Genes were organized into functionally distinct co-expression networks. 
Furthermore, sex differences were present in both gene expression and exon usage. We 
also demonstrate that these results can be used to profile trajectories of genes associated 
with several neurobiological themes, such as developmental processes, cell types, 
neurotransmitter systems, autism, and schizophrenia.  
In the second part of this study, we analyzed the temporal dynamics and laterality 
of gene expression across the eleven neocortical areas. We found that inter-areal 
transcriptional differences exhibit a temporal hourglass pattern, characterized by more 
expression differences prenatally and from adolescence onward, and almost no 
differences in infancy and childhood. Further analyses revealed distinct gradients and 
areal-restricted expression. We also found that global gene expression trajectories of 
each area become increasingly synchronized, especially after birth. Furthermore, 
analyses of gene expression between corresponding left and right areas revealed global 
symmetry throughout the fetal development and postnatal lifespan.  
Finally, we analyzed the gene expression from human, chimpanzee, and rhesus 
macaque adult brains, using the aforementioned sixteen regions. We found 6,389 genes 
were differentially expressed among species, with 3,154 specifically up- or downregulated 
in humans. Furthermore, a multi-regional approach allowed us to examine intra-species 
differentially expressed genes among all regions. In addition, we found region-specific 
gene co-expression modules that are conserved across all three species, as well as 
species-specific transcription modules. We also found several genes involved in the 
dopamine synthesis pathway were upregulated in humans, especially in the striatum. 
Lastly, we analyzed the co-expression patterns of neurotransmitter receptors systems and 
found that the glutamatergic and GABAergic systems receptors were the most conserved 
among species, while serotoninergic and cholinergic systems were the least conserved.  
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  This study provides a comprehensive dataset on the spatiotemporal human brain 
transcriptome and new insights into the transcriptional foundations of human 
neurodevelopment, as well as new insights into species-specific gene expression 
patterns. 
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RESUMO 
 
 
Um dos grandes desafios da ciência moderna consiste em descobrir a base 
biológica das propriedades únicas do cérebro humano. No entanto, ainda existem muitas 
lacunas no nosso conhecimento sobre o seu desenvolvimento e evolução. 
Na primeira parte deste estudo, o transcriptoma de dezasseis regiões do cérebro, 
incluindo o córtex cerebelar, o núcleo dorsomedial do tálamo, o estriado, a amígdala, o 
hipocampo e onze áreas do neocórtex, foi analisado ao longo de todo o desenvolvimento 
pré e pós-natal. Verificou-se que cerca de 86% dos genes são expressos e que mais de 
90% destes estão diferencialmente regulados ao nível do gene ou exão em todas as 
regiões e/ou tempo. A grande maioria dos genes foi organizada em diferentes redes 
funcionais de co-expressão, e também foram encontradas diferenças entre sexos ao nível 
da expressão génica. Adicionalmente, confirmou-se que estes resultados podem ser 
utilizados para perfilar trajectórias de genes associados com os processos de 
neurodesenvolvimento, de diferentes tipos de células, sistemas neurotransmissores e 
também algumas doenças neurológicas, como o autismo e a esquizofrenia. 
A dinâmica temporal e lateralidade da expressão génica nas onze áreas 
neocorticais foram analisadas na segunda parte do estudo. Observou-se que as 
diferenças entre áreas, ao nível do transcriptoma, exibem um padrão temporal em forma 
de ampulheta, e que este é caracterizado por grandes diferenças tanto na expressão pré-
natal como a partir da adolescência, apresentando um hiato na infância. Também se 
verificou que existem gradientes distintos de expressão, incluindo alguns com diferenças 
entre humano e macaco Rhesus, bem como transcrição restrita a determinadas áreas. A 
análise global das trajetórias de expressão génica de cada área também revelou que a 
maturação se torna cada vez mais sincronizada, especialmente durante o 
desenvolvimento pós-natal. Por último, a análise da expressão génica entre os 
hemisférios direito e esquerdo revelou que existe uma simetria global durante o 
desenvolvimento fetal e pós-natal. 
Na última parte deste estudo, foi analisada a expressão génica das dezasseis 
regiões acima referidas em cérebros adultos de humanos, chimpanzés e macacos 
Rhesus. Detetaram-se 6389 genes diferencialmente expressos entre as espécies, com 
3154 especificamente sobre ou subexpressos em humanos. Uma abordagem multi-
regional também permitiu analisar genes diferencialmente expressos entre todas as 
regiões, em cada espécie, e comparar como as áreas se correlacionam de modo 
diferente entre as espécies analisadas. Além disso, verificou-se que existem módulos de 
co-expressão de genes que são conservados nas três espécies, bem como módulos de 
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transcrição específicos para cada espécie. Também se demonstrou que vários genes 
envolvidos na via de síntese da dopamina se encontram sobrexpressos em humanos, 
especialmente no estriado. Finalmente, analisaram-se os padrões de co-expressão de 
sistemas de receptores de neurotransmissores e verificou-se que os sistemas de 
receptores glutamatérgico e GABAérgico eram os mais conservados entre as espécies, 
ao passo que os sistemas serotoninérgico e colinérgico eram os menos conservados. 
Este estudo fornece um conjunto abrangente de novos dados sobre as fundações 
biológicas da transcrição génica durante o neurodesenvolvimento humano e também 
sobre diferentes padrões de expressão de genes específicos da espécie humana. 
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CHAPTER I

 1 
INTRODUCTION 
 
  Human beings possess incredible cognitive and sensorimotor capabilities. Every day 
we communicate and organize thoughts using language, form and retrieve memories, and 
act in a creative way. This level of cognition, creativity, and sensorimotor skill is present 
only in humans. Even our evolutionary closest living relatives, the great apes, lack most of 
these capabilities. Thus, it is of no surprise that we have been fascinated with uncovering 
how our brain is capable of producing such skills (Jerison 1973, Kaas and Preuss 2007, 
Gazzaniga 2008).  
  Most of our current understanding of the molecular mechanisms governing brain 
development and function are derived from experimental studies of a handful of model 
organisms, such as the fruit fly, frog, mouse, and rat. While the use of these model 
organisms has revolutionized biomedical sciences, these systems cannot fully reproduce 
features of human brain development and dysfunction, particularly those affecting the 
most distinctly human aspects of cognition and behavior. Comparing humans to non-
human primates (NHPs) is necessary for defining uniquely human features in both healthy 
and diseased states, but this comparison is often difficult to do in a systematic manner. 
Advances in non-invasive technologies such as diffusion tensor imaging (DTI) are 
expanding the range of comparison studies that are possible. As the number of large-
scale and precise comparisons that are feasible increases, a major challenge will be 
discerning how changes at the genomic level influence different phenotypes. Mapping 
molecular evolution to phenotypic evolution is a daunting task in model organisms, and 
accomplishing this in humans and NHPs presents further obstacles. Ethical 
considerations as well as technological limitations prevent thorough experimentation, and 
analysis of transcription and protein expression will be always confined to postmortem 
samples.  
  Although discovering the genetic basis and molecular mechanisms that contribute to 
the differences concerning human behavior and cognitive abilities is certainly of great 
interest, the current feasibility of this remains a challenging task. While still challenging, 
determining the changes that underlie differential brain organization and development 
arguably provides an entry point, one that can be built upon to reach the most distinctly 
human aspects of cognition and behavior. 
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1. Human Brain Development 
Human brain development is a highly dynamic process during which different regions 
undergo distinct maturational changes (Retzius 1896, His 1904, Sidman and Rakic 1973, 
Poliakow 1979, Kostovic and Judas 2002, Kang, Kawasawa et al. 2011). Moreover, 
transient brain structures arise and disappear during specific developmental periods. 
Thus, in order to have a comprehensive analysis of the human brain development, it is 
crucial to include multiple regions and major developmental time points, allowing the 
identification of temporally- and spatially-specific changes.  
  At the present, well-defined morphological staging is limited to the embryonic 
development (O'Rahilly and Müller 2006), and no fully satisfactory staging system has yet 
been devised for the fetal and early postnatal development. In this study, we have 
specified time periods based mainly on the timing and progression of major 
neurodevelopmental events in the cerebral cortex, a structure that is central to the highest 
cognitive functions in humans and is one of the most studied human brain structures. Our 
system took into consideration previous developmental classifications of the human brain 
(Poliakov 1949, Sidman and Rakic 1973, Sidman and Rakic 1982, O'Rahilly and Müller 
2006, Kostovic and Judas 2009, Judas 2010). 
  Human brain development can be broadly divided into two periods: prenatal and 
postnatal. Although prenatal development is relatively short in comparison to postnatal 
development, it is highly dynamic. Therefore, we divided prenatal development into seven 
distinct periods to facilitate higher temporal resolution. For postnatal developmental 
periods, we considered cognitive, motor, social, and emotional milestones outlined by the 
Department of Human Health and Services (http://www.cdc.gov/ncbddd/child/). As 
previously elaborated (O'Rahilly and Müller 2006), prenatal age is with respect to 
fertilization by definition. For prenatal age we used postconceptional weeks (PCW) to 
include both proper terms used in current literature: postfertilizational (timed from the 
fertilization of the ovum) and postovulatory (timed from the ovulation). Although there is a 
small difference in the timing of these events, for the majority of purposes these three 
terms (postconceptional, postfertilizational and postovulatory) could be used 
synonymously. The following is a brief description of the periods as defined in this study: 
Period 1 (Embryonic development, 4≤ Age <8 PCW) corresponds to late embryonic 
development defined by the first lamination of the cerebral wall (i.e., ventricular zone, 
intermediate zone, marginal zone). Early embryonic processes (e.g., formation of the 
neural tube, closure of the neuropores, and formation of the primary and secondary brain 
vesicles) are completed in this period. This period is marked by extensive proliferation and 
the initiation of neurogenesis. The first axons invade the cerebral wall during this period.  
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Period 2 (Early fetal development, 8≤ Age <10 PCW) is characterized by the appearance 
and subsequent primary consolidation of the cortical plate. Deep layer neurons are 
generated and begin to radially migrate to their proper position in the cortical plate. The 
secondary proliferative zone, the subventricular zone, appears around 8 PCW. The 
internal capsule and anterior commissure begin to appear. Major neuroanatomical fetal 
landmarks are readily recognized during this period, including the ventricular zone, 
subventricular zone, intermediate zone, presubplate zone (i.e., precursor of future 
subplate proper), cortical plate, marginal zone, and subpial granular layer can be 
distinguished in the cerebral wall.  
Period 3 (Early fetal development, 10≤ Age <13 PCW) is characterized by the presence of 
the bilaminate cortical plate. Namely, the deep part of the cortical plate itself becomes 
delaminated and together with a thin, cell-sparse band of tissue (described as the 
presubplate in the previous period) represents the subplate in formation. The first 
synapses are formed in the marginal zone above the cortical plate and in the presubplate 
zone below the cortical plate, whereas the cortical plate remains free of synapses. 
Tangential migration of GABAergic interneurons can be observed. Proliferation and 
migration of neurons are the two main histogenetic processes that occur during this 
period. The corpus callosum can be identified during this period. Afferent projections start 
to invade the cortical anlage and are primarily monoaminergic. The first sulci start to 
appear in this period (i.e., lateral and callosal sulcus). 
Period 4 (Early mid-fetal development, 13≤ Age <16 PCW) is characterized by the 
secondary consolidation of the cortical plate concomitantly with the formation of a large, 
synapse-rich subplate zone. The first cortical neurons show signs of morphological 
differentiation. After its formation and during subsequent mid-fetal periods, the subplate 
zone serves as a waiting compartment for afferent axons from several subcortical 
structures. Proliferation and migration of neurons and ingrowth of afferent axons are the 
major histogenetic events occurring during this period.  At this period and subsequent 
prenatal periods, typical fetal lamination pattern of the cerebral wall can be observed. The 
cerebral wall can be divided into six major architectonic compartments or fetal zones: 
ventricular zone, subventricular zone, intermediate zone, subplate zone, cortical plate, and 
marginal zone, which contains a transient subpial granular layer. 
Period 5 (Early mid-fetal development, 16≤ Age <19 PCW) is characterized by an 
increase in the size of the subplate zone and the overall thickness of the cerebral wall. 
Ingrowth of thalamocortical axons into the subplate and migration of upper cortical layer 
projection neurons are major histogenetic events. The parieto-occipital, cingulate, and 
calcarine sulci appear in this period.  
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Period 6 (Late mid-fetal development, 19≤ Age <24 PCW) is characterized by the peak of 
subplate zone thickness and development, and by the massive ingrowth of afferent axons 
from the subplate zone into the cortical plate. Therefore, the first synapses can be 
observed in the neocortical plate. Neurogenesis ceases in the pallial wall but still 
continues in the subpallial ganglionic eminences during this period. The central sulcus, 
superior temporal sulcus, collateral sulcus, superior temporal gyrus, and parahippocampal 
gyrus can be identified.  
Period 7 (Late fetal development, 24≤ Age <38 PCW) is characterized by the 
transformation of the typical fetal lamination pattern into an adult-like lamination pattern of 
the cerebral wall. Resolution of the subplate zone starts and the Brodmann’s “six-layered 
ontogenetic Grundtypus” (i.e., the fetal equivalent of future layers 2–6) appears within the 
cortical plate during this period. Cytoarchitectonic regional and areal differentiation of the 
cortical plate/cortex is an important event that occurs during this period. Neuronal 
differentiation, ingrowth of thalamocortical axons, and gliogenesis are major histogenetic 
processes observed during this period. Synaptogenesis continues primarily in the cortex. 
Myelination of select cortical axon projections starts in this period. The ventricular zone 
gradually thins until it appears as a single layer of cuboidal/columnar cells. Majority of 
cortical gyri and sulci appear during this period.  
Period 8 (Neonatal and early infancy, birth≤ Age <6 postnatal months) is characterized by 
reorganization of long afferent and corticocortical axons, transformation and maturation of 
cortical layers (especially layer 5 and 6) from a fetal to an adult-like pattern, and rapid 
synaptogenesis and spinogenesis. The remnants of the subplate zone, although resolving, 
are still present below layer 6 and thus form a transition from immature cortex to the 
developing gyral white matter. Specific motor (e.g., grasping, raising of the head, 
stretching of the legs and kicking) and sensory (e.g., object following, head turning toward 
sound) skills appear during this period. 
Period 9 (Late infancy, 6≤ Age <12 postnatal months) is characterized by further 
development of motor skills (e.g., sitting with and without support), sensory skills (e.g., 
development of color vision), and cognitive skills (e.g., exploration with hand and mouth, 
response to one’s own name).  Resolution of the subplate zone is completed and neurons 
that survive resolution of the subplate zone are incorporated into the subcortical (gyral) 
white matter as interstitial neurons.  
Period 10 (Early childhood, 1≤ Age <6 years) is characterized mainly by reorganization 
and maturation of local circuits, and the peak of synaptogenesis. During this period rapid 
development of motor skills (e.g., walking, pincer grasp, fine movement control), social 
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and emotional skills (e.g., development of imitation, self-awareness, independence), and 
cognitive skills (e.g., thinking, mathematical abilities, language) is observed. 
Period 11 (Middle and late childhood, 6≤ Age <12 years) is characterized by further 
cognitive development and refinement of neural circuits.  
Period 12 (Adolescence, 12≤ Age <20 years) is characterized by sexual maturation and 
the appearance of adult-like connectivity pattern.  
Period 13 (Young adulthood, 20≤ Age <40 years) is characterized by the end of 
maturation processes in the brain (e.g., myelination ends in the first part of this period) and 
appearance of an adult-pattern of brain functions.  
Period 14 (Middle adulthood, 40≤ Age <60 years) is characterized by an adult-like pattern 
of brain functions and the beginning of aging processes.  
Period 15 (Late adulthood, 60 years +) is characterized by the progression of aging 
processes. 
 
 
  
 
Figure 1. Timeline of major events in human brain development.  
This diagram represents human brain development beginning with conception, and proceeding 
with cell generation, neuronal migration, axonal/dendritic outgrowth, synaptogenesis, myelination, 
and synaptic pruning. From (Andersen 2003).  
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2. Interspecies phenotypic differences  
2.1. Changes in timing 
The differences in structure between human and NHP brains are (at least mostly) due to 
changes in brain development, but the underlying molecular and cellular mechanisms 
driving these changes are not well understood. One of the main advances was the 
discovery of a correlation between the timing and duration of neurogenesis, 
corticogenesis in particular, and the size of brain structures, especially the neocortex 
(Finlay and Darlington 1995). It was found that human neurogenesis is protracted, leading 
to an increase in progenitor cells that give rise to the neocortex. As an example, upper 
layer neurons, which are the last postmitotic neurons to migrate to their final position in 
the laminar neocortex (Angevine and Sidman 1961, Rakic 1974), have an extraordinary 
expansion in numbers in primates, especially in humans, when compared to other 
mammals (Charvet, Striedter et al. 2011). This further corroborates that the delayed and 
prolonged neurogenesis is a major factor in creating the interspecies differences in brain 
size we observe in postnatal brains. However, this delay and prolongation is not restricted 
to neurogenesis. Humans have a very prolonged and protracted development 
(Huttenlocher and Dabholkar 1997, Miller, Duka et al. 2012, Petanjek and Kostovic 2012). 
Furthermore, there are several studies, from gene expression to morphology, that show 
that we have several neotenous traits (Gould 1977, Somel, Guo et al. 2010, Miller, Duka 
et al. 2012). Like other NHPs, humans require parental support during childhood, and 
because this developmental stage is longer in humans, it is one of the key factors for our 
social specializations (Bogin 1988). 
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Figure 2. Comparative brain developmental trajectories of human, macaque, and mouse. 
This figure shows the heterochronicity in development between species. Mouse prenatal 
development lasts for around 18.5 days, while macaque prenatal development completes in 165 
days. When mice are born, the human brain is still in its early mid-fetal development. When 
macaques are born, humans are already in late fetal development. The human brain development 
time at birth corresponds to 19 postnatal days in mice and 39 postnatal days in macaque, 
approximately. This figure was plotted based on (Clancy, Kersh et al. 2007). The developmental 
points of the 3 species were normalized to the rat development based on an extensive list of 
morphological features. 
 
2.2. Brain size differences 
The average adult human brain weighs approximately 1,300 g (DeFelipe 2011), which 
triples the average size of a chimpanzee brain (Sherwood et al., 2008). As the absolute 
size increases, the brain is not expected to scale uniformly. For example, the neocortex 
tends to make up a greater proportion of larger brains (Frahm, Stephan et al. 1982) and 
neocortical white matter seems to increase disproportionately compared to gray matter 
(Hofman 1985, Rilling and Insel 1999, Zhang and Sejnowski 2000). By taking these 
differences in scaling into account, it can be asked whether areas in the human brain are 
the size that would be expected for the overall size of the human brain. Association areas 
are of particular interest for cognitive functions. When compared to other primates, it 
seems the size of human association areas are what is expected for the size of the human 
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brain (Sherwood, Subiaul et al. 2008). Likewise, the size of the frontal cortex seems no 
larger than expected compared to the size of the rest of the brain (Semendeferi, Damasio 
et al. 1997, Semendeferi and Damasio 2000, Semendeferi, Lu et al. 2002, Bush and 
Allman 2004). Within the frontal cortex, Schoenemann (2005) and colleagues provide 
evidence the prefrontal cortex is expanded, but this finding may have resulted from the 
methodology of the study (Sherwood, Holloway et al. 2005). Area 10 of the prefrontal 
cortex has also been reported to be relatively larger in humans (Semendeferi, Armstrong 
et al. 2001), but the degree of this increase has been questioned (Holloway 2002). 
Furthermore, the cerebellar hemispheres also appear to be larger than expected (Rilling 
and Insel 1998, MacLeod, Zilles et al. 2003). 
 
F
Figure 3. Comparison of mouse, macaque monkey, and human adult brains. Human brain is 
remarkably larger in terms of absolute size. Although motor (blue) and pre-motor (light blue) areas 
are conserved in terms of topography and relative size, prefrontal association areas, temporal lobe, 
and cerebellar hemispheres appear to be enlarged in humans, and restricted to the medial 
prefrontal cortex in mouse (Preuss, 1995).  
 
While currently there is not strong evidence that some areas have increased 
relative to brain size in the human lineage, interpreting these results is difficult. While 
allometric considerations provide an expectation (and humans fall within this range), it 
does not follow that these changes are behaviorally irrelevant. After all, absolute brain 
size, not relative measures, seems to best predict cognitive abilities across primates 
(Deaner, Isler et al. 2007). Moreover, consideration of the number and morphology of both 
neurons and glia that occurred in human lineage should be taken into account (Elston, 
Benavides-Piccione et al. 2006, Herculano-Houzel 2011, Bianchi, Stimpson et al. 2012). 
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2.3. Changes in microstructure and connectivity 
Do humans have any structures or areas not present in other primates? Despite the large 
expansion of the cortex with respect to absolute size, current evidence does not support 
that there are any cortical areas unique to humans (Preuss 2011). This includes human 
peryslvian areas involved in speech and language, which appear to be present in at least 
some NHPs (Preuss and Goldman-Rakic 1991, Grefkes and Fink 2005, Petrides, Cadoret 
et al. 2005). Likewise, histological comparisons have not identified human-specific 
changes in organization, with the exception of layer 4a in the human visual cortex (Preuss 
and Coleman 2002). 
  In contrast, there have been several studies supporting human-specific connectivity 
patterns. One example is the arcuate fasciculus, a pathway that connects temporal-
parietal and frontal cortical areas. It has been shown that alterations of the arcuate 
fasciculus and associated cortical areas result in conduction aphasia (Anderson, Gilmore 
et al. 1999), indicating the importance of these fibers for human language. DTI analysis of 
this tract in humans, chimpanzees, and macaques revealed that temporal projections 
present in humans seem to be greatly reduced in chimpanzees and absent in macaques 
(Rilling, Glasser et al. 2008). 
  It has also been proposed that there is an increased connectivity of associative areas 
in the human neocortex, including long cortico-cortical connections and short U-shaped 
fibers (Catani, Dell'acqua et al. 2012). The latter connect neighboring areas and are 
thought to generate more elaborate gyrification (Van Essen 1997). In a recent study 
(Spocter, Hopkins et al. 2012), the neuropil fraction (used as a proxy of the total 
connectivity, assuming that more neuropil implicates more connectivity) of six different 
neocortical areas was quantified in primary and associative areas of humans and 
chimpanzees. They found that human associative areas have higher fraction of neuropil, 
especially the prefrontal areas, while chimpanzee associative areas did not show a 
significant difference for neuropil levels. This evidence that neurons are more separated in 
certain areas of the neocortex was also found in associative areas of the frontal 
(Buxhoeveden, Switala et al. 2001, Schenker, Buxhoeveden et al. 2008) and the temporal 
(Semendeferi, Teffer et al. 2011) cortices. These results reinforce the idea that humans 
have an increased connectivity, especially in the prefrontal cortex (PFC), a region involved 
in higher cognitive functions. 
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Figure 4. Arcuate fasciculus differences among primate species.   
Scheme showing the organization of the arcuate fasciculus in human, chimpanzee, and macaque 
brains. Remarkably, the human frontal cortex, but not the chimpanzee or the macaque, of the left 
hemisphere is strongly connected via the arcuate fasciculus with the left medial and inferior 
temporal gyrus. From Rilling et al., 2008. (Rilling, Glasser et al. 2008)  
 
  It is very important to notice that many of the human specializations discussed above 
seem to be elaborations on specializations shared by all primates, especially the great 
apes. When compared to other mammals, primates also have larger brains, specific brain 
areas (especially prefrontal cortex and temporal cortex specializations), and particular 
developmental features (Preuss 2000, Sherwood, Subiaul et al. 2008).  
 
 
 
  
 
chimpanzees, at le t, the arcuat actually did pass into the temporal
lobe, but that standard tractography algorithms, which consider only the
principal diffusion direction, cannot follow it through a region where it
intermingles with a different, mediolaterally oriented pathway. For this
reason, we used a newly developed algorithm designed to track through
crossing fibers by also considering the secondary diffusion direction6.
We used this technique to track the arcuate fasciculus, along with
two additional pathways that convey fibers between frontal and
parietal-temporal cortex, the superior longitudinal fasciculus and the
xtreme capsule. These pathways can be clearly identified in a co on l
section through the color map at the level of the precentral sulcus
(Supplementary Fig. 3 online). In all three species, we tracked between
a coronal region of interest (ROI) that encompassed these three
pathways a d an ROI in the white matter underlying the STG, MTG
and ITG, as well as the inferior parietal lobule (Supplementary Fig. 3
and Supplementary Methods). Note that the surface anatomy of the
macaque temporal lobe differs from those of humans and chimpanzees:
the less-convoluted macaques lack an inferior temporal sulcus, so that
there is no distinction between MTG and ITG.
Tracking results in macaques revealed that the pathway of
highest probability ran in the vicinity of the extreme capsule deep to
the insula, with weaker pathways running both dorsal and lateral to the
insula. Posteriorly, cortical terminations were observed in posterior
STG (area 22) and anterior inferior parietal cortex (area 7b). Anteriorly,
terminations were found in the frontal operculum, insular cortex and
the inferolateral margin of the frontal lobe
(area 6), including the extreme ventral aspects
of areas 44 and 45 in the arcuate sulcus, with
the strongest terminations being in area 45
(Fig. 2a,b and Supplementary Fig. 1). These
results are consistent with prior tracer5 and
DTI7 studies in macaques (Fig. 3a).
Tracking in chimpanzees revealed that,
unlike macaques, the pathway running dorsal
to the insula was stronger than that of the
extreme capsule (Fig. 3a). Cortical termina-
tions were more widespread than in maca-
ques, involving prominently the inferior
parietal lobule, including both the supramar-
ginal gyrus (area 40) and the angular gyrus
(area 39), as well as dorsolateral prefrontal and
dorsal premotor cortex (Fig. 2a,b and Sup-
plementary Fig. 1). In chimpanzees, this
dorsal pathway was dominated by connections with the inferior parietal
lobe (supramarginal gyrus and angular gyrus).
Tracking in humans, as in chimpanzees, revealed that the dorsal
pathway was dominant to the extreme capsule pathway (Fig. 3a). The
cortical terminations of humans also differed from chimpanzees and
macaques, with humans having much stronger terminations poster-
iorly, in the MTG and ITG, as well as anteriorly, in pars opercularis
(BA 44), pars triangularis (BA 45), pars orbitalis (BA 47) and
surrounding regions (Fig. 2a,b and Supplementary Fig. 1). Termina-
tions in the MTG and ITG were found in 10 of 10 human brains, 1 of 4
chimpanzee brains and 0 of 3 macaque brains (w2 ¼ 56.5, degrees of
freedom ¼ 2, P o 0.0001), and human terminations were more
extensive than those of the lone chimpanzee subject who also had
them (Supplementary Fig. 1). Connectivity with the MTG was more
widespread and of higher probability in the left than in the right
hemisphere, consistent with functional imaging evidence that lexical-
semantic (word-meaning) processing is lateralized to left MTG and
angular gyrus8, and with studies reporting leftward asymmetries in the
human arcuate fasciculus3,4. In humans, tracts extending into the
temporal lobe via the arcuate fasciculus made a much greater con-
tribution to the dorsal pathway (Fig. 3b) than they did in chimpanzees.
Substantial evidence indicates that the MTG is involved in lexical-
semantic processing8 and that pars triangularis and pars orbitalis are
involved in syntactic processes of sentence comprehension9. To explore
whether these two regions were specifically connected with one
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Figure 2 Three-dimensional tractography results.
(a) Average tractography results for humans,
chimpanzees and macaques, showing left and
right hemisphere results. (b) Schematic summary
of results shown in a. Center of gravity of human
MTG projections at x ¼ ± 48 are at Montreal
Neurological Institute coordinates, x ¼ –48,
y ¼ –42, z ¼ –3 and x ¼ 48, y ¼ –36, z ¼ –7.
abSF, ascending branch of the Sylvian fissure;
AOS, anterior occipital sulcus; AS, arcuate sulcus;
CS, central sulcus; FOS, fronto-orbital sulcus;
hbSF, horizontal branch of the Sylvian fissure;
IFS, inferior frontal sulcus; IPS, intraparietal
sulcus; ITS, inferior temporal sulcus; LCaS, lateral
calcarine sulcus; LuS, lunate sulcus; PoCS,
postcentral sulcus; PrCS, precentral sulcus; PS,
principal sulcus; SF, Sylvian fissure; SFS, superior
frontal sulcus; STS, superior temporal sulcus.
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3. Gene expression in the human brain 
A very high percentage of the known protein-coding genes are expressed in the human 
brain (Colantuoni, Purcell et al. 2000, Myers, Gibbs et al. 2007). When compared with 
several other organs, the human brain has a distinct transcriptional profile (Roth, Hevezi 
et al. 2006), higher levels of gene expression, and the expressed transcripts are more 
diversified (Ramskold, Wang et al. 2009, de la Grange, Gratadou et al. 2010). There are 
several factors that may be responsible for this diversification of RNA populations, such as 
alternative splicing and the transcription of noncoding RNAs.  It has been shown that there 
is an enrichment for splicing events (such as skipped exons, alternative poly(A) signal 
usage, and alternative promoter usage) in transcripts in the brain (Yeo, Holste et al. 2004, 
Wang, Scully et al. 2007). There is also evidence that both long noncoding RNAs and 
microRNAs are also enriched in the brain (Kuss and Chen 2008, Ponjavic, Oliver et al. 
2009, Chodroff, Goodstadt et al. 2010). All these studies revealed very relevant features 
of the brain when compared with other tissues. But, since the brain is a very complex 
organ and it is composed of several histologically and functionally distinct structures, 
studies of gene expression on the multitude of regions in the human brain may reveal 
crucial information on how the brain is constructed. As an example, studies on the human 
brain development across several regions reported that the cerebellum has a very distinct 
profile in terms of gene expression (Roth et al., 2006; Lockhart and Barlow, 2001). 
Importantly, it is also important to study these regions through development, because 
some of the patterns that govern complex processes during regional specification may be 
transient. 
  Most gene expression studies of the developing brain have been restricted to rodents 
(Zapala, Hovatta et al. 2005, Semeralul, Boutros et al. 2006). From those performed in 
humans, most have included a relatively small number of samples and are predominantly 
focused on few regions, or developmental time points (Sun, Patoine et al. 2005, 
Abrahams, Tentler et al. 2007, Johnson, Kawasawa et al. 2009, Ip, Wappler et al. 2010). 
Also, the fact that significant asymmetry in gene expression between the left and right 
hemispheres was found during early fetal development (Sun, Patoine et al. 2005), but was 
not detected during midfetal development (Johnson, Kawasawa et al. 2009, Lambert, 
Lambot et al. 2011), reinforces that it is necessary to extend the study of gene expression 
to more developmental stages, including fetal and postnatal development. 
 
 12 
4. Transcriptome evolution 
It is often suggested that differences in expression of genes, rather than the makeup of 
the genes themselves, have been the major drivers of phenotypic evolution. One 
motivation for this claim is the argument, which is proposed on the basis of exclusion, that 
the protein-coding differences are too small to account for this (King and Wilson 1975). 
Other arguments for the importance of regulatory evolution are rooted in the idea of 
circumventing the increased selective pressure on genes with pleiotropic effects 
(Blekhman, Oshlack et al. 2008). Similar to how a duplication of a gene relaxes selective 
pressure, modifications of regulatory elements allow tissue- and time-specific changes in 
gene expression levels. This increases the probability that a regulatory mutation that 
confers a selective advantage will reach fixation because it does not need to outweigh any 
disadvantages caused by an increase in expression in all tissues. Perhaps more 
importantly, most human-specific features, including those discussed above, are 
quantitative rather than qualitative (that is, they are present but to a different degree in 
other species). Thus, changes in developmental processes and timing via regulatory 
evolution, are likely to be heavily involved (Carroll 2003).  
  Global studies comparing transcription in humans and NHPs provide a method for 
determining human-specific gene expression. Even though differences in gene expression 
during development are crucial, most studies on transcriptome evolution were done in 
adult specimens due to the scarcity of developmental tissue in good working conditions, 
especially within great apes. A handful of these studies reported evidence that gene 
expression in the human brain has diverged more from other primate species than gene 
expression of other tissues examined (Enard, Khaitovich et al. 2002) and that there was a 
bias for upregulated expression in the human brain that was not observed in the other 
tissues sampled (Cáceres, Lachuer et al. 2003, Gu and Gu 2003, Khaitovich, Muetzel et 
al. 2004). However, other studies did not find higher divergence in brain gene expression 
(Hsieh, Chu et al. 2003) nor a bias for upregulated expression in the human brain (Uddin, 
Wildman et al. 2004). Some other works focused on differences in metabolic genes, 
especially in aerobic metabolism (Uddin, Wildman et al. 2004, Babbitt, Fedrigo et al. 
2010), groups of human-specific co-expressed genes (Oldham, Horvath et al. 2006, 
Konopka, Friedrich et al. 2012), and also noncoding RNAs, which were surprisingly 
conserved in terms of expression, suggesting that they may have a conserved functional 
role (Babbitt, Fedrigo et al. 2010). 
  Most of these studies were carried out with microarrays, which have inherent 
limitations. For interspecies studies, reliable expression detection is limited to genes that 
are identical, as sequence mismatches decrease hybridization reliability (Preuss, Cáceres 
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et al. 2004). Thus, these analyses are confined to a subset of genes whose sequences 
are very conserved. Also, arrays are only able to detect expression within pre-designed 
probe sets, preventing discovery of unknown transcripts. Furthermore, lowly expressed 
genes are difficult to detect at confident levels because they have to be significantly 
detected above the background, while highly expressed genes are also hard for 
differential expression calculation, as the probes reach saturation for the binding RNA, 
masking the real expression of these genes (Yang, Dudoit et al. 2001, Hekstra, Taussig et 
al. 2003). These problems were partially reduced with the introduction of next generation 
sequencing. Using RNA-seq, it is possible to uncover new transcripts, since it is not based 
on pre-designed probes. Also, the detection and quantification of gene expression does 
not depend on hybridization rates, which facilitates the detection of lowly expressed genes 
as well as finding differences in expression for highly expressed genes. However, RNA-
seq also has limitations, especially with respect to the quality of different genomes 
annotations. The relatively better annotation of the human genome makes it difficult to 
analyze interspecies expression data without having human-biased results. The improving 
annotation of NHP genomes will eventually resolve this problem (Liu, Cheng et al. 2010). 
Another problem when comparing transcriptomes among primate species is the 
differences in environment, such as diet. These differences should be as small as 
possible, in order to confidently state that the differences observed result from 
evolutionary changes and not environmental differences. This is an impossible problem to 
circumvent due to both tissue scarcity and ethical concerns that prevent designing 
controlled experiments.  
4.1. Developmental differences at the transcriptome level 
As discussed above, humans have developmental patterns and timings that differ from 
other species, even from other NHPs, with most of the regional differences in gene 
expression occurring prenatally and then decreasing over time (Colantuoni, Purcell et al. 
2000, Somel, Guo et al. 2010, Colantuoni, Lipska et al. 2011, Kang, Kawasawa et al. 
2011). It is also expected that crucial evolutionary differences at the transcriptome level 
will also occur during development. However, it is hard to compare species transcriptomes 
through development for technical reasons (it is extremely hard to harvest tissue from 
developing NHPs, especially apes) and, more importantly, because of developmental 
heterochronicity. What age in chimpanzees or macaques corresponds to a 1-year-old 
human? This is a hard question to answer. Barbara Finlay has done impressive and 
critical work for prenatal comparisons (http://translatingtime.net), based on several 
morphological data sets (Clancy, Kersh et al. 2007). Recently, a dynamic time warping 
algorithm was also developed (Yuan, Chen et al. 2011) in order to analyze time shifts in 
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gene expression based on time series data. However, aligning developmental events 
continues to be one of the hardest things to manage when performing a large-scale study 
on developmental differences in gene expression. 
Despite the difficulties in obtaining developmental specimens, several studies have 
focused on gene expression across developing primate brains. These studies highlight 
groups of genes with a developmental time-shift and focus on neotenic features (Somel, 
Franz et al. 2009), miRNA regulation (Somel, Liu et al. 2011), and transcriptional factor 
regulation (Liu, Somel et al. 2012) of groups of co-expressed genes. These differences 
are more pronounced in the human PFC when compared to cerebellum. Although this 
might be very interesting, because the PFC is one of the last brain regions to mature and 
known to be involved in human-specific capabilities, the results are difficult to interpret 
because no other neocortical areas were examined. Human neocortical areas are very 
similar in terms of expression during postnatal development (Kang, Kawasawa et al. 
2011), suggesting that the difference observed between the cerebellum and PFC might 
not be specific to the PFC. 
The observation that the transcription factor MEF2A might be regulating a module of co-
expressed genes involved in synaptogenesis (Liu, Somel et al. 2012) highlights the fact 
that alteration of the expression time course of a single transcription factor may drive 
differences in crucial developmental processes. Genes in this module are expressed later 
in human development than in other NHPs concurrent with the expression of MEF2A. 
These expression changes match up with the delay of synaptogenesis observed in 
humans (Rakic, Bourgeois et al. 1986, Huttenlocher and Dabholkar 1997).  
  Further studies are needed to corroborate these findings and to show evidence for 
mechanisms governing these differences. More importantly, it is of the utmost importance 
to extend transcriptional evolution studies to prenatal stages. This will most probably 
reveal critical differences on the transcriptional program that shape the brain. 
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5. Aims 
The main goal of this work has been the comprehensive analysis of the human brain 
transcriptome, with special focus on the neocortical areas, during the entire lifespan. 
Another aim was to reveal human-specific transcription in the adult brain, by comparing it 
to homologous regions of the chimpanzee and macaque brains. To achieve this, two main 
platforms were employed: the Affymetrix Exon Microarray and the Illumina RNA 
sequencing technology. These provided the capability for analyzing the transcriptome at a 
high resolution, allowing a comprehensive analysis of exon-level expression data. This 
study has uncovered several new features of the gene expression spatio-temporal 
dynamics during human neurodevelopment, including regional specification, differences 
between sexes, maturational properties, and interhemispherical symmetry. Furthermore, 
this analysis revealed human-specific patterns of gene expression, including differences in 
neurotransmitter receptors. These data open new avenues for the research on human 
evolutionary specializations. 
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RESULTS 
 
This section contains the results and their respective discussion and materials and 
methods. It is organized into three sub-chapters presented in journal article format: 
 
1 - Spatio-temporal transcriptome of the human brain 
 This article was published in Nature (2011). Here, we describe several aspects of 
sixteen regions of human brain throughout development, adulthood, and aging. We reveal 
that the human brain transcriptome changes very dynamically during development, 
especially prenatally. We also show that the transcriptome is organized into distinct co-
expression network modules, and that there is a sex-biased gene expression, even at the 
level of exon usage. Furthermore, we also profile developmental trajectories of genes 
involved in several neurobiological processes, like migration, differenciation, and synapse 
formation. Finally, we identified associations between single nucleotide polymorphism and 
gene expression. I contributed with tissue dissection, tissue sectioning, histological 
stainings and analysis, gene ontology analysis, selection and qRT-PCR validation of 
genes of special interest, and organizing the supplementary information. I also 
participated in the analyses of results. The manuscript was written by Nenad Šestan. 
 
2 - Temporal Dynamics and Bilaterality of Human Neocortical Areal Transcription 
 This article was recently submitted to Science and is currently under revision. Here, 
we show that neocortical areas differences in gene expression decrease drastically 
perinatally and start to increase from adolescence on, exhibiting, therefore, an hourglass 
pattern. We also show evidence that some of the genes that have temporally regulated 
inter-areal differential expression also display divergence, both spatially and temporally, 
between human and monkey. These differences in gene expression patterns between 
species may have played a role in human evolution. Furthermore, using global 
transcriptional developmental trajectories, we investigated the transcriptional dynamics 
associated with areal maturation. Our findings suggest that, globally, there are no 
significant differences in maturational trajectories among neocortical areas, even though 
some neurodevelopmental processes, such myelination and synaptogenesis, show 
differences among human neocortical areas. Finally, we show that the neocortex is 
transcriptionally symmetric across the full course of fetal development and postnatal 
lifespan. I participated in all the experiments, analyzed the results, and wrote parts of the 
manuscript and supplementary information. 
 20 
 
3 - Multi-regional analysis of gene expression evolution in the human brain 
 This article is currently under preparation for submission. Here, we describe several 
differences between human and other NHPs (chimpanzee and rhesus macaque) brain 
transcriptomes. We show that the species, and not the brain regions, contribute the most 
for the differences observed. We also show that the striatum is the region that shows more 
human-specific differential expression, and that the majority of the genes that have a 
human-specific pattern of expression are usually upregulated. Interestingly, the number of 
human-specific genes is higher than the number of chimpanzee-specific genes. On the 
other hand, the number of intra-species DEX genes is lower in humans, especially in the 
NCX. We also reveal several modules of co-expressed genes, including one with human-
specific expression in the NCX, and another with human-specific expression in the STR, 
AMY, and HIP. Intriguingly, we found that the genes that code for enzymes involved in the 
anabolic pathway of dopamine are present in these modules. After a careful analysis, we 
found that both TH and DDC were upregulated in the human striatum, while MAOA and 
COMT, two of the enzymes that are involved in the catabolic pathway of dopamine, are 
not DEX, which means that, most probably, humans have more dopamine levels in the 
STR than chimpanzee and macaques. We also analyzed neurotransmitter receptors 
networks and found that while glutamatergic and GABAergic systems are very conserved 
among species, there are some differences in serotoninergic and cholinergic systems, 
which may contribute for human-specific behavior and cognition. In this study, I performed 
all the experiments, analyzed the results, and wrote the manuscript and parts of the 
supplementary information. 
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1.1. Abstract 
Here we report the generation and analysis of genome-wide exon-level transcriptome data 
from 16 brain regions comprising the cerebellar cortex, mediodorsal nucleus of the 
thalamus, striatum, amygdala, hippocampus, and 11 areas of the neocortex. The dataset 
was generated from 1,340 tissue samples collected from one or both hemispheres of 57 
postmortem human brains, spanning from embryonic development to late adulthood and 
representing males and females of multiple ethnicities. We also performed genotyping of 
2.5 million SNPs and assessed copy number variations for all donors. Approximately 86% 
of protein-coding genes were found to be expressed using stringent criteria, and over 90% 
of these were differentially regulated at the whole transcript or exon level across regions 
and/or time. The majority of these spatiotemporal differences occurred before birth, 
followed by an increase in the similarity among regional transcriptomes during postnatal 
lifespan. Genes were organized into functionally distinct co-expression networks, and sex 
differences were present in gene expression and exon usage. Finally, we demonstrate 
how these results can be used to profile trajectories of genes associated with 
neurodevelopmental processes, cell types, neurotransmitter systems, autism, and 
schizophrenia, as well as to discover associations between SNPs and spatiotemporal 
gene expression. This study provides a comprehensive, publicly available dataset on the 
spatiotemporal human brain transcriptome and new insights into the transcriptional 
foundations of human neurodevelopment. 
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1.2. Introduction 
Human neurodevelopment is a complex and precisely regulated process that unfolds over 
a protracted period of time1-3. Human-specific features of this process are likely to be 
important factors in the evolution of human specializations2,3,5,6. However, in addition to 
giving us remarkable cognitive and motor abilities, the formation of molecularly distinct 
and intricate neural circuits may have also increased our susceptibility to certain 
psychiatric and neurological disorders4,7-10. Furthermore, sex differences play an important 
role in brain development and function and are a risk factor for disorders such as autism 
spectrum disorders (ASD)10-14. Thus, comprehensive knowledge about the spatiotemporal 
dynamics of the brain transcriptome is essential for a better understanding of 
neurodevelopment, sexual dimorphism, and evolution, as well as our increased 
susceptibility to certain brain disorders.  
 Previous transcriptome studies of the developing human brain have included 
relatively small sample sizes and predominantly focused on few regions or developmental 
time points15-19. In this study, we explore the transcriptomes of 16 regions from developing 
and adult postmortem brains of clinically unremarkable donors representing males and 
females of multiple ethnicities. 
 
1.3. Results 
Study design, data generation, and quality control  
To investigate the spatiotemporal dynamics of the human brain transcriptome, we created 
a 15-period system spanning from embryonic development to late adulthood (Table 1). 
We sampled transient prenatal structures and immature and mature forms of 16 brain 
regions, including 11 NCX areas, from multiple specimens per period (Table 2; 
Supplementary Information 2.1; Supplementary Figs. 1-3; Supplementary Table 1). The 
11 NCX areas are referred to hereafter collectively as the region NCX. We also genotyped 
donor’s DNA using an Illumina 2.5 million SNP chip (Supplementary Fig. 4; 
Supplementary Table 2). Only brains from clinically unremarkable donors with no signs of 
large-scale genomic abnormalities were included in the study (N=57, including 39 with 
both hemispheres; age, 5.7 post-conceptual weeks to 82 years; sex, 31 males and 26 
females; postmortem interval [PMI], 12.11±8.63 [mean±SD] hours; pH, 6.45±0.34 
[mean±SD]). 
 Transcriptome profiling was performed using total RNA extracted from a total of 1,340 
dissected tissue samples (RNA integrity number [RIN], 8.83±0.93 [mean±SD]; 
Supplementary Tables 3 and 4). We used the Affymetrix GeneChip Human Exon 1.0 ST 
Array platform, which features comprehensive coverage of the human genome, with 1.4 
million probe sets that assay expression across the entire transcript or individual exon, 
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thereby providing redundancy and increasing confidence in estimates of gene-level 
differential expression (DEX) and differential exon usage (DEU). Descriptions of tissue 
sampling and quality control measures implemented throughout transcriptome data 
generation steps are provided in Supplementary Information 2-5 and Supplementary 
Figures 5-8. 
 
Global transcriptome dynamics 
Spatiotemporal gene expression 
After quality control metrics were assessed, we performed quantile normalization and 
summarized core and unique probe sets, representing 17,565 protein-coding genes, into 
gene-level information. Employing stringent criteria (log2-transformed signal intensity ≥6 in 
at least one sample and mean DABG P<0.01 in at least one region and period) to define 
an “expressed” gene, we found that 15,132 (86.1%) of 17,565 genes surveyed were 
expressed in at least one brain region during at least one period, and 14,375 (81.8%) 
were expressed in at least one NCX area (Fig. 1a; Supplementary Information 6.1; 
Supplementary Fig. 9). To investigate the contribution of different factors to the global 
transcriptome dynamics, we applied multi-dimensional scaling (MDS) and principal 
component analysis (PCA), which revealed that regions and age (i.e., spatiotemporal 
dynamics) contribute more to the global differences in gene expression than other tested 
variables: sex, ethnicity, or inter-individual variation (Fig. 1b; Supplementary Information 
6.2 and 6.3; Supplementary Figs 10 and 11).  
 To identify genes that were spatially or temporally regulated, we employed a 
conservative threshold (FDR q-value<0.01 and ≥2-fold log2-transformed signal intensity 
difference), included PMI and RIN as technical covariates within all of our ANOVA models 
of differential expression, considered the influence of dissection variation, and applied a 5-
fold jackknife procedure (Supplementary Information 6.4; Supplementary Figs 12 and 13).  
We found that 70.9% of expressed genes were spatially DEX between any two regions 
within at least one period, and 24.1% were spatially DEX between any two NCX areas 
(Fig. 1a). In contrast, 90.0% of expressed genes were temporally DEX between any two 
periods across regions, and 85.3% were temporally DEX between any two periods across 
NCX areas. Moreover, 70.0% and 23.9% of expressed genes were both spatially and 
temporally DEX within brain regions and within NCX areas, respectively. The bulk of 
spatiotemporal regulation occurred during prenatal development. For instance, 57.7% of 
NCX-expressed genes were temporally DEX across fetal development (periods 3-7), in 
contrast to 9.1% during postnatal development (periods 8-12) and a mere 0.7% during 
adulthood (periods 13-15). Together, these data indicate that the majority of brain-
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expressed protein-coding genes are temporally and, to a lesser extent, spatially regulated, 
and this regulation occurs predominately during development. 
Transcriptional architecture of the human brain  
To assess the transcriptional relatedness, we calculated correlation matrices of pairwise 
comparisons between brain regions/NCX areas (Fig. 1c) and performed unsupervised 
hierarchical clustering across periods 3–15, when all analyzed regions/areas can be 
consistently followed across time. Among regions, this analysis showed distinct and 
developmentally regulated clustering of NCX (combination of 11 areas), HIP and AMY, 
with CBC exhibiting the most distinctive transcriptional profile. At the level of NCX areas, 
clustering formed the following groups during fetal periods: OFC, DFC, and MFC of the 
prefrontal cortex; VFC and primary somatomotor cortex (S1C and M1C); and parietal-
temporal perisylvian areas (IPC, A1C, and STC). V1C had the most distinctive 
transcriptional profile of NCX areas throughout development and adulthood. The 
increased correlations between NCX, HIP, AMY, and the majority of non-V1C NCX areas 
with age indicate that transcriptional differences are particularly pronounced during 
development. 
Consistent with the clustering observed, CBC showed the greatest number of region-
restricted or region-enriched DEX genes with 516 (4.8%) of 10,729 genes spatially DEX 
(Supplementary Information 6.4; Supplementary Table 5). In contrast, the number of 
genes highly enriched in the other regions was lower: NCX (46; 0.43%), HIP (48; 0.45%), 
AMY (4; 0.04%), STR (137; 1.28%), and MD (216; 2.01%). The majority of these spatially 
enriched genes were also temporally regulated, and some were transiently enriched 
during a narrow time-window, such as those featured in Supplementary Figures 14 and 15 
(NCX: FLJ32063, KCNS1; HIP: CDC20B, METTL7B; AMY: TFAP2D, UTS2D; STR: 
C10ORF11, PTPN7; MD: CEACAM21, SLC24A5; CBC: ESRRB, ZP2). These clustering 
and region-enrichment results reveal that regional transcriptomes are developmentally 
regulated and likely reflect anatomical differences.  
 
Spatiotemporal differential exon usage 
Alternative exon usage is an important mechanism for generating transcript diversity20,21. 
Using the splicing ANOVA and splicing index algorithm with conservative criteria 
(FDR<0.01 with a minimum 2-fold splice index difference between at least two 
regions/areas or periods; Supplementary Information 6.5), we found that 13,647 of 15,132 
(90.2%) expressed genes exhibited DEU across sampled regions (0.1%), periods (19.5%), 
or both (70.6%). Of 14,375 NCX genes, 88.7% exhibited DEU across sampled areas 
(<0.01%), periods (59.8%), or both (28.9%). The regulation of DEU also varied across 
time, with the vast majority of expressed genes (83.0%) exhibiting temporal DEU across 
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fetal development, while only 0.9% and 1.4% were temporally regulated across postnatal 
development and adulthood, respectively.  
 Focusing on ANKRD32, a gene we have previously shown to express an alternative 
variant in the late midfetal frontal cortex17, we confirmed and extended DEU findings by 
revealing that while the longer isoform (ANKRD32a) was equally expressed across fetal 
NCX areas, the shorter isoform (ANKRD32b), comprising the last three exons, exhibited 
dynamic areal patterns. ANKRD32b was transiently expressed in a gradient along the 
anterior-posterior axis of the midfetal frontal cortex, with the highest expression in OFC 
and lowest in M1C. Prior to this, ANKRD32b was most highly enriched in the ITC and, to a 
lesser extent, in the STC. These spatiotemporal patterns disappeared after birth, when 
only ANKRD32a was expressed, and were not observed in the mouse NCX of equivalent 
periods (Supplementary Fig. 16; Supplementary Table 6). These findings illustrate the 
complexity of DEU in the human brain and demonstrate how specific alternative 
transcripts can be spatially restricted during a narrow developmental window and with 
inter-species differences.  
 
Sex differences in the transcriptome 
Sex-biased gene expression 
Previous studies have identified sexually dimorphic gene expression in the developing and 
adult human brain12-14. Analysis of our dataset using a sliding window algorithm and t-test 
model (FDR<0.01 with >2-fold difference in log2-transformed signal intensity; 
Supplementary Information 6.6), identified 159 genes, including a number of previously 
reported and newly uncovered genes with male- or female-bias in expression located on 
the Y (13), X (9), and autosomal (137) chromosomes. A large fraction (76.7%) displayed 
male-biased expression (Fig. 2a; Supplementary Table 7). Notable spatial differences 
were observed, and more genes had sex-biased expression during prenatal development 
than during postnatal life, with the adult brain characterized by the lowest number.   
 Consistent with previous findings13,14, we found that the largest differences were 
attributable to Y chromosome genes, especially PCDH11Y, RPS4Y1, USP9Y, DDX3Y, 
NLGN4Y, UTY, EIF1AY, and ZFY, which displayed constant expression across regions 
and periods, with the exception of PCDH11Y down-regulation in the postnatal CBC (Fig. 
2b). Interestingly, the functional homologues of these genes on the X chromosome 
(PCDH11X, RPS4X, USP9X, DDX3X, NLGN4X, UTX, and EIF1AX), except ZFX during 
fetal development, were not up-regulated in a compensatory manner in female brains 
(Supplementary Fig. 17).  
We also found other X-linked and autosomal genes with sex-biased expression and 
distinct spatiotemporal patterns, including functionally uncharacterized transcripts 
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(LOC554203, C3ORF62, FLJ35409, and DKFZP586), S100A10 (which has been linked to 
depression22), and IGF2 (an imprinted autosomal gene previously implicated in brain 
growth and cognitive function23,24) that exhibited population-level male-biased 
developmental expression (Fig. 2c).  
 
Sex-biased exon usage  
We next explored sex-biased DEU using a sliding window algorithm and splicing t-test 
model (FDR<0.01 and splicing index>2; Supplementary Information 6.6). We identified 
155 genes (145 autosomal) that displayed sex-biased expression of probe sets encoding 
one or a subset of exons (Supplementary Table 8) in one or multiple regions/NCX areas. 
These included several members of the collagen family of genes (COL1A1, COL1A2, 
COL3A1, COL5A2, and COL6A3), C3, KCNH2 (a gene associated with schizophrenia25), 
NOTCH3 (a gene mutated in a common form of hereditary stroke disorder26), ELN (a gene 
located within the Williams syndrome critical region27), and NLGN4X (a X chromosome 
gene implicated in synapse function and associated with ASD and moderate X-linked 
intellectual disability11,28). Although comparably expressed in males and females at the 
population and gene-level (Supplementary Fig. 17), NLGN4X exhibited a significant male-
bias in expression of exon 7 and, to a lesser extent, exons 1, 5 and 6 in a developmentally 
regulated manner (Fig. 3). Together, these findings show that developmentally and 
spatially regulated differences in gene- and exon-level expression exist between male and 
female brains. 
 
Co-regulated transcriptional networks 
To extract additional biological information embedded in the multi-dimensional 
transcriptome dataset, we performed weighted gene co-expression network analysis29 to 
identify modules of co-regulated genes. We identified 29 modules associated with distinct 
spatiotemporal expression patterns and biological processes (Fig. 4a; Supplementary 
Information 6.7; Supplementary Table 9-11; Supplementary Figs 18-20). Among modules 
corresponding to specific spatiotemporal patterns, M8 consisted of 24 genes with a 
common developmental trend that exhibited highest levels in early fetal NCX and HIP 
(period 3) and then progressively declined with age until infancy (period 9) (Fig. 4b). In 
contrast, M15 contained 310 genes exhibiting changes in the opposite direction in the 
NCX, HIP, AMY, and STR (Fig. 4c). Gene ontology (GO) enrichment analysis showed that 
M8 genes were enriched for GO categories related to neuronal differentiation (Bonferroni-
adjusted P=7.7×10-3) and transcription factors (P=5.2×10-3) (Supplementary Information 
6.8; Supplementary Table 9).  
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 Genes with the highest degree of connectivity within a module are termed hub genes 
and are expected to be functionally important within the module. M8 hub genes included 
transcription factors TBR1, FEZF2, FOXG1, SATB2, NEUROD6, and EMX1 (Fig. 4b), 
which have been functionally implicated in NCX and HIP development4,30-38. Furthermore, 
FOXG1 variants have been linked to Rett syndrome and intellectual disability34. 
Conversely, M15 GO categories included ionic channels (P=8.0×10-8) and neuroactive 
ligand-receptor interaction (P=4.0×10-14). Sequence variants in hub genes (Fig. 4c) have 
been linked to major depression (GDA)39 and to schizophrenia and affective disorders 
(NRGN and RGS4)7,40. 
 We also identified two large-scale temporally regulated modules (M20 and M2) with 
opposite developmental trajectories of genes co-expressed across regions, which either 
gradually declined (M20) or increased (M2) in expression with age (Supplementary Figs 
21 and 22). M20 was enriched for GO categories related to zinc finger proteins (P=7.3×10-
48) and transcription factors (P=4.8×10-50), including many ZNF and SOX family members, 
while M2 was enriched for categories related to membrane proteins (P=1.8×10-21) and 
genes involved in calcium signaling (P=8.1×10-10), synaptic transmission (P=1.6×10-6), and 
neuroactive ligand-receptor interaction (P=4.1×10-4), reflecting processes important in 
postnatal brain maturation. Their hub genes encoded transcriptional factors, modulators of 
chromatin state, and signal transduction proteins, all of which likely play an important role 
in driving the networks. Dramatic expression shifts of M20 and M2 in the opposite direction 
just before birth indicate that this period is associated with transcriptional changes that 
likely reflect environmental influences on brain development and intrinsic changes in 
cellular composition and functional processes. 
 
Expression trajectories of neurodevelopment  
One important application for the generated dataset is to gain insight into normal and 
abnormal human neurodevelopment by analyzing trajectories of individual genes or 
groups of genes associated with a particular neurobiological category or disease. To test 
this strategy, we compared our expression data of DCX (a gene expressed in neuronal 
progenitor cells and migrating immature neurons), as well as genes associated with 
dendrite (MAP1A, MAPT, CAMK2A) and synapse (SYP, SYPL1, SYPL2, SYN1) 
development, with independently generated, non-transcriptome human datasets. The 
DCX expression trajectory was remarkably reminiscent of the reported changes in the 
density of DCX-immunopositive cells in the postnatal human hippocampus (Fig. 5a)36,40. In 
our transcriptome dataset, DCX expression progressively increased until early midfetal 
development (period 5) and then gradually declined with age until early childhood (period 
10). Likewise, expression trajectories of dendrite and synapse development gene groups 
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closely paralleled the growth of basal dendrites of DFC pyramidal neurons41 (Spearman 
correlation, r=0.810 for layer 3 and r=0.700 for layer 5; Fig. 5b) and DFC synaptogenesis42 
(r=0.946; Fig. 5c), respectively. Steep increases in both processes occurred between late 
midfetal and late infancy, indicating that a considerable portion of these two processes 
occurs before birth and reaches a plateau around late infancy.  
 After demonstrating the accuracy and viability of using the dataset to profile human 
neurodevelopment, we manually curated lists of genes associated with over 80 
categories, including various neurodevelopmental processes, neural cell types, and 
neurotransmitter systems (Supplementary Information 6.9; Supplementary Table 12). 
Interesting trajectories and notable differences in their onset, rates of incline and decline, 
and shapes were observed within and between brain regions for in the categories, 
including major neurodevelopmental processes (neural cell proliferation and migration, 
dendrite and synapse development, and myelination; Fig. 5d), cortical GABAergic 
inhibitory interneurons (CALB1, CALB2, NOS1, PVALB, and VIP), and glutamate 
receptors (Supplementary Figs 23 and 24). As expected, two major trends were observed 
in neurodevelopmental trajectories: changes in expression of cell proliferation genes 
preceded the increase in expression of DCX, both of which decreased during perinatal 
development while synapse development, dendrite development, and myelination 
trajectories increased. Interestingly, the NCX expression trajectory for synapse 
development (Fig. 5c, d) did not display a drastic decline during late childhood or 
adolescence as previously reported for synapse density42. We also identified network 
modules and additional genes that are highly correlated with the categories 
(Supplementary Tables 13 and 14). For example, M20 and M2 were strongly correlated 
with neuron migration (r=0.894) and myelination (r=0.972), respectively.  
 In addition, our dataset allowed us to generate expression trajectories of genes 
commonly associated with ASD and schizophrenia. We investigated a number genes 
previously linked to these disorders (Supplementary Information 6.10) and observed 
distinct and dynamic expression patterns, especially among NCX areas, including 
examples for CNTNAP2, MET, NLGN4X, and NRGN shown in Supplementary Figure 25. 
To gain insight into potential biological functions of ASD and schizophrenia-associated 
genes in human neurodevelopment, we identified other genes with significantly correlated 
spatiotemporal expression profiles and performed GO enrichment analysis 
(Supplementary Tables 15 and 16). These findings reveal spatiotemporal differences 
associated in these expression trajectories and provide additional co-expressed genes 
that can be interrogated for their role in the respective processes or disorders.  
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Expression quantitative trait loci  
Previous reports have demonstrated the connection between SNP-based genetic variation 
and expression quantitative trait loci (eQTLs) in the adult postmortem human brain, 
primarily in the cerebral cortex43-47. Our multiregional developmental dataset enabled us to 
search for association between SNP genotypes and spatiotemporal gene expression. We 
tested only for cis-eQTLs, restricting the search to SNPs within 10 kb of either 
transcription start site (TSS) or termination site (TES), as opposed to trans-eQTLs, which 
would require much larger sample sizes.  
 Implementing a conservative strategy (gene-wide Bonferroni correction followed by 
genome-wide FDR<0.1; Supplementary Information 9), we identified 39 NCX, 8 HIP, 4 
AMY, 2 STR, 6 MD, and 5 CBC genes (Supplementary Table 17) with evidence of cis-
eQTL, including two previously reported genes (ITGB3BP and ANKRD27)45,47. Consistent 
with previous studies48, associated SNPs were enriched near TSS or TES (Fig. 6a).  
 An example of a significant association in NCX, MD, and CBC is rs10785190 and 
GLIPR1L2, a member of the glioma pathogenesis-related 1 family of genes49. The 
expression differences were observed at the level of the whole transcript and exons 1 and 
2, the only exons we observed to be expressed at appreciable levels in the NCX (Fig. 6b). 
The NCX likely had more cis-eQTLs than other regions due to its smaller variation in gene 
expression resulting from the averaged expression of 11 areas. Many eQTLs identified as 
significant in NCX also have similar associations in other regions, though they were not 
statistically significant after the conservative genome-wide correction (Supplementary 
Table 17). Thus, we have identified polymorphic regulators of transcription in different 
regions across development, potentially providing insights into inter-individual differences 
and genetic control of the brain transcriptome.   
 
1.4. Conclusions 
We have described the generation and analysis of the transcriptome and corresponding 
genotyping dataset covering multiple regions of the developing and adult brain. This 
dataset (available at www.humanbraintranscriptome.org), along with another recent 
study50, provides opportunities for a variety of further investigations and comparisons with 
other transcriptome-related datasets of both healthy and diseased states. 
 Our analysis revealed several important aspects of the human brain transcriptome 
and expands current knowledge of the transcriptional events in human neurodevelopment. 
Consistent with many previous studies in other species, we found that gene expression 
and exon usage have complex, dynamically regulated patterns across time and space and 
are far more prominent than differences between sexes, ethnicities, or individuals despite 
their underlying genomic differences.  
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 We confirmed and expanded on previous findings of sexual dimorphism in gene 
expression and exon usage, including several disease-related genes. These findings offer 
possible transcriptional mechanisms underlying sex differences in the incidence, 
prevalence, and severity of many disorders. We also demonstrated how the dataset can 
be used to profile trajectories of genes associated with specific neurobiological categories 
or disorders, many of which would not likely be evident in the transcriptomes of commonly 
studied model systems. Coupled with analysis of co-expressed genes in the dataset, 
these provide information about when and where these genes are expressed in the brain, 
which can help infer their function. Our data can enhance genome-wide association and 
linkage studies by narrowing the focus to the candidate genes that are specifically 
expressed during development or restricted to a specific region known to be preferentially 
affected.  
We show associations between specific SNPs and expression levels in different regions of 
the developing human brain, indicating that genetic variation contributes to inter-individual 
transcriptome variability across regions and development. While the current number of 
specimens in our dataset restricted our power to detect many of the possible eQTLs, we 
have identified a set of cis-eQTLs, including many not previously reported, that may 
provide insights into expression-regulatory elements operating in the brain. 
Although these findings highlight the complexity of gene expression and exon usage in the 
human brain, there are several potential limitations in our data that warrant discussion. 
Foremost, we used stringent criteria in order to faithfully characterize general 
transcriptional patterns and minimize false positives, rather than to capture all the changes 
that may occur. Also, we analyzed dissected tissue samples that contain multiple cell 
types, thus diluting the genetic contribution and dynamic range of genes expressed in a 
more cell type specific manner. Current limitations prevent us from using cell type specific 
approaches in systematically analyzing the spatiotemporal transcriptome. Furthermore, 
the number of brains and regions analyzed so far is not sufficient to fully investigate the 
whole magnitude of transcriptional changes or the full range of eQTLs. Application of 
sequencing technology will allow even more in-depth analysis of the transcriptome and 
discovery of novel and low-expressing transcripts and their associated spatiotemporal 
patterns. Finally, while specific patterns of expression are often linked to equally 
specialized biological processes, it is important to keep in mind that the relationship 
between mRNA and protein levels is not always linear or translated into apparent 
phenotypic differences. As these concerns are addressed in the future with the addition of 
samples to our dataset and the generation of new datasets from human and nonhuman 
brains throughout development, it will be possible to uncover further insights into the 
transcriptional foundations of human brain development and evolution. 
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1.5. Methods summary 
The Supplementary Information provides a full description of materials and methods, 
including tissue acquisition and processing, data generation, validation, and analyses.  
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1.7. Tables 
 
Table 1 | Periods of human development and adulthood as defined in this study  
 
Period Description Age 
1 Embryonic 4≤ Age <8 Postconceptual weeks (PCW) 
2 Early fetal 8≤ Age <10 PCW 
3 Early fetal 10≤ Age <13 PCW 
4 Early midfetal  13≤ Age <16 PCW 
5 Early midfetal  16≤ Age <19 PCW 
6 Late midfetal 19≤ Age <24 PCW 
7 Late fetal 24≤ Age <38 PCW 
8 Neonatal and early infancy Birth≤ Age <6 Postnatal months (M) 
9 Late infancy 6 M≤ Age <12 M 
10 Early childhood 1≤ Age <6 Postnatal years (Y) 
11 Middle and late childhood 6≤ Age <12 Y 
12 Adolescence 12≤ Age <20 Y 
13 Young adulthood 20≤ Age <40 Y 
14 Middle adulthood 40≤ Age <60 Y 
15 Late adulthood 60 Y ≤ Age 
 
Table 2 | Ontology and nomenclature of analyzed brain regions and NCX areas 
 
Periods 1-2 Periods 3 - 15 
FC: Frontal cerebral wall  OFC: Orbital prefrontal cortex 
 DFC: Dorsolateral prefrontal cortex 
 VFC: Ventrolateral prefrontal cortex 
 MFC: Medial prefrontal cortex 
  M1C: Primary motor (M1) cortex 
PC: Parietal cerebral wall S1C: Primary somatosensory (S1) cortex 
 IPC: Posterior inferior parietal cortex 
TC: Temporal cerebral wall A1C: Primary auditory (A1) cortex 
 STC: Superior temporal cortex 
 ITC: Inferior temporal cortex 
OC: Occipital cerebral wall V1C: Primary visual (V1) cortex 
HIP: Hippocampal anlage HIP: Hippocampus 
  AMY: Amygdala 
VF: Ventral forebrain STR: Striatum 
    MGE: Medial ganglionic eminence  
    LGE: Lateral ganglionic eminence  
    CGE: Caudal ganglionic eminence   
DIE: Diencephalon MD: Mediodorsal nucleus of the thalamus 
    DTH: Dorsal thalamus   
URL: Upper (rostral) rhombic lip CBC: Cerebellar cortex 
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1.8. Figures 
 
 
Figure 1 | Global spatiotemporal dynamics of gene expression. a, Venn diagrams 
representing total number of genes considered to expressed and the number of spatially 
and temporally DEX genes for brain regions (top) and NCX areas (bottom). b, MDS plot 
showing transcriptional similarity, colored by periods (top) and regions (bottom). Euclidean 
distance of log2-transformed signal intensity (nonmetric, stress=18.9%) was used to 
measure pairwise similarity.  c, Heat map matrix of pairwise Spearman correlations 
between brain regions (top) or NCX areas (bottom) during fetal development (periods 3–
7), postnatal development (periods 8–12), and adulthood (periods 13–15).  
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Figure 2 | Sex-biased gene expression. a, Number of sex-biased DEX genes in brain 
regions/NCX areas during fetal development (periods 3–7), postnatal development 
(periods 8–12), and adulthood (periods 13–15). b, PCDH11Y exon array signal intensity 
(left) and qRT-PCR validation (right) (N=5 male brains per period). c, IGF2 exon array 
signal intensity (left) and qRT-PCR (right) validation in NCX (N=4 per sex and period). P-
values were calculated by unpaired t-test. Whiskers indicate 5th and 95th percentile. 
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Figure 3 | Sex-biased differential exon usage. a, Gene structure and probe set 
composition of NLGN4X. Depicted by yellow and green arrows are primers used for qRT-
PCR validation.  b, Heat map of the log2 male/female signal intensity ratio of each exon for 
fetal development (periods 3–7), postnatal development (periods 8–12), and adulthood 
(periods 13–15). Differences in expression of exon 7 (yellow frame) and 3’UTR (green 
frame) in adult NCX are highlighted. Note that exons 2 and 3A did not meet our 
expression criteria and are not represented. c,  qRT-PCR validation of exon 7 and 3’UTR 
expression in adult NCX (N=4 per sex). P-values were calculated by unpaired t-test. 
Whiskers indicate 5th and 95th percentile. 
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Figure 4 | Global co-expression networks and gene modules. a, Dendrogram from 
gene co-expression network analysis of samples from period 3 to 15. Modules of co-
expressed genes were assigned a color and number (M1 to M29). b, Heat map of genes 
in M8 (left) showing the spatiotemporal expression pattern after hierarchical clustering. 
The expression values for each gene are arranged in the heat map, ordered first by brain 
regions, then by age and last by NCX areas. Spatiotemporal pattern of M8 (middle) 
summarized by the first principal component (PC1) for expression of genes in the module 
across age. Top 50 M8 genes (right), defined by the highest intramodular connectivity, 
Top 10 hub genes are in red.  c, Same analyses were performed for M15. Results for 
other modules are available in Supplemental Information. 
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Figure 5 | Trajectories of genes associated with neurodevelopmental processes.  a, 
Comparison between DCX expression in HIP and the density of DCX-immunopositive 
cells in the human dentate gyrus36. b, Comparison between transcriptome-based dendrite 
development trajectory in DFC and Golgi method-based growth of basal dendrites of layer 
3 (L3) and 5 (L5) pyramidal neurons in the human DFC41. c, Comparison between 
transcriptome-based synapse development trajectory in DFC and density of DFC 
synapses calculated using electron microscopy42. For (b) and (c), PC1 for gene 
expression was plotted against age to represent the developmental trajectory of genes 
associated with dendrite or synapse development. Independent datasets were centered, 
scaled, and plotted on a logarithmic scale.  d, PC1 value percentage of maximum PC1 
value for given set of genes plotted against age to represent general trends and regional 
differences in several neurodevelopmental processes in NCX, HIP, and CBC. 
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Figure 6 | Association between SNPs and gene expression. a, b, SNP distribution 
around TSS (a) and TES (b) of the associated genes based on several Wald test P-value 
cut offs after gene-wide Bonferroni correction. c, GLIPR1L2 expression association with 
rs10785190 genotype, a SNP located in exon 1. The horizontal solid and dashed 
LOWESS curves are the developmental trend of gene and exon 1 and 2 expression, 
respectively. d, qRT-PCR validation of exon 1 and 2 expression in NCX for each genotype 
(N=14 GG, 14 AG, 8 AA) plotted relative to the local regression smooth curve to facilitate 
comparison across developmental periods. P-values were calculated by unpaired t-test. 
Whiskers indicate 5th and 95th percentile. 
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1.  Introduction 
In this Supplementary Information we provide further information regarding the study 
design, materials and methods, and additional data. The materials and methods section 
provide detailed description of the collection, dissection methods, and quality control 
assessments of postmortem human brain tissue used in this study. We provide technical 
descriptions of data generation and analyses using different platforms. We also make 
available additional data that were discussed in the main manuscript. Finally, we present 
supplementary figures and tables generated from sample metadata and specific gene 
lists.  
 
2. Supplementary Information on the Study Design 
2.1. Definition of periods of human development and adulthood used in this study 
We created a classification system of human brain development and adulthood comprised 
of 15 time periods, particularly emphasizing the timing of specific neurodevelopmental 
processes in the cerebral cortex, a structure that is central to the most distinctive traits of 
human cognition. To avoid confusion with the well-known Carnegie stages for human 
embryonic development51, we divided our specimens into developmental periods covering 
both prenatal and postnatal development and adulthood. Our system took into 
consideration previous developmental classifications of the human brain51-56.  
 
2.2. Ontology and anatomical definition of sampled brain regions and NCX areas 
Brain development is a highly dynamic process during which each region undergoes 
distinct organizational and maturational changes. Thus we created a structural ontology 
that contains brain structures (e.g., NCX areas, HIP, AMY, STR, MD, CBC) that are well 
defined throughout most of time periods and several transient structures (e.g., MGE, LGE, 
CGE, URL). In total, 8 structures were analyzed for period 1, 10 regions for period 2 and 
up to 16 regions for periods 3–15. Below we describe this ontology and anatomical 
definition of sampled brain regions and NCX areas based on histological verification.  
 
2.2.1. Neocortex (NCX) 
Samples collected from period 1 and 2 specimens contained the entire thickness of the 
cerebral wall. Samples collected from period 3–7 specimens contained the marginal zone, 
cortical plate, and part of the underlying subplate (Supplementary Fig. 3). Samples from 
period 8–15 specimens were dissected such that the entire gray matter (layer 1-6) and 
part of the underlying subplate (periods 8 and 9) or white matter (periods 10 – 15) were 
collected (Supplementary Fig. 3). Nissl staining of the neighbouring thin block was used to 
histologically verify the identity of the dissected area and to microscopically evaluate 
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tissue. Neocortical cytoarchitecture of each sample was compared to areal 
cytoarchitectonic maps to distinguish Brodmann areas (BA)57. Samples with incorrect 
cytoarchitecture or abnormal microscopical appearance were excluded from the study. 
Neocortical areas (see below) were grouped according to the lobes from which they were 
sampled. 
 
2.2.1.1. Frontal cortex (FC) 
For period 1, the sampled area corresponded to the anterior third of telencephalic vesicle 
(cerebral wall) corresponding to prospective FC.  
 
For period 2, the sampled area corresponded to different parts (orbital (OFC), dorsolateral 
(DFC), ventrolateral (VFC), and medial (MFC) of the anterior part of telencephalic vesicle 
(cerebral wall) corresponding to prospective FC. In addition, paracentral region 
corresponding approximately to the prospective motor and parietal somatosensory 
(M1C/S1C) cerebral wall was dissected as one sample (MSC).  
 
For periods 3–7, prior to the appearance of all gyri and sulci, multiple areas of the FC 
were sampled as follows (Supplementary Fig. 2): 
• Orbital prefrontal cortex (OFC) was sampled from the middle part of the orbital 
surface of the cerebral hemisphere, immediately next to the prospective gyrus rectus. 
• Dorsolateral prefrontal cortex (DFC) was sampled from the middle third of the 
dorsolateral surface of the anterior third of the cerebral hemisphere. 
• Ventrolateral prefrontal cortex (VFC) was sampled from the posterior part of the 
frontal operculum, above the lateral sulcus and prospective insula. 
• Medial prefrontal cortex (MFC) was sampled from the perigenual and subgenual 
region of the medial surface. 
• Primary motor cortex (M1C), prior to the appearance of the central sulcus, was 
sampled from the anterior third of the middle third of the cerebral hemisphere, medial third 
and upper part of the lower third of the dorsolateral surface. We used the striatum at the 
septal level as the landmark between the anterior and middle one third of the dorsolateral 
cortical surface. In some cases, we sampled M1C and S1C areas as single area and 
termed it motor-somatosensory cortex (M1C/S1C) due to the lack of clear anatomical and 
histological boundaries between immature M1C and S1C. After the appearance of the 
central sulcus M1C was sampled in front of the central sulcus from the middle and upper 
part of the lower third of the dorsolateral surface of the hemisphere. 
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For periods 8–15, sampled areas were as follows (Supplementary Fig. 1): 
• OFC was sampled from the anterolateral two thirds of the orbital gyri. OFC 
corresponds approximately to BA 11.  
• DFC was sampled from approximate border between the anterior and middle third of 
the medial frontal gyrus. DFC corresponds approximately to BA 9 and 46.  
• VFC was sampled from the posterior third of the inferior frontal gyrus, corresponding 
to the opercular and triangular part of the inferior frontal gyrus. VFC corresponds 
approximately to BA 44 and 45.  
• MFC was sampled from perigenual and subgenual parts of the anterior cingulate 
gyrus and the anteromedial part of the superior frontal gyrus. MFC corresponds 
approximately to BA 24, 32 and 33.  
• M1C was sampled from the ventrolateral part of the precentral gyrus, corresponding 
most closely to the orofacial region of M1C. M1C corresponds to BA4.  
 
2.2.1.2. Parietal cortex (PC) 
For period 1, the sampled areas corresponded to the dorsal middle third of the cerebral 
wall.  
 
For period 2, the sampled areas included the paracentral region corresponding 
approximately to the prospective motor and parietal somatosensory (M1C/S1C) cerebral 
wall, and the posterior half of the dorsal middle third of the cerebral wall corresponding 
approximately to the prospective inferior parietal cortex (IPC). 
 
For periods 3–7, prior to the appearance of gyri and sulci, multiple areas of the PC were 
sampled as follows (Supplementary Fig. 2): 
• Primary somatosensory cortex (S1C), prior to the appearance of the central sulcus, 
was sampled immediately caudal to the M1C (see M1C description above). After the 
appearance of the central sulcus, S1C was sampled behind the central sulcus from the 
middle and upper part of the lower third of the dorsolateral surface of the cerebral 
hemisphere adjacent to the M1C area. 
• Posterior inferior parietal cortex (IPC) was sampled from the lower posterior part of 
the dorsolateral surface of the middle third of the cerebral hemisphere adjacent to the end 
of the lateral sulcus. 
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For periods 8–15, sampled areas were as follows (Supplementary Fig. 1): 
• S1C was sampled from the ventrolateral part of the postcentral gyrus adjacent to the 
M1C area. S1C corresponds to BA 1–3. 
• IPC was sampled from the posterior half of the supramarginal gyrus. IPC corresponds 
approximately to BA 40. 
 
2.2.1.3. Temporal cortex (TC) 
For period 1, the sampled area corresponded to the anterior two thirds of the lateral part 
of the posterior third of the cerebral wall.  
 
For period 2, the sampled areas included the posterior two thirds of TC corresponding 
approximately to the prospective auditory and superior temporal cortex (A1C/STC) 
cerebral wall, and the anterior third corresponding approximately to the prospective 
inferior temporal cortex (ITC). 
 
For periods 3–7, prior to the appearance of gyri and sulci, multiple areas of the TC were 
sampled as follows (Supplementary Fig. 2): 
• Primary auditory cortex (A1C) was sampled from the upper part of the temporal 
bank of the lateral sulcus. 
• Posterior superior temporal cortex (STC) was sampled from the upper part of the 
superior third of the temporal lobe adjacent to the lateral sulcus and A1C area. 
• Inferior temporal cortex (ITC) was sampled from the lower part of the inferior third of 
the temporal lobe adjacent to the temporal lobe pole. 
 
For periods 8–15, sampled areas were as follows (Supplementary Fig. 1): 
• A1C was sampled from the planum temporale and the transverse temporal gyri. A1C 
corresponds to BA 41.  
• STC was sampled from the posterior third of the superior temporal gyrus. STC 
corresponds approximately to BA 22.  
• ITC was sampled from the anterior third of the inferior temporal gyrus. ITC 
corresponds approximately to BA 20. 
 
2.2.1.4. Occipital cortex (OC) 
For periods 1 and 2, sampled tissue corresponded to the posterior (occipital) part of the 
cerebral wall.  
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For periods 3–7, (Supplementary Fig. 2) prior to the appearance of gyri and sulci, 
sampled tissue corresponded to prospective primary visual cortex (V1C). Prior to the 
appearance of the calcarine fissure, V1C was sampled from the posterior third of the 
medial wall of the prospective occipital lobe. After appearance of the calcarine fissure, 
V1C was sampled as described below. 
 
For periods 8–15, (Supplementary Fig. 1) V1C was sampled from the area surrounding 
the calcarine fissure. Only samples in which the stria of Gennari could be recognized were 
included. V1C corresponds to BA 17. Small pieces of the neighbouring BA18 could have 
been occasionally present in the sample, but the majority of the sample corresponded to 
BA17. 
 
2.2.2. Hippocampus (HIP) 
For periods 1 and 2, HIP was sampled from the hippocampal anlage, located on the 
ventromedial side of the cerebral hemisphere.  
 
For periods 3–15, (Supplementary Figs 1 and 2) HIP was sampled from the middle third 
of the retrocommissural hippocampal formation, located on the medial side of the temporal 
lobe. Sampled areas always contained dentate gyrus and the cornu ammonis. Samples 
dissected from the frozen tissue may contain small quantities of the neighbouring choroid 
plexus. 
 
2.2.3. Amygdala (AMY) 
We aimed at dissecting the whole AMY from period 3–15 specimens (Supplementary Figs 
1 and 2). Very small quantities of surrounding white matter and potentially other 
surrounding structures in the basal telencephalon were included in samples. 
 
2.2.4. Ventral forebrain (VF) 
Depending on the time period we sampled different parts of the VF. For period 1, the 
sampled region corresponded to the ventral forebrain (VF), which included primordium of 
the ganglionic eminence. 
2.2.4.1. Medial ganglionic eminence (MGE) 
2.2.4.2. Lateral ganglionic eminence (LGE) 
2.2.4.3. Caudal ganglionic eminence (CGE) 
We sampled the MGE, LGE and CGE separately from period 2 specimens. Small 
quantities of surrounding tissue may be included in the samples. 
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2.2.4.4. Striatum (STR) 
Striatum (STR) was sampled from periods 3–15 specimens (Supplementary Figs 1 and 
2). We dissected the anterior part of striatum containing the head of the caudate nucleus 
and the putamen, separated by the internal capsule and ventrally connected to the 
nucleus accumbens. Small quantities of surrounding white matter are included in the 
samples. 
 
2.2.5. Diencephalon (DIE) 
Depending on the time period, we sampled different parts of the DIE. For period 1, the 
sampled region corresponded to the entire DIE. 
 
 
2.2.5.1. Dorsal thalamus (DTH) 
For period 2, the sampled region corresponds to the dorsal part of the thalamic anlage 
(DTH). 
 
2.2.5.2. Mediodorsal nucleus of the thalamus (MD) 
For periods 3–15 (Supplementary Figs 1 and 2), the whole mediodorsal nucleus of the 
thalamus (MD) was sampled from the dorsal and medial thalamus. Small quantities of 
surrounding thalamic nuclei could be present in the samples.  
 
2.2.6. Upper (rostral) rhombic lip (URL) 
Sampled region corresponds to the URL and adjacent tissue located above the upper 
rhomboid fossa for periods 1 and 2. 
 
2.2.6.1. Cerebellar cortex (CBC) 
CBC was sampled from the lateral part of the posterior lobe for periods 3–15 
(Supplementary Figs 1 and 2). The sampled area contained all three layers of cerebellar 
cortex and underlying white matter but not the deep cerebellar nuclei. CBC approximately 
corresponds to the lateral pontocerebellum.  
 
2.3. Workflow of quality control measures 
To summarize the quality control (QC) measures taken in this study, we have made a 
diagram (Supplementary Fig. 5) showing QC steps during the generation of the dataset. 
Five QC steps were performed on 94 brains that were considered for this study. The first 
QC step was assessment of donors and tissue (see exclusion criteria in Supplementary 
section 3.3). Twenty-three brains did not pass the first QC step and were excluded from 
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further analysis. Of the remaining 71 brains that were included, 58 of them were 
subsequently processed (as of December 2010) and remaining brains are currently being 
processed. The second QC step was assessment of dissection process based on 
dissection score (DS; for explanation see Supplementary section 3.4.3). There were 74 
dissected samples that did not pass this QC step, leaving 1,414 samples from 58 brains 
that were processed and from which RNA extracted for further analysis. The third QC step 
was control of RNA quality based on RNA integrity number (RIN; see Supplementary 
section 5.1), of which 15 samples did not pass. The fourth QC step was assessment of 
preparation and hybridization of RNA samples to the Affymetrix microarray chip (see 
Supplementary section 5.3). Following the removal of 53 samples after this QC step, 
1,346 samples were successfully processed on Affymetrix microarray chips and analyzed 
for gene expression. The fifth QC step was detection of outliers. There were five samples, 
all from a single brain, excluded on this basis of hierarchical sample clustering (see 
Supplementary section 5.4, paragraph 1). One additional sample was excluded by 
correlation analysis (see Supplementary section 5.4, paragraph 2) As of December 2010, 
1,340 microarray samples passed QC steps and were included in this study. 
 
3. Tissue Procurement and Sampling 
3.1. Tissue procurement 
This study was conducted using postmortem human brain specimens from tissue 
collections at the Department of Neurobiology at Yale University School of Medicine and 
the Clinical Brain Disorders Branch of the National Institute of Mental Health. Additional 
specimens were procured from the Human Fetal Tissue Repository at the Albert Einstein 
College of Medicine (AECOM), the Brain and Tissue Bank for Developmental Disorders at 
the University of Maryland, the Birth Defects Research Laboratory at the University of 
Washington, Advanced Bioscience Resources Inc. and the MRC-Wellcome Trust Human 
Developmental Biology Resource at the Institute of Human Genetics, University of 
Newcastle, UK. Tissue was collected after obtaining parental or next of kin consent and 
with approval by the institutional review boards at the Yale University School of Medicine, 
the National Institutes of Health, and at each institution from which tissue specimens were 
obtained. Tissue was handled in accordance with ethical guidelines and regulations for the 
research use of human brain tissue set forth by the NIH 
(http://bioethics.od.nih.gov/humantissue.html) and the WMA Declaration of Helsinki 
(http://www.wma.net/en/30publications/10policies/b3/index.html). Appropriate informed 
consent was obtained and all available non-identifying information was recorded for each 
specimen. Specimens range in age from 5.7 post-conceptual weeks (PCW) to 82 years. 
Of 57 postmortem brain specimens included in this study, 18 were obtained with either left 
 51 
or right hemisphere, and 39 were obtained with both hemispheres. Embryonic and fetal 
age was extrapolated based on the date of the mother’s last menstruation, characteristics 
of the fetus noted upon ultrasonography scanning, foot length of the fetus, and visual 
inspection. The postmortem interval (PMI) was defined as hours between time of death 
and time when tissue samples were frozen. 
 
3.2. Neuropathological evaluation 
All clinical histories, tissue specimens, and histological sections were evaluated to assess 
for hypoxia, cerebrovascular incidents, tumours, microbial infections, neurodegeneration, 
demyelination, and metabolic disease. In addition, cadavers from period 4 onward 
underwent a complete autopsy and were refrigerated beforehand to minimize degradation. 
To prepare tissue sections for microscopic neuropathological histological examination, 
small samples (usually the dorsal parietal cortex, striatum with ependymal layer and 
subependymal zone, hippocampus, and cerebellar cortex) of fresh or frozen tissue were 
dissected and fixed in 4% paraformaldehyde and processed for histology and 
immunohistochemistry as described below.  
 
3.3. Selection criteria for brain specimens 
To better ensure consistency between samples and decrease potential variation due to 
ante- and postmortem conditions, specific selection criteria were arbitrarily established. 
Most postnatal and adult brains also underwent comprehensive toxicological screening. 
The aim was to collect tissue specimens from clinically unremarkable donors without 
history or signs of neurological or neuropsychiatric illness or drug abuse. The following 
selection criteria were strictly adhered to when deciding whether to exclude or include 
each brain specimen. 
• Brains with chromosomal or large-scale genomic abnormalities, detected by 
karyogram and/or Illumina Human Omni-2.5, were excluded. 
• Prenatal and neonatal specimens were excluded if drug or alcohol abuse by the 
mother during pregnancy was reported or if potassium chloride, salt water, or urea were 
injected into the amniotic sac during surgical procedure. 
• Only brains free of obvious malformations or lesions were collected. Disqualifying 
characteristics included any obvious abnormality of the neural tube, forebrain, brainstem, 
cranial nerves, cerebellum, or spinal cord (i.e., prominent intraparenchymal haemorrhage 
and ischemia, infection, periventricular leukomalacia, abnormal meninges, dysplasia, 
hypoplasia, alterations in the pial or ventricular surface, extensive white matter lesions). 
• Samples were excluded if microscopic analysis revealed extensive neuronal loss, 
neuronal swelling, glioneuronal heterotopias, or dysmorphic neurons and neurites. 
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• Samples that tested positive for Hepatitis B, Hepatitis C, or HIV were excluded. 
• Early postnatal and adult (periods 8–15) specimens were excluded if excessive drug 
or alcohol abuse was reported, if the individual had any known neurological or psychiatric 
disorders, or if any prolonged agonal conditions (coma, prolonged pyrexia, hypoxia, 
seizures, prolonged dehydration, hypoglycaemia, multiple organ failure) were reported. 
Other excluding factors included ingestion of neurotoxic substances at the time of death, 
suicide, severe head injury, significant haemorrhages, widespread vascular abnormalities, 
ischemia, tumours, stroke, congenital neural abnormalities, and signs of 
neurodegeneration (spongiosis, amyloid plaques, neurofibrillary tangles, Lewy bodies, and 
amyloid angiopathy). 
 
3.4. Tissue processing and dissections  
Depending on the condition and period of the procured specimens, four different 
dissection methods were used. Photos and/or video were used to document dissections 
using a digital camera. Regions of interest were matched between different specimens, 
ages, and hemispheres of each brain. Supplementary Table 3 provides a complete list of 
all tissue samples for which we have included Exon array data in this study. Specific 
dissection protocol depended upon the period of the specimen and the method by which it 
was preserved. For all brain specimens procured at Yale University School of Medicine 
and the Human Fetal Tissue Repository at AECOM, brain regions and NCX areas of 
interest (Supplementary Table 1) were collected from fresh tissue. For all other 
specimens, regions/areas were collected from frozen tissue slabs or whole specimens 
stored at -80 ºC. To ensure consistency between specimens, all dissections were 
performed by the same person. Small samples of fresh or frozen URL (period 1 and 2) or 
CBC (period 3-15) were used to measure tissue pH.  
 
3.4.1. Tissue dissection methods  
Different dissection procedures were used for each specimen, depending upon the period 
of the brain (see below). Our pilot experiments indicated that the quality of RNA and DNA 
was largely unaffected by variation between the dissection methods used.  
 
3.4.1.1. Regional sampling from fresh brain specimens 
 Brains were chilled on ice for 15–30 minutes prior to sectioning. Brains were placed 
ventral side up onto a chilled aluminium plate (1 cm thick) on ice. The brainstem and 
cerebellum were removed from the cerebrum by making a transverse cut at the junction 
between the diencephalon and midbrain. Next, the cerebrum was divided into left and right 
hemispheres by cutting along the midline using a Tissue-Tek Accu-Edge trimming blade, 
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260 mm. The cerebellum was separated from the brainstem by cutting directly posterior to 
the brainstem, along the cerebellar peduncles. The regions of interest were dissected 
using a scalpel blade and immediately frozen in liquid nitrogen. Dissected samples were 
either immediately processed for RNA extraction or stored at -80 °C for later RNA 
extraction. The remaining brain tissue was cut to obtain 1 cm (period 5–15 specimens) or 
0.5 cm (periods 3 and 4 specimens) thick serial, coronal sections. The tissue slabs were 
snap frozen in isopentane/dry ice at -30 to -40 ºC and stored at -80 ºC. 
 
3.4.1.2. Regional sampling from frozen brain specimens  
All previously frozen periods 3–15 specimens and tissue slabs were microscopically 
inspected and the desired region was demarcated, then dissected using a dental drill 
(AnyXing, 300D) and a Lindemann Bone Cutter H162A.11.016 or diamond disk saw 
(Dental Burs USA; r=11 mm) on a 1 cm thick aluminium plate over dry ice. Dissected 
tissue samples were stored at -80 ºC prior to further processing.  
 
3.4.1.3. Regional sampling from specimens processed in RNAlater  
Frozen period 2 specimens were sectioned coronally at approximately 2 mm, beginning at 
the frontal pole, using a dental diamond disk saw. For gradual thawing, tissue slabs were 
transferred from -80 °C storage to overnight storage in RNAlater ICE (Ambion) at -20 °C. 
Tissue slabs were visually inspected for gross anatomical neuropathological 
abnormalities. Next, regions of interest were sampled under a dissection microscope at 4 
°C and stored in Buffer RLT Plus from the RNeasy Plus Mini Kit (Qiagen) at 4 °C. RNA 
was immediately extracted. 
 
3.4.2. Histological verification of tissue sampling  
To verify that the region or NCX area of interest is properly and consistently sampled, we 
also collected small tissue blocks, from both frozen and fresh brain specimens, adjacent to 
the tissue sample dissected for the RNA extraction. We have done this for the majority of 
M1C, S1C, IPC, A1C and V1C samples, which in our experience were hard to match 
across different specimens but can be histologically verified using Nissl method in 
postnatal specimens due to cytoarchitectonic differences. This method was also 
occasionally used for other regions or NCX areas. These tissue blocks were then fixed in 
4% paraformaldehyde for 48 h, sectioned at 50 µm thickness using a vibratome, and Nissl 
stained to verify the identities of dissected adjacent tissue (examples of Nissl stained brain 
regions and NCX areas from a fetal and adult brain are provided in Supplementary Fig. 3). 
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3.4.3. Dissection scoring  
We developed a scoring system to evaluate the precision of how well the sampled 
region/area was represented at the same position of corresponding samples of the same 
period. 
 
Score Sample description 
1 or 2 The region/area of interest was absent (1) or largely absent (2) and thus 
not collected. 
3 The region/area of interest was not complete but was of suitable quality 
to collect. 
4 The region/area of interest was largely intact but was not histologically 
verified or could not be collected at precisely the same position from 
which the corresponding contralateral sample was collected.  
5 The region/area of interest was fully intact, verified by gross inspection 
or Nissl staining (NCX areas), and collected at precisely the same 
position as corresponding samples of the same period. 
 
3.4.4. Tissue pulverization. To ensure proper representation of the region of interest, 
frozen tissue samples were pulverized in liquid nitrogen using a ceramic mortar and pestle 
(Fisher Scientific, cat# 12-961C and 12-961-5C). Pulverized samples were transferred to 
wide-mouth cryogenic vials (Nalgene, cat# 03-337-7B) and stored at -80 ºC until used for 
RNA extraction. 
 
4. DNA Isolation and Genotyping Data Analyses 
4.1. DNA extraction and genotyping  
For genotyping analysis, up to 25 mg of brain tissue, usually collected from the CBC, was 
homogenized using a bead mill homogenizer (Bullet Blender, Next Advance) and lysed in 
Buffer ATL (Qiagen) at 56 °C for 3–4 h. Genomic DNA was isolated using a non-phenolic 
procedure (DNeasy Blood & Tissue Kit, Qiagen) followed by proteinase K and RNase A 
treatment (Qiagen). Optical density values of extracted DNA were measured using a 
NanoDrop (Thermo Scientific) and PicoGreen dsDNA assay kit (Invitrogen). DNA integrity 
was confirmed by agarose gel electrophoresis. Illumina Omni-2.5 million SNP arrays were 
used for genotyping. DNA samples were processed at the Yale Center for Genome 
Analysis according to the Infinium HD Assay Super, Automated Protocol for Human Omni 
2.5-Quad Bead Chip (Illumina).  
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4.2. Copy number variation (CNV) analysis and genomic quality control  
All SNP chips were scanned using the Illumina iScan system. The intensity files were 
analysed using Illumina GenomeStudio v2010.2 software. Sex of each sample was 
determined from the SNP genotyping results using GenomeStudio to confirm the 
metadata of each sample. Two algorithms were used to detect CNV from SNP intensity 
data. The cnvPartition algorithm in GenomeStudio was used to detect CNV. The 
measurement of B allele frequency and log-transformed R ratio of all SNPs were exported 
to the program PennCNV to confirm CNVs. The two sets of results were compared and 
only CNVs detected by both algorithms were included in the final results (Supplementary 
Fig. 4). Only specimens with no signs of chromosomal or large-scale genomic 
abnormalities were considered for the study.  
 
4.3. Corroborating and refining ethnic background from genotypes  
Ethnicity of donors was reported by next of kin. However, in the majority of prenatal and 
some postnatal cases the ethnicity of the father was not available. For this reason, the 
ethnic background was corroborated and refined by comparing SNP analysis of each 
individual to SNP data available in HapMap III. The whole allele frequency dataset of the 
following ethnic populations was downloaded from HapMap III 
(ftp://ftp.ncbi.nlm.nih.gov/hapmap/frequencies/2010-08_phaseII+III/): (1) Utah residents of 
Eastern and Western European descent (CEU); (2) Toscani in Italy (TSI); (3) Yoruba, in 
Ibadan, Nigeria (YRI); (4) African ancestry in Southwest USA (ASW); (5) Luhya in 
Webuye, Kenya (LWK); (6) Maasai in Kinyawa, Kenya (MKK); (7) Chinese in Metropolitan 
Denver, Colorado (CHD); (8) Japanese in Tokyo, Japan (JPT); (9) Mexican ancestry in 
Los Angeles, California (MEX) and (10) Gujarati Indians in Houston, Texas (GIH).  
A group of SNPs frequently expressed in some populations but rarely in others was first 
selected. The maximum allele frequency and minimum allele frequency in the 10 
populations were calculated for each SNP.  Population specific SNPs were defined as 
those for which the difference between the maximum and minimum allele frequency was 
greater than 0.6. These population-specific SNPs were cross-referenced against the SNPs 
identified by genotyping of our samples. Only the common set of SNPs was used in the 
following calculation.  
The common set of SNPs is designated as Si, where i is a variable value that represents a 
specific SNP. The genotype Gi of SNP Si could be AA, AB or BB, where A and B are two 
alleles for the SNP. The populations are designated as Pj, where j is a value of 1 through 
10 that represents a specific ethnicity, as defined above. The A-allele frequency of SNP Si 
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within population Pj is fij. For any individual in a specific population Pj, the probability of 
having the genotype Gi at SNP Si is: 
 
 
 
The log-transformed likelihood function (Lj) that describes the probability of any individual 
from population Pj having exactly the same genotypes as the analyzed samples at a 
specific set of SNPs would be: 
 
 
 
Therefore, the log-transformed likelihood ratio for population Pj compared to the reference 
population P0 is:    
 
 
The likelihood ratio for each population was used to assign ethnicity. “European Ancestry” 
was assigned to samples for which the two highest-score populations were CEU and TSI. 
“African Ancestry” was assigned if the four highest-score populations were YRI, ASW, 
LWK and MKK. “Asian Ancestry” was assigned if the three highest-score populations were 
JPT, CHD, and GIH. “Hispanic Ancestry” was assigned if the highest-score population was 
MEX. “Mixed” was assigned as the default ancestry if none of the above conditions could 
be met. 
 
5. RNA Isolation, Exon Array Processing, and Quality Assessment 
5.1. RNA extraction 
A bead mill homogenizer (Bullet Blender, Next Advance) was used to lyse the pulverized 
tissue. Each pulverized tissue sample was transferred to a chilled safe-lock 
microcentrifuge tube (Eppendorf). A mass of chilled stainless steel beads (Next Advance, 
cat# SSB14B) equal to the mass of the tissue was added to the tube. Two volumes of 
Buffer RLT Plus (Qiagen) were added to the tissue and beads. Samples were mixed in the 
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Bullet Blender for 1 min at a speed of six. Samples were visually inspected to confirm 
desired homogenization and then incubated at 37 °C for 5 min. Buffer RLT Plus was 
added up to 0.6 ml, and samples were mixed in the Bullet Blender for 1 min. Total RNA 
was extracted using a non-phenolic procedure (RNeasy Plus Mini Kit, Qiagen), followed 
by DNase treatment (TURBO DNase, Ambion) as per manufacturers’ instructions. Optical 
density values of extracted RNA were measured using a NanoDrop (Thermo Scientific) to 
confirm an A260:A280 ratio above 1.9. RIN was determined for each sample using 
Bioanalyzer RNA 6000 Nano Kit or Bioanalyzer RNA 6000 Pico Kit (Agilent), depending 
upon the total amount of RNA.  
 
5.2. Exon array hybridization  
Exon array hybridizations were performed at the Yale Center for Genome Analysis and at 
Gene Logic Inc. (Gaithersburg, MD). Reverse transcription (RT) was performed to 
generate cDNA from total RNA using RT primers designed using an oligonucleotide 
matching algorithm. For the selective cDNA synthesis, the Ambion WT Expression kit 
(Ambion) was used in combination with the GenechipWT Terminal Labeling and Controls 
Kit (Affymetrix) for target preparation, according to manufacturer recommendations. PolyA 
controls were added to the input RNA to measure efficiency of target amplification. 
Fragmented and labelled second cycle cDNA (5.5 µg) was added to a hybridization 
cocktail prior to loading of 200 µl onto individual Affymetrix Human Exon 1.0 ST arrays, 
which features comprehensive coverage of the human genome, with 1.4 million probe sets 
that assay exon expression across the entire transcript. Microarrays were hybridized at 45 
°C for 16–24 hours, washed and stained using an Affymetrix FS450 fluidics station, 
according to manufacturer recommendations. Microarrays were scanned on a GeneChip 
Scanner 3000 and visually inspected for hybridization artifacts. Exon chip analysis was 
performed using Affymetrix Power Tools 1.12.0. Probe level data was summarized into 
probe set level data using the Robust Multichip Average (RMA) background correction 
algorithm in combination with an R-script. The raw image files (.DAT files) were analysed 
using Affymetrix GeneChip Operating Software to generate .CEL files. 
 
5.3. Exon array quality assessments 
Several quality control measures were implemented throughout microarray sample 
preparation and transcriptome data generation steps (Supplementary Fig. 5) to reduce 
errors due to spatial artifacts on the chips, technical differences between chips in probe 
saturation, differences in the intensity of the probes along the 5’to 3’ gradient of genes, or 
due to other unaccounted batch effects. First, an idealized reference chip was constructed 
for all arrays hybridized at each facility by computing the 15% trimmed mean of the log2-
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transformed probe intensities for each of the 5.5 million perfect match probes across all 
arrays. Spatial artifacts were defined as severe non-random spatial patterns in the ratios 
of intensities of probes on one chip relative to corresponding probes on the ideal reference 
chip; such artifacts are believed to arise from non-uniform hybridization conditions across 
the surface of an array. By design, microarray probes are randomly distributed across an 
array to avoid spatial biases, i.e., probes that represent adjacent regions on the genome 
are not located physically adjacent on an array. Consequently, in the absence of spatial 
artifacts due to error sources in pre-processing steps, one would expect a random pattern 
of probes with higher or lower intensities relative to the reference chip. Supplementary 
Figure 6 shows ratio intensity plots for arrays with severe spatial artifacts. 
 In addition, exon array hybridization uniformity is estimated by gene expression 
uniformity from 5'-end to 3'-end (Supplementary Fig. 6c). Samples with altered 
hybridization uniformity and microarrays displaying regional biases or other spatial 
artifacts were excluded/or re-tested. Low-quality RNA samples identified by these quality 
control measures were excluded from further analysis (N=53). 
 To evaluate technical reproducibility and the possibility of batch effects, four identical 
samples were submitted to and processed at different testing centers. To evaluate 
biological reproducibility, we calculated the correlations between the same regions 
collected from different individuals of the same period. The correlations were high for both 
technical (Spearman correlation, r2 = 0.967; N=8 total) and biological replicates (r2 = 
0.926; 1,340 total), reinforcing the validity of our approach and data. 
The impact of confounding factors on the quantity, quality, and transcriptional profile of 
RNA was controlled for by computing correlations between gene expression and the 
following variables: PMI, pH, RIN, and DS. Of these factors, PMI and RIN showed a weak 
anticorrelation and correlation, respectively, with the number of expressed genes 
(Spearman correlation, r = -0.382 and 0.278, respectively; Supplementary Fig. 12), 
indicating that the collected tissue samples are suitable for profiling the transcriptome. 
 
5.4. Detection of outliers 
We used several approaches to identify outliers based on processed exon array samples. 
First, we performed average-linkage hierarchical clustering of all samples corresponding 
to different regions using 1-correlation as a distance and related them to the following 
variables: age, sex, ethnicity, PMI, DS, RIN, and the array processing site. These 
confounding factors for each sample were labeled by color. For the NCX, the expression 
and the RIN of areas from the same hemisphere of an individual were averaged. 
Hierarchical clustering revealed notable clustering of the samples based on age and 
regions (Supplementary Fig. 8). Out of 1,346 samples, 5 samples from the same brain 
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were found to be outliers based on hierarchical clustering and subsequently removed from 
further analyses.  
Second, the averaged Spearman’s correlation coefficient of a region/area was calculated 
for a period, and those samples with values outside 3 standard deviations (SDs) of the 
mean were considered as outliers. Individual samples or brain specimens identified as 
outliers by either hierarchical clustering (N=1 brain, 5 samples total) or correlation analysis 
(N=1 sample) were re-processed and/or excluded from the study. Finally, a total of 1,340 
exon microarray samples from 57 brains passed the quality control steps and were 
included in this study (Supplementary Tables 3 and 4). 
 
5.5. Exon array data pre-processing  
Partek Genomics Suite version 6.5 (Partek Incorporated, St. Louis, MO, USA) was used to 
normalize raw exon array data and to summarize expression of the probe set and 
transcript cluster. Affymetrix CEL files that passed QC analyses were imported into Partek 
Genomics Suite using the default Partek settings: RMA background correction58, quantile 
normalization, mean probe set summarization, and log2-transformation. All analyses 
reported used only the core and unique probe sets, which hybridize to unique genomic 
positions and are based on well-curated RefSeq (www.ncbi.nlm.nih.gov) and Ensembl 
transcripts (www.ensembl.org) as well as GenBank transcripts 
(http://www.ncbi.nlm.nih.gov/genbank/) annotated as complete protein-coding sequences. 
A total of 17,565 protein-coding genes were surveyed.  
 Datasets were annotated according to the UCSC human genome hg19 reference 
sequence (http://genome.ucsc.edu/cgi-bin/hgGateway). 105,271 core probes (within 
62,448 probe sets out of 230,918 core probe sets) contained SNPs defined in the probe 
group file HuEx-1_0-st-v2.r2-SNPs-Excluded.pgf provided by Affymetrix, which is based 
on the dbSNP database (version 129, April 2008) and SNPinprobe_1.0 database. As 
previously observed59,60, inclusion of SNP-containing probes can affect the hybridization of 
the probes and thus produce misleading signal intensity values. To test the effects of 
these SNP-containing probes, the gene and exon expression were evaluated twice, with 
one evaluation excluding SNP-containing probe sets by filtering out the affected probes 
that hybridized to regions with common SNPs (minor allele frequency (MAF) ≥ 0.05). The 
Pearson correlation analysis was performed to compare gene and exon expression levels 
of the data with and without SNP-containing probe sets. Almost all of the correlation 
coefficients (98.8%) for all 1,340 samples were within the range of 0.980-0.995 for genes 
and 0.975-0.995 for exons, suggesting that SNP-containing probe sets have a very 
minimal effect on measured expression levels (Supplementary Fig. 7). Nevertheless, we 
removed SNP-containing probe sets during the normalization step in the Partek program 
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to be control for SNP-related confounding effects. The median of all individual probe sets 
of one transcript cluster was used as the estimate of gene expression values. To filter out 
low expression signals (including noise or poorly hybridized probes), which may lead to 
false positives, detection above background (DABG) P-values of exon probe sets and 
transcript clusters were calculated using Affymetrix power tools (APT, 
http://www.affymetrix.com/partners_programs/programs/developer/tools/powertools.affx).  
 
6. Exon Array Data Analysis  
6.1. Gene-level analysis  
The expression level for all core and unique probe sets within an exon were averaged to 
obtain an expression value for the exon, and the median of all exons within one gene 
(transcript cluster) was used as the estimate of gene expression. To reduce the noise in 
the dataset and the false positives in the following differentially expressed genes and 
alternative exon usage investigations, we excluded genes with a log2-transformed 
expression value <6 in all 1,340 samples. We defined an “expressed” gene as a gene with 
a log2-transformed expression value ≥6 in at least one sample and mean detection above 
background (DABG) P<0.01 in one or more of the sampled brain regions or NCX areas 
during at least one time period. To demonstrate the underlying distribution of the data 
using these criteria to define expression, the signal intensity distribution plots of 
expressed, non-expressed gene, and intronic controls (designed from the intron regions of 
a set of housekeeping genes) are shown in Supplementary Figure 9.  
  
6.2. Multidimensional scaling (MDS)  
MDS analysis was performed by generating expression vector for all expressed genes for 
each of the analyzed samples. We calculated the Euclidean distance between each pair of 
vectors to obtain a distance matrix with dimension 1,340 x 1,340. The R function isoMDS 
was used to calculate two-dimension MDS. The returned two vectors were used as 
coordinates x and y for each of the 1,340 samples to make a scatter plot in a 2-dimension 
plane. The 1,340 data points, each representing one tissue/array sample, were plotted 
and colored according to the phenotype of the samples, such as time period, brain region, 
sex, ethnicity, or donor’s code (Supplementary Fig. 10). 
 
6.3. Principal component analysis (PCA) 
PCA from prcomp package and three-dimensional view from rgl package, both retrieved 
from R (http://www.r-project.org/), were used to identify and visualize the major 
contributors. They were both used to analyze the gene expression of 11 neocortical areas 
and 6 regions across 15 time periods from all 1,340 samples separately. The major 
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contributors will dominate the clustering of samples. Our results show that the samples 
were clustered by developmental periods and functional regions. Three different 
directional views are shown in order to visualize the clustering (Supplementary Fig. 11).   
 
6.4. Identification of spatial and temporal DEX genes  
Analysis of variance (ANOVA) was used to identify differentially expressed (DEX) genes 
across all regions of interest and during all periods (1-15). Genes that were differentially 
expressed in at least one brain region or NCX area were identified as spatial DEX based 
on ANOVA by using a region/area as an ANOVA factor. Genes differentially expressed in 
at least one time period were identified as temporal DEX based on ANOVA using a period 
as a factor. In order to exclude the possibility that variation in RIN scores and PMI within 
the acceptable range might influence procedures, we included PMI and RIN as technical 
covariates within our ANOVA model of differential expression. We found that RIN 
accounted for a mean variance of 2.16 in the spatial analysis for all genes, which was 8% 
of the mean total variance across genes, and a variance of 1.02 in the temporal analysis, 
which was 3% of the mean total variance of that analysis. We found that PMI accounted 
for a mean variance of 1.89 in the spatial analysis, which was 8% of the mean total 
variance, and a variance of 0.33 in the temporal analysis, which was 1% of the mean total 
variance of that analysis. Resulting P-values from ANOVA were corrected for multiple 
comparisons using the Benjamini and Hochberg false discovery rate (FDR) method62. A 
conservative statistical threshold (FDR <0.01 and minimum fold difference >2 between 
brain regions/areas or periods) was used to identify DEX genes. Genes that were not 
significantly expressed above background were excluded from ANOVA tests. 
To ensure that our results are robust and are not unduly influenced by any particular 
sample, we used a five-fold jackknife procedure. Samples were split into 5 random groups 
and re-analyzed for DEX genes 5 times by leaving out one group in each cycle of 
analysis. The genes from each of the five re-sampling showed a high rate of overlap with 
the genes obtained from the whole dataset (Supplementary Fig.13). 
    To identify spatially DEX genes that were selectively highly enriched or restricted in 
only one of the regions, irrespective of their temporal regulation, we used a combination of 
t-test and fold difference analyses. We limited this spatial DEX analysis to periods 3-15, 
when regions/areas of interest are defined using equivalent criteria and can be 
consistently followed across time. We used a sliding-window algorithm to detect regionally 
enriched genes within a group of sequential periods. The window size was set as 5, 
scanning periods 3-7, 4-8, 5-9, 6-10, 7-11, 8-12, 9-13, 10-14, 11-15. For each window, a 
two-sample t-test was applied to determine if the expression level of a gene in one 
selected region was significantly different from the expression level in the samples from 
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other regions. To calculate the fold difference in averaged signal intensity, two regions 
were used: the region of interest and, from the remaining regions, the one that had the 
highest averaged expression value. The P-values from the t-tests were transformed to 
FDR using the Benjamini and Hochberg method. A gene with greater than 2-fold 
differences in a given window was considered to be highly enriched in or restricted to one 
region. If the window contained both prenatal and postnatal periods or both postnatal and 
adult periods, a final step was performed in order to determine if the DEX genes should be 
assigned to one or both of the developmental groups. We calculated the fold difference 
attributed to the two periods bordering each side of the developmental groups (6-7 and 8-
9 for prenatal-postnatal group; 11-12 and 13-14 for postnatal adult group). If the fold 
difference was greater than 1.5, the DEX gene was assigned to that developmental group, 
resulting in either one or both groups being assigned the gene. 
 
6.5. Analysis of DEU  
To identify expressed genes that exhibit differential exon usage (DEU) across all regions 
of interest and during all periods, we used the splicing ANOVA method and the splicing 
index (SI) algorithm61. Normalized intensities (NI) were calculated as the expression of an 
individual exon relative to the expression of the gene. Splicing index was defined as the 
fold difference of the normalized intensity of exons between two groups (periods and/or 
regions). Both spatial DEU and temporal DEU were analysed. For spatial DEU, the 
ANOVA factor is set as the brain region/area. All periods were tested and the maximum of 
splicing indexes among regions was calculated. For temporal DEU, the ANOVA factor is 
set as the period. Sixteen regions/areas were tested, and the maximum of splicing 
indexes among periods was calculated. We included PMI and RIN as technical covariates 
within our ANOVA models testing alternative exon usage. Resulting P-values from 
ANOVA were corrected for multiple comparisons using the Benjamini and Hochberg FDR 
method62. To detect meaningful DEU, stringent criteria (FDR < 0.01 and maximum splicing 
index > 2) were used, and exons expressed at low levels or with low variance (standard 
deviation of exon expression level <0.5 in all samples, which indicates they are very likely 
to be saturated in all samples) were excluded.  
To test the robustness of our DEU, we used a five-fold jackknife procedure. Samples were 
split into 5 random groups and re-analyzed for DEU genes 5 times by leaving out one 
group in each cycle of analysis. The genes from each of the five re-sampling showed a 
high rate of overlap with the genes obtained from the whole dataset (Supplementary 
Fig.13). These analyses indicate that our findings are robust and did not depend on any 
particular sample. 
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6.6. Identification of sex-bias in DEX and DEU 
Genes differentially expressed (DEX) between males and females were identified by the 
combination of a sliding window algorithm, two-sample t-test, and fold difference analysis. 
The sliding-window algorithm was used to detect sex-specific gene expression differences 
within a group of sequential periods. The window size was set as 5, which ensured 
adequate representation of both sexes, and periods 2-6, 3-7, 4-8, 5-9, 6-10, 7-11, 8-12, 9-
13, 10-14, 11-15 were scanned. For each window, a two-sample t-test was applied to 
determine if the expression level of a gene in male samples was significantly different from 
the expression level in female samples in the same region. The P-values from the t-tests 
were transformed to FDR using the Benjamini and Hochberg method62. For each gene, 
the fold difference (log2-transformed) between male and female samples in each region 
was also calculated. A FDR cutoff of 0.01 and 2-fold difference were used as a cutoff to 
identify genes that are DEX between males and females in each window. If the window 
contained both prenatal and postnatal periods or both postnatal and adult periods, a final 
step was performed in order to determine if the differentially expressed genes should be 
assigned to one or both of the developmental groups. We calculated the fold difference 
attributed to the two periods bordering each side of the developmental groups (6-7 and 8-
9 for prenatal-postnatal group; 11-12 and 13-14 for postnatal-adult group). If the fold 
difference was greater than 1.5, the differentially expressed gene was assigned to that 
developmental group, resulting in either one or both groups being assigned the gene.  
Sex-bias in differential exon usage (DEU) was investigated by splicing index and two-
sample t-test. Each exon cluster is normalized by dividing its expression by the gene-level 
expression to yield a normalized intensity (NI). The splicing index is then calculated simply 
as a “fold change” between the normalized levels of each exon cluster from male and 
female samples. As in the sex-specific DEX analysis, the sliding window algorithm was 
also used. A FDR cutoff of 0.01 and 2-fold difference were used for sex-specific DEU. 
Exon clusters that were expressed at low levels (log2 intensity <6) or with low variance 
(standard deviation of exon expression level <0.5 in all 1,340 samples, which indicates 
they are very likely to be saturated in all samples) were excluded. Y chromosome genes 
were also excluded from the analysis. 
Analyses of sex-bias in DEX and DEU were performed without considering PMI and RIN 
as covariates because we did not find any significant differences of PMI and RIN values 
between female and male tissue samples. PMI, 12.01 ± 9.01 (N=31, mean ± SD) for 
males and 11.4 ± 8.09 (N=26, mean ± SD) for females; RIN, 8.86 ± 0.87 for males and 
8.79 ± 0.99 for females. 
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6.7. Weighted gene co-expression network analysis 
6.7.1. Dataset filtering  
Only samples from periods 3–15 were included in the weighted gene co-expression 
network analysis (WGCNA). During these periods, brain regions and NCX areas are well-
defined using equivalent criteria and can be consistently followed across time. NCX areas 
were not present in periods 1 and 2.  
 
6.7.2. Network construction and module detection  
To reduce noise, only genes with log2-intensity values greater than 6 in at least one 
sample and a coefficient of variance greater than 0.08 were used. A total of 9,093 genes 
fit these criteria. Signed weighted gene co-expression network analysis was performed 
using WGCNA R package65. General information about network analysis methodology and 
WGCNA software is available at 
www.genetics.ucla.edu/labs/horvath/CoexpressionNetwork. Pairwise Pearson correlation 
coefficients were calculated for all genes selected. The resulting Pearson correlation 
matrix was transformed into a matrix of connection strengths (an adjacency matrix) using 
a power function (connection strength = ), which was then converted to a 
topological overlap matrix. WGCNA seeks to identify modules of densely interconnected 
genes by hierarchical clustering based on topological overlap 62. The first principal 
component of each module was calculated and smoothed by smoothing spline against 
log10 (age in days). The top 50 genes expressing the highest within module connectivity 
were selected and exported to VisANT for network visualization66.  
 
6.7.3. Module filtering 
The grey module consisted of genes not assigned to any of the module was removed. To 
check the effects of RIN, PMI, dissection, and pH on module identification, we constructed 
a linear model PC1i = age i + region i + sex i + RIN i +PMI i + pH i + DS i (where PC1i, age i, 
region i, sex i, RIN i, PMI i, pH i, DS i, are the first principle component, log10 [days after 
conception], sex, RIN, PMI, pH and DS of sample i, respectively). ANOVA was then 
performed, and the coefficient of determination (r2) and P value of each factor was 
calculated.  The modules with r2 of any factor greater than 0.1 and r2 of any confounder 
(RIN, PMI, pH and DS) larger than the largest r2 of the main factors (age, region and sex) 
were considered as modules corresponding to confounders. Five modules were detected 
as confounder-related modules and removed from further analysis. 
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6.7.4. Comparison of modules with transcriptional profiling of neurobiological 
categories 
To gain insight into module functions, we compared each module with our manually 
created functional gene lists for specific neurobiological categories. The correlation 
between module eigengene (the first principle of module expression) and the PC1 
summarization of each functional gene list was calculated and listed in Supplementary 
Table 10.  
 
6.8. Gene ontology (GO) enrichment analysis 
Functional enrichment was assessed using DAVID Bioinformatics Resources 6.763,64 
(http://david.abcc.ncifcrf.gov/).  
 
6.9. Creation of gene lists for and transcriptional profiling of neurobiological 
categories 
We manually curated lists of genes functionally related to specific neurodevelopmental 
processes, neural cell types, and neurotransmitter systems, by selecting individual genes 
or a small group of genes from the existing gene ontology (GO) database 
(http://www.geneontology.org/) whose functions, and thus expressions, have been most 
closely associated with specific neurobiological category based on published data from 
model organisms and human medical genetics. We expected that the selected genes or 
gene group may accurately reflect the trajectories of neurobiological processes in 
neurodevelopment.  To summarize the principle gene expression profile of each category, 
PCA was performed. The resulting first principal component (PC1) was plotted against 
logarithmic age in days, and a smooth curve was fitted by smoothing spline to display the 
developmental trajectories. For categories with only one gene, the expression level was 
used as PC1 (Supplementary Table 12 and data available on the website).  
We also curated gene lists for neurotransmitter systems by compiling genes encoding 
critical enzymes for transmitter synthesis and receptor subunits. To compare the 
spatiotemporal patterns of genes in the same group, we plotted genes in each group 
individually and fitted the individual gene expression pattern by smoothing spline. Each 
group has 6 plots, one for each region (Supplementary Table 12 and data available on the 
website). 
To test the accuracy of this strategy, three gene expression trajectories (DCX, dendrite 
development genes, synapse development genes) were compared with independently 
generated, non-transcriptome datasets for DCX-positive cell density, synaptic density, and 
the number of basal dendrites in the corresponding brain regions/areas, respectively 
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(Figure 5). The independent data were scaled by  . µ and σ are the mean and the 
standard deviation of values, respectively, corresponding to the time periods for which 
both our gene expression and the independently generated data were available. Our 
scaled gene expression data were used to generate a spline curve, and the predicted 
values on this curve were calculated corresponding to available time points of previously 
generated independent data on DCX, dendrite development, and synaptogenesis, which 
used samples at different time points but within our defined periods. We then calculated 
the correlation coefficient between our predicted data and the actual values.  
To compare the developmental trajectories for cell proliferation, neuron migration, dendrite 
development, myelination and synapse development gene markers, PC1 of each group 
was subjected to smoothing spline curve fitting. The fitted value  was then scaled to 0 to 
1. The range of fitted vector  is set to 1, and the scaled values were calculated as 
 . The scaled values were then plotted to represent the 
trajectory of each group with a measure of the percentage of changes. 
To select genes potentially associated with the neurodevelopmental processes and neural 
cell types, the top 100 genes positively correlated with PC1 of each functional gene list 
were presented in Supplementary tables 13 and 14. 
 
6.10. Expression trajectories and gene correlations for ASD- and schizophrenia-
associated genes  
A list of genes commonly associated with autism spectrum disorders (ASD) was obtained 
from recently published reviews10,67 and relevant databases (www.g2conline.org). A list of 
genes commonly associated with schizophrenia was obtained from meta-analysis list68 
and relevant databases (www.szgene.org/topresults.asp; www.g2conline.org). In the 
szgene database list, genes with an assigned overall grade A, which indicates the 
highest/strictest association, were included in the analysis. Lists of genes for the two 
disorders and other correlated transcripts are provided in Supplementary Tables 15 and 
16. 
To generate representations of the dynamics in spatiotemporal expression of 
representative genes (CNTNAP2, MET, NLGN4X, NRGN), a heat map matrix was created 
for each of these genes according to the following method. For each combination of 
developmental period and brain region/area, the log2-transformed expression level values 
of related samples were averaged to obtain a single value of expression level at the 
specific period and specific region/area. All of these average values were collected into a 
data matrix, where each row represented one brain region/area and each column 
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represents one period. After the matrix was created, a heat map plot was created using R 
function ‘heatmap.2’ in package ‘gplots’ (Supplementary Figure 25).   
The top 50 genes, ranked by their correlation with individual genes previously associated 
with ASD and schizophrenia, are presented in Supplementary Table 15 and 16. Genes 
with the highest correlation to the disease-related genes were grouped, and subjected to 
functional enrichment assessment using DAVID Bioinformatics Resources 6.7 
(http://david.abcc.ncifcrf.gov/). 
 
7. Transcriptome Validation Methods  
7.1. Quantitative real time RT-PCR and semi-quantitative RT-PCR 
An aliquot of the total RNA that was previously extracted from each brain region was used 
for secondary validation through real-time PCR analysis. One µg of total RNA was used 
for cDNA synthesis using SuperScript III First-strand synthesis Supermix (Invitrogen) and 
subsequently diluted with nuclease-free water to 1 ng/µl cDNA. Gene-specific high-melting 
temperature primers for genes of interest were designed using NCBI/Primer-BLAST 
(http://www.ncbi.nlm.nih.gov/tools/primer-blast/) and expressed sequence information 
obtained from GenBank (NCBI). PCR reactions were conducted on an ABI 7900 
Sequence Detection System (Applied Biosystems) using a hot start SYBR-green based 
method (Fast SYBR Green Master Mix, ABI) followed by melt curve analysis to verify 
specificity of the product. The Ct value (cycle number at threshold) was used to calculate 
the relative amount of mRNA molecules. The Ct value of each target gene was normalized 
by subtraction of the Ct value from housekeeping genes to obtain the ΔCt value. The 
relative gene expression level was shown as 2-ΔCt or -ΔCt. All human genes of interest 
were normalized to the housekeeping gene GAPDH. Semi-quantitative RT-PCR was 
performed using the same template and hot start Taq DNA polymerase (Qiagen) under 
the following conditions: activation at 95 ºC for 10 min, followed by 30–40 cycles at 94 °C 
for 30 sec, 56 °C for 30 sec, 72 ºC for 60 sec, and extension at 72 ºC for 10 min.  The 
cycling conditions were chosen so that none of the templates analyzed reached a plateau 
at the end of the thermal cycling, i.e., they were in the exponential phase of amplification.  
PCR products were separated on a 2% agarose gel and photographed using UV 
illumination to visualize ethidium bromide staining. Images were inverted in Adobe 
Photoshop. 
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7.2. List of PCR primers used in this study 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Gene Forward primer (5' ->3') Reverse primer (5' ->3') 
GAPDH TTCTTTTGCGTCGCCAGCCGA GTGACCAGGCGCCCAATACGA 
HDAC2 TGGCCGGGGAGCCCATGG GGCAGTGGCTTTATGGGGCCTATAT 
TF CGGAAGATGAGGCTCGCCGT TGCTCCGACACTGCACACCA 
RGS16 TGGCAAGTTCGAGTGGGGCA GGAAAGCGTGGAAGGCAGCCA 
GABRA6 TTTGGGCCCGTGTCAGATGTGG GGTGTCAGGCGTCCAGATTTTACTG 
RGS9 GGACTACGGCCTGGACCGAGT ACAATCCCTCCCAGGGACACAGA 
PCDH11Y GGCCTGCCCCTTGGCTATCC GGCCTCTTCCACAGTTGGTTGAACA 
ANKRD32a TGTTTGTTGCAGAGGCAGTC GACCCAAGCACACCAGTTTT 
ANKRD32b ACTAGGGGAGACAATGCCTGT CCCACCAATCCATACTGCTT 
NLGN4X (exon 7) TGAGACTCACAGGCGCCCCA CGTGTGCCTGCAGCGACTCA 
NLGN4X (3’UTR) CCCTCTGCCCTACCCGCTCA GCCGGGATGGGATGACTGCC 
GLIPR1L2 CCTGGCAGTAGGGGGCGTTT TCCCAAGTCATGAAGCGCAAGTTAG 
Rpl32 CAACATCGGTTATGGGAGCAACA TGACATTGTGGACCAGGAACTT 
Ankrd32a CAGGGCCCCACTAGTACGTGC AGCTCTGGCCGACCTTCTGCT 
Ankrd32b GGCATGGGTCCAGACCTTCTAGTT GCGTCCAGCCAGCATTGTCTT 
   IGF2 Hs00171254_m1 (Applied Biosystems)   
GAPDH Hs99999905_m1 (Applied Biosystems)   
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7.3. Immunohistochemistry and histochemistry 
For neuropathological evaluation and validation studies, brain tissue samples were fixed in 
4% PFA for 2–3 days at 4 °C. Following fixation, tissue was cryoprotected in graded 
sucrose solutions (up to 30%) at 4 °C, then frozen at -40 °C in 2-methylbutane (J.T. 
Baker), and stored at -80 °C. Alternatively, fixed tissue samples were paraffin-embedded 
for routine neuropathological evaluations.  
Frozen tissue samples were cut at 60 µm using a Leica CM3050S cryostat and either 
mounted onto Superfrost/Plus slides (Fisher Scientific Co.) or used free-floating. Tissue 
sections were incubated in 1% hydrogen peroxide/PBS to quench endogenous peroxidase 
activity. Sections were washed in PBS (3 x 15 min) and incubated in blocking solution 
containing 5% (v/v) normal donkey serum (Jackson ImmunoResearch Laboratories), 1% 
(w/v) bovine serum albumin, and 0.4% (v/v) Triton X-100 in PBS for 1 h at room 
temperature. Primary antibodies were diluted in blocking solution and incubated with 
tissues sections overnight at 4 °C. Sections were washed with PBS (3 x 15 min) prior to 
being incubated with the appropriate biotinylated secondary antibodies (Jackson 
ImmunoResearch Labs) for 1.5 h at room temperature. All secondary antibodies were 
raised in donkey and diluted at 1:200 in blocking solution. Sections were subsequently 
washed in PBS and incubated with avidin-biotin-peroxidase complex (Vectastain ABC 
Elite kit; Vector Laboratories) for 1 h at room temperature. Finally, sections were washed 
in PBS (3 x 15 min) and signals were developed using a DAB peroxidase substrate kit 
according to the manufacturer’s protocol (Vector Laboratories). Following washes in PBS, 
sections were mounted on Superfrost Plus charged slides, dried, dehydrated, and cover 
slipped with Permount (Fisher Scientific Co.). Sections were digitized using ScanScope 
scanner (Aperio). Digitized images were assembled in Adobe Photoshop and Illustrator.  
NADPH-diaphorase histochemistry was performed as previously described69. 
 
8. Dissection of the Mouse Neocortex 
We performed qRT-PCR in orthologous areas of the mouse NCX at equivalent 
developmental periods using a mathematical model to translate neurodevelopmental time 
across mammalian species70 (www.translatingtime.net). For analysis of mouse Ankrd32 by 
qRT-PCR, CD1 mice were obtained from Charles River Laboratories. Mice were sacrificed 
according to institutional regulations. Brains from embryonic day (E)15, postnatal day (P) 3 
and adult mice (3 brains per period) were dissected either fresh in cold PBS or after 
storage of the whole brain in RNAlater reagent (Qiagen). Dissected regions were sampled 
according to the “Prenatal Mouse Brain Atlas” (for E15 mouse brain) and “Atlas of the 
Developing Mouse brain” (for P3 and adult mouse brain)71,72. The following regions were 
dissected: 
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E15:  
MFC – sampled from medial part of the frontal cortex.  
DLFC – sampled from dorsolateral part of frontal cortex (containing prospective primary 
motor cortex). 
S1C – sampled from anterior part of parietal cortex. 
A1C – sampled from prospective primary auditory cortex (upper part of prospective 
temporal cortex). 
V1C – sampled from occipital part of the hemisphere. 
  
P3 and adult:  
OFC – sampled from orbital part of the frontal cortex after removal of olfactory bulb 
(containing VO and LO areas according to Paxinos et al.). 
MFC – sampled from medial part of the frontal cortex (containing PrL and IL areas 
according to Paxinos et al.). 
M1C – sampled form the dorsal part of the frontal cortex (containing M1 and M2 areas 
according to the Paxinos at al.). 
S1C – sampled from the rostral part of the parietal cortex (containing all S1 area 
subdivisions according to Paxinos et al.). 
A1C – sampled from the upper part of the temporal cortex (containing AuD, Au1 and AuV 
areas according to Paxinos et al.). 
V1C – sampled from the occipital part of the hemisphere (containing V1, V2ML, and V2L 
areas according to Paxinos et al.). 
 
RNA extraction of P3 and adult samples was performed following the same protocol used 
for human tissue samples (see Supplementary Information 5.1). Due to the small amount 
of tissue for E15 samples, a Trizol (Invitrogen) extraction protocol was performed 
according to manufacturer’s instructions. Eighty ng of total RNA was used for cDNA 
synthesis, and quantitative RT-PCR was performed and analyzed as the same method 
with human brain samples. Ct values were normalized to the housekeeping gene Rpl32. 
Three technical replicates were performed on each sample. 
 
9. Expression Quantitative Trait Loci Analysis 
The genotyping results consisted of 2.5 million SNPs for each of 57 brains using Illumina 
Omni-2.5 SNP arrays. We used PLINK to calculate the minor allele frequency (MAF), 
Hardy-Weinberg p-value and SNP-wise call rate for each SNP. The eQTL analysis was 
restricted to 890,000 SNPs that had MAF > 0.1, Hardy-Weinberg p-value > 0.05, and 
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SNP-wise call rate greater than 0.99 in order to reduce genotyping errors and increase 
statistical power. The analysis was further restricted to SNPs within 10 kb of the 
transcription start or stop sites of the 15,132 expressed genes. 
The expression data in 11 NCX areas were averaged to get a single expression value in 
NCX for each gene, and cis-eQTL analysis was conducted separately for each region as 
described below. We adjusted for other non-genetic factors impacting gene expression 
measures in two ways. First, our phenotype was the expression level relative to the 
average developmental trend for each gene (see below); this allowed us to focus on the 
individual variation independently of the developmental trends. Second, we included 
possible confounding factors as covariates in our linear model for relative expression; 
these covariates included RIN, PMI, sex, the first two principal components of the global 
transcriptome, and ethnicity. 
In order to compare individual differences in single gene expression across 
developmental time points, we adjusted the expression values as follows. For each gene, 
we sorted the expression values in 57 brains according to their age and fitted a smooth 
function (computed by local regression or LOWESS) to obtain the average expression 
levels over development stages. We calculated a relative expression level by subtracting 
the value of this trend curve from the normalized individual gene expression value.  
After separating genes and SNPs by chromosome, PLINK was used to conduct a quick 
scanning for possible associations between all genes and SNPs near the beginning and 
end of the gene as described above with the following arguments:  'plink --file myfile --
pheno expression.txt --all-pheno --assoc --pfilter 1e-3 '. Using these phenotypes, we ran 
linear regression using PLINK with following settings: “plink --file selectfile --pheno 
select_expression.tx --sex --all-pheno --covar covariants.csv --covar-name PC1, PC2, 
PMI, RIN, Cauc, Afric, Asia, Hisp --linear --pfilter 1e-3”. 
A conservative two-level strategy was applied for multi-test correction. We performed a 
Bonferroni correction for all tests involving the same gene to obtain a gene-wise adjusted 
p-value for the SNP with the lowest p-value. We estimated the genome-wide q-value 
(FDR) for all 15,132 genes according to the Benjamini-Hochberg formulation, employing 
the R function p.adjust. We selected those genes and SNPs with q-value less than 0.1 for 
our final list of detected cis-eQTLs. 
 In order to check the distribution of SNP distance from either a RefSeq annotated 
transcription start site (TSS) or transcription end site (TES) of the associated gene for all 
SNPs that passed gene-wide correction without genome-wide correction, we tested all 
SNPs within 1Mb of TSS and TES and then used Bonferroni correction to obtain the gene-
wide adjusted p-value. Those SNPs with gene-wide p-value <0.05 were collected and their 
distances from TSS and TES were calculated.  
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10.  Supplementary Tables 
Supplementary Tables are provided in a single Microsoft Excel file on the CD rom. 
 
Supplementary Table 1. Donor/specimen metadata  
This table summarizes donor information, including sex, age, ethnicity, pH, PMI, cause of 
death, and medical history for each human brain subject. Brain tissue was obtained from 
clinically normal donors and multiple brain specimens per period were analyzed to reduce 
the effects of individual variation. Demographic and quality control characteristics were as 
follows: age, 5.7 post-conceptual weeks (PCW) to 82 years (Y); sex, 31 males and 26 
females; PMI, 12.11±8.63 (mean±SD) hours; pH, 6.45±0.34 (mean±SD). 
 
Supplementary Table 2. List of CNVs per specimen 
Complete list of predicted copy number variations (CNVs) in each individual donor. 
Putative CNVs were predicted by two different algorithms (cnvPartition in GenomuStudio 
and PennCNV) using SNP intensity data generated by Illumina Human Omni 2.5-Quad 
Bead Chips. After validation of genomic normality, 57 brains were used in the 
transcriptome analysis. 
 
Supplementary Table 3. Tissue sample metadata 
This table summarizes quality control data for individual tissue samples, including RNA 
integrity number (RIN) and tissue dissection score (DS). Averaged RIN for each sample 
was 8.83±0.93 (mean±SD), and only those with a RIN above 5 and DS above 2 were 
processed for exon array analysis. 
 
Supplementary Table 4. List of exon array CEL files  
List of all exon array CEL files that passed the quality control steps throughout microarray 
cDNA preparation, hybridization, and outlier detection (Supplementary Information 5). A 
total of 1,340 samples were considered in downstream analyses.  
 
Supplementary Table 5. List of region-enriched DEX genes  
This table shows spatially DEX genes that were enriched in or restricted to only one of the 
regions (region-enriched genes). Using a combination of a sliding window algorithm and 
two-sample t-test, region-enriched DEX genes were analyzed within the periods of 3-7, 4-
8, 5-9, 6-10, 7-11, 8-12, 9-13, 10-14, 11-15, respectively. The fold differences were 
calculated by comparing the gene expression value from one region of interest with 
another region that showed the second highest expression value. A gene with greater 
than 2-fold differences in a given window was considered to be region-enriched. The post 
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hoc group assignment analysis was performed by calculating the fold differences 
attributed to the two periods bordering each side of the developmental groups (6-7 and 8-
9 for prenatal-postnatal group; 11-12 and 13-14 for postnatal adult group). If the fold 
difference was greater than 1.5, the gene was assigned to that developmental group, 
resulting in either one or both group(s) being assigned. 
 
Supplementary Table 6. Tukey’s pairwise analysis of human and mouse ANKRD32 
isoforms  
The Tukey’s pairwise comparison was performed after ANOVA to determine which pairs of 
NCX areas were significantly different from each other. The TukeyHSD function in R was 
used to calculate the gene expression mean difference and corresponding p-value. 
 
Supplementary Table 7. List of sex-biased DEX genes 
Differentially expressed genes between males and females were analyzed by a 
combination of a sliding window algorithm and t-test. The window size was set as 5 in 
order to ensure adequate representation of both sexes, and periods 2-6, 3-7, 4-8, 5-9, 6-
10, 7-11, 8-12, 9-13, 10-14, 11-15 were examined. For each window, a two-sample t-test 
was applied to determine the sex-biased genes in the same region (cutoff of FDR 0.01 
and 2-fold difference). The post hoc group assignment analysis was performed by 
calculating the fold differences attributed to the two periods bordering each side of the 
developmental groups (6-7 and 8-9 for prenatal-postnatal group; 11-12 and 13-14 for 
postnatal-adult group). If the fold difference was greater than 1.5, the gene was assigned 
to that developmental group, resulting in either one or both group(s) being assigned the 
gene. 
 
Supplementary Table 8. List of sex-biased DEU genes 
Genes with differential exon usage between males and females were analyzed by a 
combination of splicing index and two-sample t-test under a sliding window algorithm. The 
window size was set as 5 in order to ensure adequate representation of both sexes, and 
periods 2-6, 3-7, 4-8, 5-9, 6-10, 7-11, 8-12, 9-13, 10-14, 11-15 were examined. For each 
window, exon cluster expression was normalized by dividing its gene-level expression. 
The splicing index was then calculated as a “fold change” between the normalized levels 
of each exon cluster to determine the sex-specific DEU (cutoff of FDR < 0.01 and 2-fold 
difference). 
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Supplementary Table 9. Co-expression network modules  
List of 29 modules corresponding to spatiotemporal patterns identified by weighted gene 
co-expression network analysis (WGCNA) with its functional interpretation, list of hub 
genes, and result of gene ontology analysis performed by DAVID algorithm. Top 10 hub 
genes are listed for each module, though some consist of less than 10 due to small 
module sizes. Two large modules (M20; 3,287 genes and M2; 2,745 genes) appeared to 
be simultaneously co-regulated across all regions with opposite developmental trajectories 
(Supplementary Figs 21 and 22). In addition to the predominant temporal patterns, region-
specific modules were also identified, such as M9 (MD), M19 (CBC), M23 (STR). Several 
modules exhibited no obvious spatiotemporal expression patterns but were enriched in 
genes associated with cell cycle (M1), cytoskeleton (M3), olfactory receptors (M13), and 
sex-specific transcription (M22). 
 
Supplementary Table 10. Correlation between network modules and neurobiological 
categories  
The correlation coefficient was calculated between each network module and functional 
gene group of specific neurobiological categories. Manually generated annotations for 
various functional groups and consisting gene list are also provided in Supplementary 
Table 12. The first principle component of each module expression (eigengene by 
WGCNA analysis) and each gene group were applied for correlation coefficient 
computation. Notably, M8 module (high in prenatal NCX, HIP, and AMY) showed strong 
correlation with layer 2 to 6 cortical glutamatergic neurons, while M15 module (high in 
postnatal NCX, HIP, AMY, and STR) showed strong correlation with dendrite 
development, synapse development, glial cells (astrocytes, myelination, and 
oligodendrocytes), GABA shift, and certain cortical GABA cell types. Also, M20 module 
(high in prenatal) showed strong correlation with cell proliferation, neuron differentiation, 
neuron migration, and cortical deep layer glutamatergic neurons, while it shows strong 
anti-correlation with synapse development, dendrite development, glial cells (astrocytes, 
microglia, oligodendrocytes, and myelination), GABA shift, and certain cortical GABA cell 
types. On the contrary, correlation of M2 module (high in postnatal) showed opposite trend 
with these functional groups.   
 
Supplementary Table 11. Correlation between network modules and confounders 
This table shows correlation between network modules and all the factors associated with 
the samples, including possible confounders (RIN, PMI, pH, and DS). To check the effects 
of RIN, PMI, pH, and dissection on module identification, the coefficient of determination 
(r2) and P value was calculated after constructing a linear ANOVA model.  The modules 
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with r2 of any factor greater than 0.1 and r2 of any confounder (RIN, PMI, pH, and DS) 
larger than the largest r2 of the main factors (age, region and sex) were considered as 
modules corresponding to confounders. Five modules were detected as confounder-
related modules and removed from further analyses. One module (grey), consisting of 
genes not assigned to any other module, was also removed. 
 
Supplementary Table 12. Gene lists for neurobiological categories 
List of the manually generated gene group annotations for various neurobiological 
categories. We summarized the gene list into three major categories: neurodevelopmental 
processes, neural cell types, and major neurotransmitter systems. Each category was 
classified into functional groups and subgroups based on existing GO categories 
(www.geneontology.org) and published data from model organisms and human medical 
genetics. 
 
Supplementary Table 13. Genes correlated with genes involved in 
neurodevelopmental processes 
The correlation coefficient was calculated between each functional gene group involved in 
specific neurodevelopmental processes and all genes expressed. The first principle 
component of each gene group was computed against each gene expression level. Top 
100 genes are listed. 
 
Supplementary Table 14. Genes correlated with genes expressed in specific neural 
cell types 
The correlation coefficient was calculated between each functional gene group involved in 
specific neural cell types and all genes expressed. The first principle component of each 
gene group was computed against each gene expression level. Top 100 genes are listed. 
 
 
 
Supplementary Table 15. Transcripts correlated with ASD-associated genes 
This table shows the top 50 correlated transcripts with autism spectrum disorder (ASD) 
related genes, which were compiled from recent reviews and relevant databases 
(Supplementary information 6.10). Correlation coefficient (r2) was calculated between the 
expression level of each gene and all transcripts expressed. Functional annotation 
suggested that these genes were predominantly associated with phosphoprotein 
(Bonferroni-adjusted P=1.3 × 10-30), synapse (Bonferroni-adjusted P=9.1 × 10-30), synaptic 
transmission (Bonferroni-adjusted P=5.8× 10-26), cell junction (Bonferroni-adjusted P=1.5 × 
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10-20), neuron projection (Bonferroni-adjusted P=3.4 × 10-19), and ionic channels 
(Bonferroni-adjusted P=3.8 × 10-17). 
 
Supplementary Table 16. Transcripts correlated with schizophrenia-associated 
genes 
This table shows the top 50 correlated transcripts with schizophrenia related genes, which 
were compiled from recent meta-analyses and relevant databases (Supplementary 
information 6.10). Correlation coefficient (r2) was calculated between expression level of 
each gene and all transcripts expressed. Functional annotation suggested that these 
genes were mainly associated with glycoprotein (Bonferroni-adjusted P=1.5 × 10-16), 
plasma membrane (Bonferroni-adjusted P = 1.5 × 10-12), ionic channel (Bonferroni-
adjusted P=2.6 × 10-9), synaptic transmission (Bonferroni-adjusted P=3.8 × 10-7), and 
phosophoprotein (Bonferroni-adjusted P=5.3 × 10-7). 
 
Supplementary Table 17. Regional cis-eQTLs 
This table shows cis-eQTL within 10kb flanking two ends of the target gene, detected in 6 
brain regions (NCX, HIP, AMY, STR, MD and CBC). Rows in red are eQTLs with genome-
wide FDR < 0.1, rows in black are eQTLs with genome-wide FDR < 0.2. SNP count is the 
number of local SNPs tested for the gene. MAF is minor allele frequency in our dataset. 
HWE p-value is the Hardy-Weinberg-Equilibrium test p-value of our genotyping result. 
Number of BB calls is the number of individuals with genotype of homozygous minor 
allele. WALD p-value is the original association p-value calculated by PLINK. Covariants 
p-value is the WALD p-value with co-factors of RIN, PMI, sex, ethnicity, and first two 
principle components. Gene-wide p-value was calculated from the original WALD p-value 
after Bonferroni correction by number of local SNPs. Permutation p-value was calculated  
from label-swapping adaptive permutation by PLINK with maximum of 1,000,000 times. 
FDR p-value was calculated from the Gene-wide p-value after genome-wide FDR 
correction. 
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11.  Supplementary Figures  
 
Supplementary Figure 1 | Demarcation of adult brain regions and NCX areas. a-c, 
Representative adult human brain images from period 14 are shown illustrating the 
 78 
sampling locations depicted on the lateral (a) and medial (b) surfaces of the hemisphere 
and the dorsal surface of the cerebellar hemisphere (c). Relative sizes of the sampled 
regions of interest are depicted on coronal slices (c, L2 – L15) of the left cerebral 
hemisphere. Red lines in (a) and (b) represent locations of coronal sections. The posterior 
side of the slice is shown, and the average section thickness is 1 cm. Brain regions and 
NCX areas of interest are represented by different colors and two or three letter 
abbreviations (for full names see section 2.2 of the Supplementary Information). A1C* is 
located on the temporal bank of the lateral sulcus (i.e., planum temporale and transverse 
gyrus of Heschl), and cannot be observed on the lateral view of the hemisphere; for 
illustrative purposes only, relative size and position of the A1C* was depicted on the 
lateral surface. The dotted line and asterisk (L2) depict an artifact during tissue 
processing. For detailed sampling procedures see section 2.2 of the accompanying 
Supplementary Information. These images were generated using fixed brain specimens 
not used to generate transcriptome data. 
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Supplementary Figure 2 | Demarcation of fetal brain regions and NCX areas. a-c, 
Representative fetal human brain images from period 6 are shown illustrating the 
sampling locations of tissues used for transcriptome analysis. Relative positions of the 
regions of interest are depicted on the lateral (a) and medial (b) surfaces of the 
hemisphere and the dorsal surface of the cerebellar hemisphere (c). Relative sizes of the 
sampled regions of interest are depicted on coronal slices (c, L1 – L7) of the left cerebral 
hemisphere. Red lines in (a) and (b) represent locations of coronal sections. The posterior 
side of the slice is shown, and the average section thickness is 0.5 cm.  Regions of 
interest are represented by different colors and two or three letter abbreviations (for full 
names see section 2.2 of the Supplementary Information). In total, 16 regions of interest 
were sampled as follows: 5 regions from the frontal lobe cortex (OFC, DFC, VFC, MFC 
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and M1C), 2 regions from the parietal lobe cortex (S1C and IPC), 4 regions from the 
temporal lobe cortex (A1C, STC, ITC and HIP), 1 region from the occipital lobe cortex 
(V1C), 3 regions from subcortical structures (MD, AMY and STR) and 1 region from the 
cerebellum (CBC). Sampled regions of interest always contained cortical plate and part of 
the underlying subplate zone. For detailed sampling procedures see section 2.2 of the 
Supplementary Information. These images were generated using fixed brain specimens 
not used to generate transcriptome data. 
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Supplementary Figure 3 | Histological evaluation and dissection of NCX areas. a, 
Nissl staining was used to validate the following NCX areas: OFC, DFC, VFC, MFC, M1C, 
S1C, IPC, A1C, STC, ITC, and V1C. Sampling from fetal (period 6) and adult (period 14) 
specimens was carried out according to the methods and criteria used for the dissection of 
exon array samples. Staining in fetal NCX areas revealed densely packed neurons in the 
cortical plate (CP) with no obvious distinctions among cortical layers. The marginal zone 
(MZ) and subplate (SP) were present in the fetal samples. Conversely, adult NCX neurons 
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were at a lower density and were arranged in layers (L1–L6) containing neurons of distinct 
size and shape (e.g., L5-specific Betz cells in M1C; arrow). The adult cortical layers had a 
greater thickness than the fetal cortical plate, and white matter (WM) was apparent below 
the laminar pattern. Scale bars, 250 µm. b, c,  Nissl staining images of the fetal (b, period 
6) and adult (c, period 14) VFC are shown to illustrate the microscopic boundaries of the 
NCX tissue sampled for transcriptome analysis. In the fetal brains (b), the entire cortical 
plate (L1–L6) and adjacent subplate zone was sampled. In the adult brains (c) all six 
cortical layers (L1–L6) and underlying gyral white matter were sampled. Dotted lines in (b) 
and (c) represent dissection boundaries. These three images were generated using fixed 
brain specimens not used for the exon array analysis. 
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Supplmentary Figure 4 | Demographics, genotyping, and RNA integrity of analyzed 
brain specimens. a, Sex distribution of specimens. b, Ethnicity distribution of specimens 
according to SNP genotypes. c, Number of CNVs per individual specimen distributed 
across sexes and time periods. d, RNA quality was evaluated by determining the RNA 
integrity number (RIN) for each sample (8.83±0.93, mean±SD), and only those with a RIN 
above 5 were processed (1,340 samples). Age is represented as log2–transformation of 
postconceptional days. Time of birth, separating prenatal from postnatal periods, is 
marked by vertical solid line. 
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Supplementary Figure 5 | Quality control workflow. Blue diamonds represent a quality 
control (QC) step, yellow squares represent criteria used to determine quality of the 
samples, green squares represent actions taken after quality control, red hexagons 
represent samples excluded from further analysis, and purple squares represent samples 
considered for further analysis. For details see Supplementary Information 2.2.  
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Supplementary Figure 6 | Exon array hybridization quality control. a,  b, The color of 
each dot in the plot represents relative intensity of a probe in the target chip compared to 
the average intensity of that probe in the same batch of chips. Individual probes of one 
gene were randomly located on the whole chip, and consequently there should be no 
obvious spatial pattern in the plot. The relative intensity plot of a low quality chip for 
sample 118-S1C-R with spatial artifacts (a) and the relative intensity plot of the high 
quality replicate chip for the same sample (118-S1C-R_REPEAT), without any obvious 
spatial artifact (b). c, The longest transcript of each gene was split into 100 segments with 
equal length, from 5'-end to 3'-end, and the log2-transformed signal intensity ratio for each 
segment was calculated compared with the expression of the whole gene across 1,340 
chips. The statistics of the ratios for all genes were displayed by a box plot for each 
segment. The flat solid line consisting of the mean lines of the box plots displays the array 
hybridization uniformity. 
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Supplementary Figure 7 | Expression analysis with and without SNP-containing 
probe sets. The gene and exon expression were evaluated twice, including and excluding 
105,271 probes with SNPs. The Pearson correlation analysis was performed to show the 
degree to which SNPs affect the expression data. The density plots give the distribution of 
Pearson Correlation Coefficient (PCC) values for all 1,340 samples (gene and exons are 
represented by blue and green lines, respectively). The majority of PCC values (98.8%) 
were within the range of 0.980-0.995 for gene and of 0.975-0.995 for exon, suggesting 
that SNPs have a minimal effect on gene and exon expression. 
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Supplementary Figure 8 | Hierarchical clustering of NCX samples. Dendrogram 
branching shows hierarchical sample clustering of NCX. The colors underneath label the 
potential confounders: age (blue to red representing younger to old), sex (light blue, male; 
pink, female), ethnicity (African, blue; African/European, green; Asian, yellow; European, 
light brown; Hispanic, dark red), PMI (low to high representing blue to red), dissection 
score (low to high representing blue to red), RIN (low to high representing blue to red), 
and the array processing site (Site 1, blue; Site 2, white). The samples clustered 
predominately by age (periods) and not by sex, ethnicity, PMI, dissection score, RIN, or 
the array processing site. Three major clusters (a stage 1 and 2 cluster, a prenatal cluster, 
and a postnatal cluster) were found in the NCX. Clustering data for other regional samples 
(HIP, AMY, STR, MD and CBC) are not shown but revealed the same trend. 
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Supplementary Figure 9 | Distribution plot of exon array signal intensities for 
“expressed”, “non-expressed”, and intronic controls. The “expressed” genes are 
defined by two criteria of log2-transformed signal intensity and DABG p-value 
(Supplementary information 6.1). The first group of genes included genes with averaged 
DABG P <0.01 in at least one region and log2 intensity ≥6 in at least one sample. These 
genes were considered as “expressed” genes (blue). The second group included genes 
whose averaged DABG P >0.01 or log2 intensity <6 in all samples and were considered 
“non-expressed” group (red). The final group is intronic controls (dark green) consisting of 
probe sets designed from intron regions of a set of housekeeping genes. Note the distinct 
distribution of “expressed” genes compared to “non-expressed” genes and intronic 
controls. 
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Supplementary Figure 10 | Multi-dimensional scaling according to sex, ethnicity, 
and donor. Two-dimensional multi-dimensional scaling plot showing genome-wide 
transcriptional similarity between any two samples. Each sample is represented as a 
single point. Proximity indicates transcriptional similarity between two samples. Euclidean 
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distance of log2-transformed signal intensity (expression) values was used to measure the 
pairwise dissimilarity. The isoMDS function in the R package was used to create the 
configuration of all points in the two dimensional space.  a, colors indicate sex. b, colors 
indicate ethnicity. c, colors and shapes indicate donor. 
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Supplementary Figure 11 | Principal component analysis. a, Three-dimensional plot of 
PCA of NCX samples across 15 time periods. Each point represents one NCX sample. 
Samples are colored by period. Three dimensional figures are rotated to provide a better 
view of the separation within prenatal (left) and postnatal (right) periods. b, PCA plot for all 
1,340 samples across 6 brain regions and all time periods. Each point represents one 
sample. Samples are colored by brain region. 
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Supplementary Figure 12 | Correlations between PMI, pH, RIN, DS, and gene 
expression. a - c, Correlation of the number of expressed genes with PMI (a), RIN (b), 
and pH (c). Each data point represents one brain (a, c) or one sample (b). Weak 
anticorrelations and correlations were observed with PMI (Spearman correlation, r=-0.382) 
and RIN (Spearman correlation, r=0.278), respectively. No correlation was observed with 
pH (Spearman correlation, r=0.054). d, Correlation between PMI and RIN. Each data point 
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represents one brain specimen. Y-axis is the averaged RIN of individual brain specimens. 
X-axis is PMI of the same specimens. The Spearman correlation is -0.471, indicating that 
PMI and RIN are anticorrelated. e, The Y-axis is the number of spatial DEX genes with 
significantly differential expression between brain regions and NCX areas detected by 
ANOVA test (FDR <0.01 and 2-fold difference) for the indicated period. The X-axis is the 
standard deviation of DS of all samples in that period. No significant correlation was 
observed between variation of DS and number of spatially DEX genes (Spearman 
correlation, r = -0.077). We limited this analysis to periods 3-15, when regions/areas of 
interest are well-defined using equivalent criteria and can be consistently followed across 
time, thus allowing us to assess whether the impact of variation in DS within the same 
stage contribute to differences in the number of detected spatially DEX genes for that 
particular period. 
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Supplementary Figure 13 | Five-fold jackknife procedure. The robustness of our DEX 
and DEU analysis models were tested randomly dividing samples into 5 groups and re-
analyzing spatial/temporal DEX and DEU 5 times while leaving out one group of samples 
in each cycle. Overlap plots for DEX and DEU genes between whole dataset and each 
cycle are shown. The average overlap rates were as follows: spatial DEX (93.47%), 
temporal DEX (98.0%), spatial DEU (94.3%), and temporal DEU (99.4%). This analysis 
indicates that our findings did not depend on any particular sample. 
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Supplementary Figure 14 | Prenatal region-enriched gene expression. An example of 
a transiently expressed and region enriched DEX gene for each region is shown. These 
genes were highly expressed in during prenatal and in some cases early postnatal 
development in predominantly one region and then were not expressed or had low 
expression level in other regions. Samples and associated signal intensity values are 
colored by region. 
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Supplementary Figure 15 | Postnatal region-enriched gene expression. An example 
of a transiently expressed and region enriched DEX gene for each region is shown. These 
genes were highly expressed in during postnatal life in predominantly one region and then 
were not expressed or had low expression level in other regions. Samples and associated 
signal intensity values are colored by region. 
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Supplementary Figure 16 | Spatiotemporal analysis of differential exon usage of 
ANKRD32.  a, Plotted are log2-transformed signal intensity levels (y-axis) for each probe 
set and the corresponding exons (x-axis) of ANKRD32. The exons are labeled according 
to RefSeq notation. The location of isoform specific primers used in b and c are depicted 
by blue (ANKRD32a) and green (ANKRD32b) arrows.  b,c, qRT-PCR (b, mean ± SEM) 
and semi-quantitative RT-PCR (c) validation analyses of the long (blue) and short (green) 
ANKRD32 isoforms (ANKRD32a and ANKRD32b, respectively) represented as relative 
gene expression levels. ANKRD32a was consistently expressed across early fetal (period 
3), late midfetal (period 6), and adult NCX areas. In contrast, ANKRD32b exhibited 
significant differences in expression between areas of the early fetal and midfetal NCX 
(one-way ANOVA, P=1.3x10-5 and P=1.9x10-7, respectively; followed by Tukey’s pairwise 
test; see Supplementary Table 6). During early fetal period 3, ANKRD32b was most highly 
enriched in the ITC and, to a lesser extent, in the STC (one-way ANOVA P=1.3x10-5, 
followed by Tukey’s pairwise test). d, qRT-PCR in orthologous areas of the mouse NCX at 
equivalent developmental periods (see Supplementary Information 8) Primers were 
generated against the mouse genomic region orthologous to the human ANKRD32b 
5’UTR. Ankrd32a and Ankrd32b isoforms were expressed as early as E15, which equates 
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to approximately 12–13 PCW (period 3) in humans. Ankrd32b was expressed at lower 
levels compared to the Ankrd32a and was enriched in the prospective S1C, A1C, and 
V1C (see Supplementary Information 8 for tissue sampling) but not in the frontal cortex 
(one-way ANOVA, P=9.2x10-4, followed by Tukey’s pairwise test). At P3, which 
approximately corresponds to 20 PCW (period 6) in humans, mouse Ankrd32b was 
expressed at low levels uniformly across NCX and was not enriched in any of the NCX 
areas, including the multiple frontal areas (one-way ANOVA, P=0.14).  We detected 
substantial levels of the Ankrd32a but not the Ankrd32b in the adult mouse NCX, which 
was similar to what was observed in the adult human NCX. 
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Supplementary Figure 17 | Expression of Y and X chromosome homologues in male 
and female brain. Ratio of male vs female median expression of protein-coding genes in 
all analyzed regions and NCX of male and female brain during fetal development (periods 
3-7), postnatal development (periods 8-12), and adulthood (periods 13-15). One circle 
represents one protein-coding gene surveyed in this study. The largest differences were 
attributable to Y chromosome genes PCDH11Y, RPS4Y1, USP9Y, DDX3Y, NLGN4Y, 
UTY, EIF1AY, and ZFY (blue circles), which displayed a robust and constant expression 
differences across development and adulthood. Interestingly, with the exception of zinc 
finger X-chromosomal protein (ZFX), we observed that their functional homologues on the 
X chromosome (PCDH11X, RPS4X, USP9X, DDX3X, NLGN4X, UTX, and EIF1AX) were 
expressed at comparable levels in male and female brains across different regions and 
periods (Supplementary Table 7), indicating that in general these X chromosome 
homologues are not upregulated in a compensatory manner in developing or adult female 
brains. 
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Supplementary Figure 18 | WGCNA Module 9. M9 was associated with a specific 
enrichment in the MD. a, Heat map of genes in M9 after hierarchical clustering showing 
the spatiotemporal pattern of the module. The expression values for each gene were 
ordered first by brain regions, then by age, and last by NCX areas. b, The spatiotemporal 
pattern of M9 was summarized using PCA analysis. The first principal component (PC1) 
was plotted against age, after being grouped and color-coded according to brain regions. 
The pattern was summarized by the smoothed curves of PC1 values. Dashed lines 
represent division between periods of the development, and the solid line separates 
prenatal from postnatal periods. c, d, Analysis of spatiotemporal expression of a 
representative gene, RGS16, with high intramodular connectivity revealed a similar 
pattern to the one observed for the entire module. Line plots show the log2-transformed 
exon array signal intensity (c) and relative expression level of quantitative RT-PCR (-ΔCt) 
during periods 3-15 (d). 
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Supplementary Figure 19 | WGCNA Module 19. M19 was associated with a specific 
enrichment in the CBC. a, Heat map of genes in M19 after hierarchical clustering showing 
the spatiotemporal pattern of the module. The expression values for each gene were 
ordered first by brain regions, then by age, and last by NCX areas. b, The spatiotemporal 
pattern of M19 was summarized using PCA analysis. The first principal component (PC1) 
was plotted against age, after being grouped and color-coded according to brain regions. 
The pattern was summarized by the smoothed curves of PC1 values. Dashed lines 
represent division between periods of the development, and the solid line separates 
prenatal from postnatal periods. c, d, Analysis of spatiotemporal expression of a 
representative gene, GABRA6, with high intramodular connectivity revealed a similar 
pattern to the one observed for the entire module. Line plots show the log2-transformed 
exon array signal intensity (c) and relative expression level of quantitative RT-PCR (-ΔCt) 
during periods 3-15 (d). 
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Supplementary Figure 20 | WGCNA Module 23. M23 was associated with a specific 
enrichment in the STR. a, Heat map of genes in M23 after hierarchical clustering showing 
the spatiotemporal pattern of the module. The expression values for each gene were 
ordered first by brain regions, then by age, and last by NCX areas. b, The spatiotemporal 
pattern of M23 was summarized using PCA analysis. The first principal component (PC1) 
was plotted against age, after being grouped and color-coded according to brain regions. 
The pattern was summarized by the smoothed curves of PC1 values. Dashed lines 
represent division between periods of the development, and the solid line separates 
prenatal from postnatal periods. c, d, Analysis of spatiotemporal expression of a 
representative gene, RGS9, with high intramodular connectivity revealed a similar pattern 
to the one observed for the entire module. Line plots show the log2-transformed exon 
array signal intensity (c) and relative expression level of quantitative RT-PCR (-ΔCt) during 
periods 3-15 (d). 
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Supplementary Figure 21 | WGCNA Module 20. M20 was associated with a progressive 
decrease in gene expression across all regions starting from the embryonic period. a, 
Heat map of genes in M20 after hierarchical clustering showing the temporally co-
expressed pattern is consistent across all regions. The expression values for each gene 
were ordered first by brain regions, then by age, and last by NCX areas. b, The 
spatiotemporal pattern of M20 was summarized using PCA analysis. The first principal 
component (PC1) was plotted against age, after being grouped and color-coded according 
to brain regions. The pattern was summarized by the smoothed curves of PC1 values. 
Dashed lines represent division between periods of the development, and the solid line 
separates prenatal from postnatal periods. c,  d, Analysis of spatiotemporal expression of 
a representative gene, HDAC2, with high intramodular connectivity revealed a similar 
pattern to the one observed for the entire module. Line plots show the log2-transformed 
exon array signal intensity (c) and relative expression level of quantitative RT-PCR (-ΔCt) 
during periods 3-15 (d). 
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Supplementary Figure 22 | WGCNA Module 2. M2 was associated with a progressive 
increase in gene expression across all regions starting at the embryonic period. a, Heat 
map of genes in M2 after hierarchical clustering showing the temporally co-expressed 
pattern is consistent across all regions. The expression values for each gene were 
ordered first by brain regions, then by age, and last by NCX areas. b, The spatiotemporal 
pattern of M2 was summarized using PCA analysis. PC1 was plotted against age, after 
being grouped and color-coded according to brain regions. The pattern was summarized 
by the smoothed curves of PC1 values. Dashed lines represent division between periods 
of the development, and the solid line separates prenatal from postnatal periods. c, d, 
Analysis of spatiotemporal expression of a representative gene, TF, with high intramodular 
connectivity revealed a similar pattern to the one observed for the entire module. Line 
plots show the log2-transformed exon array signal intensity (c) and relative expression 
level of quantitative RT-PCR (-ΔCt) during periods 3-15 (d). 
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Supplementary Figure 23 | Expression trajectories of genes associated with specific 
cortical GABAergic interneuron subclasses. a, Transcriptome-based expression 
trajectories for commonly used markers of different subclasses of cortical GABAergic 
inhibitory neurons. b, Representative images of immunohistochemical detection of CALB2 
(calretinin; Swant 6B3; 1:2000), NADPH-d (a histochemical marker of NOS, including 
NOS1), CALB1 (calbindin; Swant 300, 1:1000), VIP (vasoactive intestinal peptide; Abcam 
ab8795, 1:20), and PVALB (parvalbumin; Swant PV235, 1:5000) in the NCX during 
periods 6-8. Expression trajectories were reminiscent of the changes in the 
immunohistochemical detection of interneuronal markers in the fetal and early postnatal 
human NCX. Of the cortical GABAergic interneuron markers analyzed in this study, 
CALB2 gene expression was higher than the other markers during periods 1 and 2 (black 
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line in a). Consistently, CALB2-immunopositive interneurons were the most abundant of 
the analyzed marker of GABAergic interneuron cell types in the NCX during midfetal 
periods (b). Notably, CALB2-immunopositive cells were numerous in the upper part of the 
cortical plate (CP). Conversely, NADPH-d/NOS1-positive interneurons were less abundant 
than CALB2-immunopositive interneurons (green line in a). Although some NOS1-positive 
cells were found in deeper layers of the CP, the majority was found in the CP-subplate 
(SP) border. Consistent with the gene expression data and previous independent 
immunohistochemical studies73, CALB1- and VIP-immunopositive interneurons were the 
next to be detected in the NCX and can be easily identified during period 7. PVALB 
expression (dark blue line in a) and immunohistochemical staining (b) were the last to be 
detected in the NCX around birth. (SGL; subpial granular layer, MZ; marginal zone, L; 
layer, WM; white matter). 
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Supplementary Figure 24 | Expression trajectories of genes encoding subunits of 
glutamate receptors. Expression levels of different subunits of ionotropic glutamatergic 
receptors (AMPA, Kainate and NMDA) are shown for neocortex and cerebellum. Most 
subunits started to be expressed early during development and remained expressed 
throughout entire lifespan. However, spatiotemporal differences in expression patterns of 
different subunits were observed. Note that GRIN3A in CBC was the only subunit that 
appeared not to be expressed in postnatal or adult period.  
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Figure 25 | Spatiotemporal expression patterns of disease-related genes.  a-d, Heat 
map matrix representations of spatiotemporal expression of representative genes whose 
variants have been previously linked to (a-c) ASD (CNTNAP2, MET, NLGN4AX) and (d) 
schizophrenia (NRGN). The expression images display log2-transformed signal intensity 
across analyzed regions/areas and time periods using a heat map color scale from low 
(blue) to high (red). The dashed horizontal line separates NCX areas from other brain 
regions. The birth time is marked by vertical solid line. a,  CNTNAP2, which encodes a 
neurexin family protein implicated in ASD, was highly enriched in the areas of the fetal 
OFC and DFC, as previously reported15,17. The expression levels of CNTNAP2 suddenly 
increased in other cortical areas during early infancy (period 8), after which it remained 
expressed in all NCX areas. b,  MET, which encodes a hepatocyte growth factor receptor, 
has been linked to ASD74 and exhibited a partially overlapping but distinct NCX areal 
expression pattern. MET was highly enriched in the early midfetal ITC and then increased 
in the surrounding temporal-occipital areas and the OFC, where it remained enriched 
throughout development. c, NLGN4X, a gene encoding a protein involved in synapse 
formation and function75, was upregulated during the second half of the prenatal NCX 
development, which coincided with an increase in the expression of genes associated with 
synapse and dendrite development (Fig. 5 b, c). NLGN4X was also identified as a sex-
specific DEU gene (Fig. 3). Mutations in NLGN4X have previously been associated with 
ASD, which are more prevalent in males. Many of the ASD-associated risk SNPs and 
deletions were present in exons 5, 6, and 7 NLGN4X76,77, which displayed male-biased 
DEU. c, NRGN40, which encodes a postsynaptic protein kinase substrate, was highly 
expressed in all NCX areas starting after birth, progressively increased in expression until 
late childhood, and remained well-expressed in adulthood. 
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2.1. Abstract 
 
Transcriptional processes involved in the areal patterning and lateralization of the human 
neocortex are poorly understood. Here, we analyzed the temporal dynamics and laterality 
of protein-coding gene expression across topographically defined areas of the prenatal 
and postnatal human neocortex. We found that inter-areal transcriptional differences 
exhibit a temporal hourglass pattern, characterized by robust expression differences 
prenatally and, to a lesser extent, from adolescence onward, though not in infancy and 
childhood. Further analyses of temporally regulated inter-areal divergence revealed 
distinct gradients and/or compartments of expression, including some that were different 
between human and rhesus macaque. We also found that global gene expression 
trajectories of each area become increasingly synchronized in postnatal development. 
Analyses of gene expression between left and right areas revealed global symmetry 
throughout the fetal development and postnatal lifespan. Thus, human neocortical areal 
transcription is temporally specified, increasingly synchronized over the course of 
postnatal development, and globally symmetric. 
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2.2. Introduction 
The human cerebral neocortex (NCX) is parcellated into functionally distinct sensory, 
motor, and association areas that provide biological substrates underlying perception, 
behavior, and cognition (1-7). The functional specializations of these modalities within a 
neocortical area depend on the pattern of its synaptic connections. While the basic 
features of this areal map and connections are shared among mammals, important 
variations exist in their organization that provides a substrate for human-specific cognition 
and behavior (8-13). For example, when compared with the rhesus macaque, a closely 
related and the most studied non-human primate (NHP), the human NCX has 
approximately an 8-fold larger surface area and more functionally distinct areas (6). Yet 
this areal expansion was not uniform, as it seemed to have predominantly affected frontal 
and temporo-parietal association areas (6, 9, 11-13). 
Another key feature of the human NCX is that it covers the surface of the left and 
right hemispheres, each comprising a topographically matched, though slightly structurally 
and functionally asymmetric areal map (14-25). This asymmetric organization plays a 
crucial role in functional lateralization of many cognitive and motor functions, such as 
language and handedness, between the hemispheres. Multiple lines of evidence indicate 
that these asymmetries are reflected at the molecular (21), cellular (22, 23) and circuitry 
level (18, 25). First signs of structural asymmetry appear during the late mid-fetal period 
(20, 24, 25) and become more prominent during early postnatal development when 
functional asymmetries become noticeable (25).  
Several lines of evidence indicate that distinct human neocortical areas, as well as 
hemispheres as a whole, mature at different rates (26-30). For example, axons in primary 
sensory-motor areas start to myelinate before those in the association areas (26). Other 
processes such as synaptogenesis also exhibit prominent inter-areal differences in their 
maturational trajectories (27). Finally, there is also evidence indicating that the right 
hemisphere matures faster than the left during late fetal and early postnatal development 
(31-33).  
There is increasing evidence to suggest that processes regulating both areal 
patterning and asymmetry, as well as the maturational trajectories of these processes, are 
affected in major psychiatric and neurological disorders (25, 30, 33-36). Moreover, the 
progression of certain neuropathologies follows a stereotypic areal pattern (37), indicating 
that the mechanisms involved in the areal patterning and asymmetry may play a role in 
disease manifestation. However, little is known about these developmental processes in 
normal and diseased brains, or how they differ from other mammals, especially closely 
related NHPs.  
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The majority of what we know about the areal patterning of NCX has been derived 
from experimental studies in a handful of mammals, mostly through work in the mouse. 
These studies have revealed that the positional identity of areas is defined by the 
combination of patterning genes with distinct spatio-temporal expression patterns and 
extrinsic influence of ingrowing corticopetal axons, in particular those originating from the 
thalamus (2-5). However, the relevance of these studies to human NCX development is 
limited for several reasons. In addition to its increased size and complexity compared to 
the rodent NCX (10, 12), the development of the human NCX is spread over a much 
longer time period (9, 12, 38), so that even those rodent studies that sample multiple time 
points are difficult to relate to specific developmental processes in the human. In contrast 
to areal patterning, the development of NCX asymmetry has been studied almost 
exclusively in humans, but the number of such studies has been very limited. A number of 
genes were found to be expressed asymmetrically during the early fetal (21), but not the 
late mid-fetal or adult NCX (39, 40), suggesting that transcriptional asymmetry may be 
temporally regulated and precede structural and functional lateralization. In the present 
study, we sought to substantially extend on this previous research, both qualitatively and 
quantitatively, by analyzing the transcriptome of a spatially and temporally rich human 
neocortical collection, and to compare some of the transcriptome findings with the rhesus 
macaque.    
 
2.3. Results 
Inter-areal transcriptional divergence exhibits a temporal hourglass pattern.  
To gain insight into the transcriptional processes involved in the areal patterning of the 
human NCX, we performed a secondary analysis of exon-level mRNA transcriptome data 
of 11 topographically defined areas (38): the orbital (OFC), dorsolateral (DFC), 
ventrolateral (VFC), medial (MFC) and primary motor (M1C) areas of the frontal lobe; the 
primary somatosensory (S1C) and posterior inferior (IPC) areas of the parietal lobe; the 
primary auditory (A1C), posterior superior (STC) and anterior inferior (ITC) areas of the 
temporal lobe; and the primary visual (V1) area of the occipital lobe (Fig. 1A and 
Supplementary Material and Information). This dataset was generated using 886 tissue 
samples isolated from left and right hemispheres of 53 clinically unremarkable post-
mortem human brain specimens spanning from early fetal development through ageing 
(from 10 weeks of post-conception (PCW) to 82 years of age) or periods 3-15 as 
previously designated (38), an interval during which the areas can be consistently 
followed across time. 
Assayed tissue samples showed robust and unique transcriptional signatures.  
Hierarchical clustering based on all transcriptome data revealed grouping of areas by their 
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topographical proximity and functional segregation (Fig. 1A). However, principal 
component analysis (PCA) showed that transcriptional differences across periods account 
for the majority of the variance among samples (fig. S1). Analysis of gene expression 
using the core probe sets (Supplementary Note 3.1) revealed that 13,956 of the 17,557 
assayed genes (74.49%) were expressed in the NCX in at least one area of at least one 
period. Interestingly, the average number of genes expressed in all 11 NCX areas per 
brain remained relatively constant across time (10,833 +/- 462 s.d.). However, more 
genes were found to be expressed at any time or area during 28 weeks of fetal 
development (periods 3-7) than during the first 20 years of postnatal development 
(periods 8-12) or several decades of adulthood (periods 13-15) (Fig. 1B). Negligible 
correlations were observed between expressed genes and several possible confounding 
factors: the postmortem interval (PMI), RNA integrity number (RIN), and pH (figs. S2-S4). 
These findings indicate that gene expression is more dynamic during fetal development, 
likely reflecting transcriptional differences between fetal areas and periods. 
To estimate the degree of transcriptional differences between areas and how 
these may change across time, we use analysis of variance (ANOVA) to identify genes 
that exhibit differential expression (DEX) among areas per period (henceforth referred to 
as the inter-areal divergence; Supplementary Note 3.3). We found that inter-areal 
transcriptional divergence exhibits a temporal hourglass pattern, characterized by robust 
and dynamic differences prenatally and, to a lesser extent from adolescence onwards, 
though not in infancy and childhood (Fig. 1C and fig. S5). To estimate the contribution of 
individual areas to the overall inter-areal divergence, Tukey’s pairwise comparison was 
performed after ANOVA to determine the total number of significant (P < 0.01) DEX gene 
comparisons of each area with all the other areas for a given period. The relative 
contribution of areas to the overall hourglass shape varied across periods. During fetal 
periods, MFC, ITC, and the primary areas (V1C, A1C, S1C and M1C) exhibited the most 
prominent dissimilarity, whereas only MFC and V1C showed robust dissimilarities during 
adolescence and adulthood (Fig. 1C). Together, these findings show that the pattern of 
inter-areal transcriptional divergence is temporally specified and exhibits an hourglass 
pattern, with infancy and childhood representing a long phase of minimal divergence. Our 
results also show that the spatial pattern of inter-areal divergence is mainly driven by a 
subset of areas. 
 
Temporal transcriptional hourglass pattern reflects areal and functional differences. 
We hypothesized that increased inter-areal transcriptional divergence during fetal 
development and from adolescence onwards reflect the differences in the underlying 
molecular and cellular processes between these two phases. Consistent with this 
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hypothesis, only 848 of 3,125 (27%) inter-areal DEX genes were DEX both in fetal 
development and from adolescence onwards. To gain insights into the differential 
organization of the NCX transcriptomes during the two phases of increased inter-areal 
differences, we performed weighted gene co-expression network analysis (Supplementary 
Note 3.7) to identify modules of co-expressed genes with often-shared functional 
relevance. Within fetal development, we identified 122 modules (M1-M122: table S4), and 
from adolescence on we found 207 modules (M123-M329; table S5). Functional 
annotation of the modules revealed significant differences between the organization of 
fetal and adolescent/adult differential areal transcriptomes. Furthermore, the gene 
ontology (GO) enrichment analysis (Supplementary Note 3.8) revealed significant 
differences between fetal and adolescent/adult DEX and intra-modular genes in the 
enrichment for GO categories (tables S3, S4, and S5).  Exclusively fetal GO categories 
included: phosphoprotein, neuron differentiation, cell cycle, neuron development, cell 
morphogenesis, mitosis, cell morphogenesis involved in neuron differentiation, cell 
adhesion, and cellular component morphogenesis (Bonferroni-adjusted P ≤6.61E-11 per 
category). In contrast, exclusively adolescent and adult GO categories included: synaptic 
vesicle, transport, domain:C2 1 and 2, intrinsic to plasma membrane, intrinsic to 
membrane, clathrin-coated vesicle, neurological system process, neurotransmitter 
binding, coated vesicle, integral to membrane, and monovalent inorganic cation transport 
(Bonferroni-adjusted P ≤ 2.39E-06 per category).  
  Many fetal co-expression modules had pronounced areal gradients and/or well-
defined compartments with distinct boundaries (Figs. 2A-H and fig. S13). In addition to 
expected gradients with prefrontal/frontal-enriched graded expression along the anterio-
posterior axis (e.g., M54, M62, M80, M91), we found patterns including those with 
temporal (e.g., M2, M13, M5), occipital (e.g., M105), perisylvian (e.g., M118), and ventro-
medial areas (MFC, OFC, V1C; e.g., M100). The majority of the modules exhibited 
temporally specified areal patterns that changed dramatically across fetal periods and lost 
their prominent areal differences postnatally (fig. S13; see also tables S4 and S5 with 
description of spatio-temporal patterns). Areal expression patterns of 6 selected intra-
modular hub genes were validated (median correlation with array data, r = 0.88) by 
quantitative reverse-transcriptase polymerase chain reaction (qRT-PCR) (Fig. 2I-L and fig. 
S14). CLMP (ASAM), a gene encoding an adhesion molecule (Fig. 2I and fig. S14A-B), 
and WNT7B, a gene involved in early brain development and dendritic arborization (41) 
(Fig. 2K and fig. S14E-F), displayed an expression gradient along the rostro-caudal axis in 
anterior-posterior and posterior-anterior directions, respectively. We also validated genes 
with enriched expression in the temporal areas, such as NR2F2 (COUP-TF2) (Fig. 2L and 
fig. S14G-H), a gene enriched in the caudal ganglionic eminence and involved in 
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migration of interneurons (42), or restricted to the temporal areas, including the previously 
uncharacterized gene C13ORF38 (Fig. 2J and fig. S14C-D). 
 Adolescence and adulthood co-expression modules exhibited a more temporally 
steady and less complex spatial patterns (Fig. 3A-E and fig. S15). Consistent with our 
previous finding of dramatic differences in the number of DEX gene among areas in these 
periods (Fig. 1C), the most common areal co-expression patterns reflected enrichments in 
MFC (e.g., M215), V1C (e.g., M214), MFC and ITC (e.g., M239), and differences between 
the primary sensory-motor areas (e.g., M269), and association areas (e.g., M183). 
Expression patterns of several intra-modular hub genes were validated with qRT-PCR 
(median r = 0.82), such as GABRQ in MFC, TRPC3 in V1C, VAV3 in primary sensory 
areas, and BAIAP3 in all association areas (Fig. 3 and fig. S16).  Together, these findings 
indicate that the transcriptional hourglass shape reflects temporal differences in processes 
related to the construction and functional specializations of areas. 
 
Inter-areal differences exhibit inter-primate divergence.  
To investigate whether some of the observed temporally regulated inter-areal expression 
patterns exhibit inter-primate divergence, we performed qRT-PCR on the previously 
selected intra-modular hub genes (Figs. 2I-L and 3F-I, and figs. S14 and S16) in 
homologous regions of human and rhesus macaque neocortices at equivalent ages 
(Supplementary Note 5). Of the hub genes that had prominent inter-areal differential 
expression prenatally but not postnatally (CLMP, C13ORF38, NR2F2, KCNK12, 
WBSCR17 and WNT7B), only NR2F2 and WNT7B had spatio-temporal areal expression 
profiles that were well correlated (r > 0.8) between human and macaque, indicating that 
their expression patterns are well conserved. In contrast, the inter-areal expression 
pattern of WBSCR17 was only conserved during late-fetal periods (r > 0.8), while 
KCNK12 had moderate correlation only during early fetal periods (r = 0.63), indicating that 
the some of the spatio-temporal expression patterns are shaped by regulatory programs 
that differ between humans and NHPs. Comparative analysis of adolescence and 
adulthood intra-modular hub genes (BAIAP3, GABRQ, TRPC3 and VAV3) revealed that 
the inter-areal expression patterns of BAIAP3 and VAV3 were conserved in both 
adolescent and adult human and macaque NCX (r > 0.8) (Fig. 3F-I and fig. S16). In 
contrast, the areal expression patterns of GABRQ and TRPC3 were only conserved in 
adulthood (r > 0.8) but not in adolescence (r ≤ 0.6). While limited in their scope, these 
findings show that certain intra-modular hub genes exhibit temporally regulated and 
species-differential inter-areal expression patterns, and may reflect broader differences in 
developmental gene expression programs between the two primates. 
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Areal transcriptome trajectories become more synchronized during postnatal 
development. 
 Previous work has shown that NCX areas mature at different rates with primary sensory-
motor areas maturing first, followed by association areas (26-30, 36). To investigate the 
transcriptional dynamics associated with areal maturation, we generated intra-areal global 
expression trajectories by correlating the transcriptome profile of each sample to the 
averaged transcriptome profile of the corresponding area in mid-adulthood (period 14; 
Supplementary Note 3.5.1). We also correlated the transcriptome profiles to the 
corresponding area in early fetal development (period 3), to control for putative bias of 
selecting only a specific period (Fig. 4A). These trajectories allowed us to detect large-
scale changes in the transcriptome over time in individual areas. Surprisingly, all areal 
maturational trajectories had similar shape, with steep increase during mid- and late fetal 
development and the major inflection point on the curve during late infancy (Fig. 4A).   
However, the average deviation of the areal trajectory from the average overall 
maturational trajectory (maturational difference index; see Supplementary Note 3.5.2) 
varied more among areas during fetal than postnatal periods (Fig. 4B). MFC and ITC 
appear to mature faster than other areas prenatally, while DFC and V1C mature slower. 
Thus, inter-areal differences in maturational rates did not follow global antero-posterior or 
medio-lateral neurogenetic gradients observed in rodents (43). Furthermore, these 
findings indicate that at the global level areal transcriptomes become more synchronized 
during postnatal development. Interestingly, we also observed a decline in some areal 
trajectories, most prominently V1C, in period 15. Moreover, V1C changes in aging deviate 
in the same direction in both fetal and adult trajectories suggesting that the changes are 
not a reversal toward fetal expression as previously reported (44), but instead are likely 
unique to the aging process. These transcriptome changes could not be explained by the 
difference in confounding factors between V1C and non-V1C areas (RIN, P = 0.41; PMI, P 
= 1; pH, P = 1), as well as between adult periods (RIN, P = 0.96; PMI, P = 0.84; pH, P = 
0.13). Consistent with previous findings in aged prefrontal cortex (44), this suggests that 
aging is associated with global transcriptomic changes that vary considerably among 
areas.   
 Next, we followed the maturational trajectories of specific neurobiological 
processes and categories, using the first principal component to summarize the 
expression of genes associated with various developmental processes, neural cell types, 
and neurotransmitter systems (Supplementary Note 3.6). Notable trajectories and 
differences in their onset times, rates of increase and decrease, and shapes were 
observed within and between areas. Many of them showed more prominent inter-areal 
variations prenatally than postnatally (Supplementary Note 3.6 and figs. S6-12). These 
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included cell proliferation (which displayed antero-posterior and medio-later gradients), 
dendrite development, synapse development (which showed accelerated rate in M1C and 
S1C), glutamatergic neurons, astrocyte-specific genes, CALB1 (a marker of specific 
interneuron type), muscarinic receptor M3, and kainite inotropic receptor genes. In 
contrast, it was rarer to have trajectories exhibiting more robust inter-areal variations at 
postnatal periods, such as the expression of PVALB (a marker of specific interneuron 
type). Some trajectories, such as myelination, were variable both prenatally and 
postnatally, while some, such as, oligodendrocyte- and microglia-specific genes (fig. 
S10C-F) remained very similar between areas across both prenatal and postnatal periods. 
These findings indicate that specific transcriptional trajectories vary across the areas, with 
prenatal development being generally more variable among areas. 
 
Areal transcriptomes are globally symmetric across time. 
Since the initial discoveries of the functional lateralization of speech and language in the 
perisylvian areas of NCX  (14, 45), an abundance of data has demonstrated functional 
and structural asymmetries between hemispheres (16-20, 23, 24, 33). However, 
transcriptome studies of left-right differences in areal gene expression have remained rare 
and limited to a small temporally restricted dataset (21, 39, 40). Furthermore, the previous 
findings are also potentially inconsistent, as evidence for gene expression asymmetry has 
been found in early fetal (21), but not the mid-fetal or adult NCX (39, 40). Our analysis of 
the left-right areal transcriptomes across periods 3-15 failed to identify statistically 
significant inter-hemispheric areal differences, using a paired t-test with an FDR threshold 
of 0.01. To increase the dynamic range and sample size for left-right comparison, we also 
repeated the analysis using a sliding window algorithm that covers four consecutive 
periods. On average, 99.4% of expressed genes had smaller than 1.5 fold differences in 
left-right expression and this number varied slightly across time (Fig. 5A and B). However, 
none of these or the remaining 0.6% of genes with more than 1.5 fold differences in left-
right expression  passed the FDR threshold.  
To test the concept of the arrival of corresponding developmental stages sooner in 
the right than in the left hemisphere (24, 32), we compared the individual areal 
maturational trajectories between hemispheres. This analysis revealed no trend in faster 
maturation of one hemisphere over the other (Fig. 5C and D). Our findings indicate that 
the well-described examples of functional and structural lateralization are not reflected in 
transcriptome asymmetry at the population level across almost the full course of human 
neocortical development and adulthood. 
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2.4. Discussion 
Taken together, our analyses of temporal dynamics and bilaterality of areal transcriptomes 
revealed several novel aspects of human neocortical development. Although the total 
number of genes expressed in NCX remained relatively constant across time, we found 
the degree of transcriptional differences between areas, as measured by the number of 
DEX genes, is temporally regulated exhibiting an hourglass pattern. The greatest inter-
areal differences were present prenatally, followed by periods from adolescence onwards, 
with infancy and childhood representing a phase of minimal inter-areal transcriptional 
divergence.  
We also provided evidence that these three global phases of inter-areal 
transcriptional divergence reflect underlying developmental and functional differences. 
Fetal DEX genes and co-expression modules had highly dynamic spatio-temporal 
expression patterns and tended to be related to early neurodevelopmental processes 
associated with cell generation and neural circuit construction. Consistent with this finding, 
previous neuroanatomical studies have shown that area-specific features of axonal 
projections and neuronal differentiation are already evident in the mid-fetal NCX (39, 46, 
47). Interestingly, the relative contribution of areas to the overall inter-areal transcriptional 
divergence varied across fetal development and may reflect the underlying processes 
involved in areal patterning. Additionally, our results indicate that fetal MFC and ITC, 
which have high number of DEX genes and whose global transcriptional trajectories point 
to faster maturation, may have differentiated earlier than other analyzed areas. This 
developmental pattern resembles the evolutionary pattern of NCX differentiation arising 
from dual archicortical and paleocortical moieties (48). Also, increased transcriptional 
divergence of prospective primary motor-sensory areas (V1C, A1C, S1C, and M1C) 
pointed to their early transcriptional specification.  
The fetal phase is followed by a sharp drop in inter-areal transcriptional divergence 
during late fetal development and the appearance of a long phase covering infancy and 
childhood in which areas become more similar. In addition, the global gene expression 
maturational trajectories become more synchronized over the course of early postnatal 
development. We hypothesize that this areal transition from high divergence to similarity 
as well as increased synchronization are related to changes in neurodevelopmental 
processes that occur at the same time. Over one hundred years ago, Brodmann 
discovered (1) that the anatomy of the entire neocortical plate is transiently transformed 
by the appearance of an ontogenetic six-layered Grundtypus (i.e., the fetal equivalent of 
future layers 2–6) during late fetal and neonatal development (periods 7 and 8 in this 
study). More recently, it has been shown that during those periods layer 5 pyramidal 
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neurons of the whole human NCX transiently express nitric oxide synthase 1 protein (47). 
Thus, these global structural and molecular changes in the late fetal and neonatal human 
NCX may function as mechanisms by which areas become more similar in their 
expression patterns.   
The drop in inter-areal transcriptional divergence also occurs while the human 
neocortical map is being reorganized, largely through the influence of extrinsic forces like 
activity-dependent mechanisms, experience, and environmental and social input (3, 46, 
49). Also, infancy and childhood are critical and sensitive periods for the acquisition and 
refinement of cognitive and motor functions characterized by higher plasticity (36, 46, 49). 
Thus, we hypothesize that following the initial establishment of area-specific subcortical 
and cortico-cortical projections in fetal development, the robust inter-areal transcriptional 
differences are no longer needed and are surpassed by more general neuronal and glial 
differentiation transcriptional programs involved in maturation of neural circuits. Some of 
these more general programs, such as the transcription of myelination genes, and some 
interneuron and neurotransmitter systems-related genes, also exhibit inter-areal difference 
in the neonatal and postnatal NCX, but they appear to be less robust or less dynamically 
regulated than many of the fetal programs. Interestingly, specific transcriptional 
trajectories seem to be more synchronized between areas than expected from analyses of 
maturational trajectories of several phenotypic traits such as synaptogenesis (27), cortical 
thickness (28, 29, 36) and myelination (26). This finding also suggests these phenotypic 
inter-areal differences arise in part by post-transcriptional and activity-dependent 
mechanisms. Furthermore, early postnatal inter-areal transcriptional differences were 
more pronounced for some interneuron markers and neurotransmitter systems, 
suggesting that they either play a role in postnatal functional areal differentiation and/or 
are substantially affected by this process.  
Inter-areal transcriptional divergence increases again during adolescence, a period 
of great developmental changes in the human brain (49), and slowly increases as the 
brain matures and ages. Unlike genes from the fetal phase, DEX genes and co-expressed 
genes during adolescence and adulthood tend to be related to categories such as 
synaptic transmission and cell-cell signaling. Thus, adolescence and adulthood, especially 
the aging process, are accompanied by specific changes in areal transcriptomes.  
Interestingly, the temporal pattern of inter-areal transcriptional divergence 
resembled the hourglass model of transcriptome divergence between various species of 
the fruitfly (50). We show here that some of the genes that have temporally regulated 
inter-areal differential expression also display divergence, both spatially and temporally, 
between human and macaque monkey.  These differences in gene expression patterns 
between species may have played a role in human evolution.   
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Although surprising, given well-described structural and functional asymmetries, 
our findings show that areal transcriptomes are largely symmetric at the population level 
and mature at similar rates in the left and right hemispheres across the full course of 
human brain development and adulthood. In accordance to this finding, a recent large-
scale structural MRI study has also shown population-level cortical symmetry (7). With the 
present study design, we cannot exclude that transcriptional asymmetry is present in 
areas not profiled in this study, may be diluted at the population level by inter-individual 
variations, may be limited to the small subset of genes not present on the array, or may be 
driven by more subtle changes in specific cellular components that we have not been able 
to detect. However, it may also be that neocortical asymmetry is driven by stochastic, 
hormonal, epigenetic, functional connectivity-based, and/or activity-dependent 
mechanisms that are not clearly reflected in gene expression. 
 
 
2.5. Methods Summary 
The Supplementary Information provides a full description of materials and methods, 
including tissue acquisition and processing, data generation, validation, and analyses.  
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2.7. Figures 
 
Fig. 1. Neocortical areal differences in gene expression exhibit a temporal 
hourglass pattern.   
(A) Unsupervised hierarchical clustering of the 11 NCX areas profiled in this study, based 
on the transcriptome of each NCX area throughout the fetal development and postnatal 
lifespan, shows relative transcriptional differences. (B) Boxplots of subsampling 
permutations show the number of expressed (blue) and differentially expressed genes 
(red) among neocortical areas across fetal development (periods 3-7), infancy (periods 8 
and 9) and  childhood (periods 10 and 11), and adolescence (period 12) and adulthood 
(periods 13-15). (C) Post-hoc Tukey tests were used to identify significant comparison of 
inter-areal (IA) DEX combinations. A 3D heatmap shows the number of IA DEX 
combinations per NCX area across time. 
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Fig. 2. Fetal gene co-expression modules illustrating the diversity of human spatial 
patterns and inter-primate similarities and differences.  
(A-H) Average scaled-expression of all genes in co-expression module (M) 91 (A), M13 
(B), M105 (C), M100 (D), M2 (E), M80 (F), M5 (G), and M118 (H) show a gradient-like 
expression pattern in periods 3 (A, B, C), 4 (D), 5 (E), and 6 (F, G, H).  (I-L) Radar charts 
of qRT-PCR of intra-modular hub genes CLMP (M91) (I), C13ORF38 (M80) (J), WNT7B 
(M6) (K), and NF2R2 (M13) (L) demonstrate a gradient-like expression pattern in human 
(blue) in directions of areas grouped by their corresponding lobes (e.g., frontal, parietal, 
occipital and temporal; versions of these radar charts with all 11 areas across different 
periods are shown in figure S14).  Rhesus macaque (red) expression patterns show 
similarities and differences to human.  
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Fig. 3. Adolescent/adult gene co-expression modules illustrating the diversity of 
human spatial patterns and inter-primate similarities and differences.  
(A-E) Average scaled-expression of all genes in M215 (A), M214 (B), M239 (C), M269 (D) 
and M183 (E), in period 13, show an area-specific (A, B and C) or a primary sensory 
areas-specific (D and E) patterns. (F-I) Box plots show qRT-PCR expression levels of 
area-enriched human (blue) and rhesus macaque genes (red): GABRQ (M215) (F), 
TRPC3 (M214) (G). Genes with patterns that discriminate primary sensory areas and 
associative areas are also shown: VAV3 (M214) (H) and BAIAP3 (M183) (I), respectively. 
Radar charts of qRT-PCR data for the four genes with all 11 areas across different 
periods are shown in figure S16. 
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Fig. 4. Areal transcriptional trajectories become more synchronized during 
postnatal development.  
(A) A maturational trajectory plot shows the Pearson correlation of gene expression in 
each sample to the corresponding averaged gene expression in period 14 (solid line) or 
period 3 (dashed line). (B) Bar plots show the average deviation of the areal trajectory 
from the average overall maturational trajectory (maturational difference index).  Prenatal 
(fetal) development exhibits more deviation than postnatal development. 
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Fig. 5.Areal transcriptomes are globally symmetric across fetal development and 
postnatal lifespan.   
(A) Average distribution of hemispheric bias for all profiled neocortical areas through 
overlapping time points of development and adulthood. (B) A heat map shows the 
distribution of fold differences in expression of all analyzed genes between left and right 
hemispheres for each profiled neocortical area across time. Each row corresponds to a 4-
period sliding window (first row: 3-6; last row: 12-15). Maturational trajectories of left (solid 
line) and right (dashed line) hemispheres of each NCX area (C), and maturational 
difference index between hemispheres in prenatal (fetal) and postnatal development (D) 
further demonstrate a symmetric gene expression profile. 
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1. Introduction 
In this Supplementary Information we provide further information regarding materials and 
methods. For a detailed description of the collection, dissection methods, and quality 
control assessments of post-mortem human brain, please refer to our previous study (38). 
Tissue was obtained from several sources including the Human Fetal Tissue Repository 
at the Albert Einstein College of Medicine, the NICHD Brain and Tissue Bank for 
Developmental Disorders at the University of Maryland, the Laboratory of Developmental 
Biology at the University of Washington (supported by grant HD000836 from the Eunice 
Kennedy Shriver National Institute of Child Health and HumanDevelopment) and the 
JointMRC/Wellcome Trust HumanDevelopmental Biology Resource (http://hdbr.org) at the 
IHG, Newcastle Upon Tyne (UK funding awards G0700089 and GR082557). We also 
make available additional data that were discussed in the main manuscript. Finally, we 
present supplementary figures and tables generated from sample metadata and specific 
gene lists. 
 
2. Neocortical Areas and Time Periods 
For this study, we used a subset of a dataset previously reported (38). In that dataset, the 
full course of human brain development and adulthood was divided into 15 periods. In the 
present study, we analysed 11 areas of the neocortex (NCX) in periods 3-15, an interval 
during which the areas can be consistently followed across time. The first 2 periods, which 
correspond to the embryonic and the first two weeks of the early fetal development, were 
not analysed in the present study since they don’t contain the same 11 areas from periods 
3-15. 
The complete list of periods and NCX areas analysed in this study can be found in the 
Supplementary Tables 1 and 2, respectively.  
 
3. Exon Array Data Analyses  
3.1. Gene-level analysis 
The expression levels for all core probe sets within an exon were averaged to obtain an 
expression value for the exon, and the median of all exons within one gene (transcript 
cluster) was used as the estimate of gene expression. To reduce the noise in the dataset 
and the false positives in the following differentially expressed genes investigations, we 
excluded genes with a log2-transformed expression value <6 in all samples. To consider a 
gene “expressed” in a particular area or at a particular time period, we required it to have a 
mean DABG P<0.01in that NCX area. 
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3.2. Principal component analysis 
The whole data set was subjected to the principal component analysis (PCA). The first 
and the second principal components (PC1 and PC2) were plotted and samples were 
colored by periods  (Figure S1). To explore the effects of confounders, we plotted the first 
four principal components against RIN (Figure S2), PMI (Figure S3) and pH (Figure S4), 
and colored samples by periods. 
 
3.3. Identification of spatial DEX genes 
Analysis of variance (ANOVA) was used to identify differentially expressed (DEX) genes 
across all regions of interest. Genes that were DEX in at least one NCX area were identified 
based on ANOVA by using area as an ANOVA factor. In order to exclude the possibility that 
variation in RIN scores and PMI within the acceptable range might influence procedures, we 
included PMI and RIN as technical covariates within our ANOVA model of differential 
expression. Resulting P-values from ANOVA were corrected for multiple comparisons using 
the Benjamini and Hochberg false discovery rate (FDR) method (51). A conservative 
statistical threshold (FDR <0.01 and minimum fold difference >2 between NCX areas) was 
used to identify DEX genes. Genes that were not significantly expressed above background 
were excluded from ANOVA tests. A post-hoc Tukey's HSD (honestly significant difference) 
test was used to calculate differences between each pair of neocortical areas, in each 
period. The number of significant comparisons for each area, per period, was then used as 
the inter-areal (IA) DEX combinations number. 
 
3.4. DEX analysis quality control 
3.4.1. Subsampling 
Random subsamples were used to calculate the number of expressed and DEX genes. All 
samples were divided into three groups: prenatal, postnatal, and adult. The number of 
samples randomly chosen was calculated as ¾ of the lowest number of samples 
contained within any of the three groups. For 100 trials, this fixed number of samples was 
randomly drawn from each group and the number of expressed or DEX genes was 
calculated using the selected subset of samples.  
 
3.4.2. Permutation test 
A permutation test was used to determine the dependence between group label and the 
mean number of expressed or DEX genes in the subsampling results.  For each pair of 
groups (prenatal-postnatal, prenatal-adult, postnatal-adult), the test statistic was 
computed by subtracting the group with the smaller mean number from the group with the 
larger mean number. To calculate the null statistic, the group labels were shuffled, and 
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mean difference was calculated retaining the same group order used to calculate the test 
statistic. The permutation was performed 999,999 times to generate the null distribution 
and calculate a one-sided p-value. 
 
3.5. Transcriptome maturation  
3.5.1 Maturational trajectories 
Period 14 is characterized by an adult-like pattern of brain functions (38), and can be 
considered as the period when cortical areas reach full maturation. We calculated the 
mean gene expression for each NCX area in this period and used it as the fully mature 
NCX reference for further comparisons. We then used the Pearson correlation of each 
sample to its areal reference as a measure of maturation. The values of correlation were 
then smoothed to fit a trajectory by R function smooth.spline.  
 
3.5.2 Maturational difference index 
To better understand differences among areas in maturation, we calculated the average 
maturational trajectory for all areas. Areal deviations from the average maturational 
trajectory were used to calculate the maturational difference index for each area, in each 
period. The average maturational difference index was then calculated for prenatal and 
postnatal development.  
 
3.6. Creation of gene lists and transcriptional profiling of neurobiological categories  
We manually curated lists of genes functionally related to specific neurodevelopmental 
processes, neural cell types, and neurotransmitter systems, by selecting individual genes 
or a small group of genes from the existing gene ontology (GO) database 
(http://www.geneontology.org/) whose functions, and thus expressions, have been most 
closely associated with specific neurobiological category based on published data from 
model organisms and human medical genetics. Detailed information on gene selection 
and neurobiological categories are provided in ref. 38 and 
www.humanbraintranscriptome.org database. We expected that the selected genes or 
gene group may accurately reflect the trajectories of neurobiological processes in 
neurodevelopment. To summarize the principle gene expression profile of each category, 
PCA was performed. The resulting first principal component (PC1) was plotted against 
logarithmic age in days, and a smooth curve was fitted by smoothing spline to display the 
developmental trajectories. For categories with only one gene, the expression level was 
used as PC1. 
To compare the spatio-temporal patterns of genes in the same group, we plotted 
genes in each group individually and fitted the individual gene expression pattern by 
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smoothing spline. To compare the developmental trajectories for neurodevelopmental 
processes (Fig. S6 and S7), glutamatergic neurons (Fig. S8), interneurons (Fig. S9), glial 
cells (Fig. S10), and neurotransmitter receptors (Figs. S11 and S12), PC1 of each group 
was subjected to smoothing spline curve fitting. The fitted value  was then scaled to 0 to 
1. The range of fitted vector  is set to 1, and the scaled values were calculated as 
 . The scaled values were then plotted to represent the 
trajectory of each group with a measure of the percentage of changes. Furthermore, the 
average trajectory was calculated as a function of average value for all areas per period. 
Deviations from the average maturational trajectory were used to calculate the 
maturational difference index for all areas. The average maturational difference index was 
then calculated for prenatal and postnatal periods (3-7 and 8-15, respectively). 
 
3.7. Weighted gene co-expression network analysis (WGCNA) 
 3.7.1. Dataset filtering  
 WGCNA was applied to samples from periods 3-6 and periods 12-15, respectively. Since 
the analysis is sensitive to noise, only genes with log2-expression value greater than 6 in 
any of the sample and coefficient of variation (CV) greater than 0.05 were used for 
analysis. 
 
 3.7.2. Network construction and module detection  
Signed co-expression networks were built using the WGCNA package (52, 53) in R. For 
all genes included, a pair-wise correlation matrix was computed, and an adjacency matrix 
was calculated by raising the correlation matrix to a power. The power was set to 18 for 
both of Periods 3-6 and Periods 12-15, according to a scale-free topology criterion (54). 
For each pair of genes, a robust measure of network interconnectedness (topological 
overlap measure) was calculated based on the adjacency matrix. The topological overlap 
based dissimilarity was then used as input for average linkage hierarchical clustering. 
Modules were generated by hybrid dynamic tree-cutting. To obtain rare expression 
patterns, we set the minimum module size to 5 genes, deepSplit to 3, and the minimum 
height for merging modules to 0.15. 
Each module was summarized by an eigengene, which is the first principal component 
of the scaled module expression. Thus, the module eigengene explained the maximum 
amount of variation of the module expression levels.  
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3.8. Gene ontology (GO) enrichment analysis 
Functional enrichment was assessed using DAVID Bioinformatics Resources 6.7 (55, 56) 
(http://david.abcc.ncifcrf.gov/).  
 
3.9. Spatio-temporal dynamics of co-expression modules 
The expression patterns of modules were manually categorized based on module 
eigengenes. Modules that showed gradients in expression (Fig. S13) or region-specific 
expression (Fig. S15) were selected. To display the changes of expression across 
periods, the expression of genes in each selected module was scaled and the module 
expression was calculated by averaging the scaled expression across genes. The module 
expression was then plotted as a heatmap to show the change of gradients across 
periods. To demonstrate gradients for a selected period, the module expression in that 
period were plotted on a reference brain and labeled by gradients of colors.  
 
3.10. Analysis of left-right bias in gene expression 
Differences in gene expression between left and right hemispheres were analyzed by the 
combination of a sliding window algorithm, and a paired t-test. The sliding-window 
algorithm was used to detect left/right gene expression differences within a group of 
sequential periods. The window size was set to span 4 periods. For each window, a 
paired t-test was applied to determine if the expression level of a gene in left hemispheres 
was significantly different from the expression level in right hemispheres in the same area. 
The P-values from the t-tests were transformed to FDR using the Benjamini and Hochberg 
method (51). For each gene, the fold difference (log2-transformed) between left and right 
hemisphere samples in each region was also calculated. An FDR of 0.1 was used as a 
cutoff to identify genes that are DEX between left and right hemispheres in each window.  
Using the same approach as in 3.5., we calculated the maturation trajectories of both 
hemispheres. The mean areal correlation of each period was calculated by hemisphere. 
The difference between hemispheres was then calculated for each area in each period. 
Bar plots were used to summarize the difference between hemispheres in prenatal and 
postnatal development. 
 
4. Transcriptome Validation Methods 
4.1. Quantitative real-time RT-PCR  
An aliquot of the total RNA that was previously extracted from each brain region was used 
for secondary validation through real-time PCR analysis. One µg of total RNA was used 
for cDNA synthesis using SuperScript III First-strand synthesis Supermix (Invitrogen) and 
subsequently diluted with nuclease-free water to 1 ng/µl cDNA. Gene-specific high-
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melting temperature primers for genes of interest were designed using NCBI/Primer-
BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-blast/) and expressed sequence 
information obtained from GenBank (NCBI). PCR reactions were conducted on an ABI 
7900 Sequence Detection System (Applied Biosystems) using a hot start SYBR-green 
based method (Fast SYBR Green Master Mix, ABI) followed by melt curve analysis to 
verify specificity of the product. The Ct value (cycle number at threshold) was used to 
calculate the relative amount of mRNA molecules. The Ct value of each target gene was 
normalized by subtraction of the Ct value from housekeeping genes to obtain the ΔCt 
value. The relative gene expression level was shown as -ΔCt. All genes of interest were 
normalized to the housekeeping gene RPL32. Also, in Table S6 we provide sequences of 
primers used in validation.  
qRT-PCR results were shown in radar charts, which were plotted using Origin 8.6 
plotting software. Gradient-like patterns of gene expression (Fig. 2I, J, K, L) were shown 
by grouping areas per lobe: frontal (MFC, OFC, DFC, VFC, M1C), parietal (S1C, IPC), 
temporal (STC, A1C, ITC), and occipital (V1C). Region specific/enriched patterns of 
genes (Fig. 3F, G, H, I) were plotted by grouping regions of interest against all other areas 
combined. Also, we show the expression values of each area using radar charts (Fig. S14 
and S16) and we compared patterns of expression between the species, calculating 
Pearson’s correlation coefficient for brains with matched age.  
 
5. Dissection of Rhesus Macaque (Macaca mulatta) Neocortical Areas 
We performed qRT-PCR using RNA isolated from homologous areas of the rhesus 
macaque (Macaca mulatta) NCX at equivalent developmental periods using a 
mathematical model to translate neurodevelopmental time across species (57) 
(www.translatingtime.net). Macaque experiments were carried out in accordance with a 
protocol approved by Yale University’s Committee on Animal Research and NIH 
guidelines. All brains were dissected using the same protocol used for human specimens. 
Areas were sampled according to ref. (58).  
 
6. Supplementary Tables 
Supplementary Tables are provided in a single Microsoft Excel file on the CD rom. 
 
Table S1. Periods of human brain development as defined in this study  
List of the periods of human brain development used in this analysis and their 
corresponding age. 
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Table S2. Ontology and nomenclature of analysed NCX areas 
List of the neocortical areas analyzed and their corresponding Brodmann areas. 
 
Table S3. Gene Ontology of DEX genes 
List of gene ontology analysis performed by DAVID algorithm for DEX genes during fetal 
development, infancy and childhood, and adolescence and adulthood; list of fetal-only, 
and adolescence- and adulthood-only terms. 
 
Table S4. Pre-natal (periods 3 to 6) co-expression modules 1-122  
List of 122 modules corresponding to spatio-temporal patterns identified by weighted gene 
co-expression network analysis (WGCNA) with its functional interpretation and result of 
gene ontology analysis performed by DAVID algorithm; list of intra-modular genes and 
their intra-modular connectivity; and list of modules with gradient-like patterns: anterior-
posterior, temporal, posterior perisylvian, and occipital.  
 
Table S5. Post-natal (periods 12-15) co-expression modules 123-329  
List of 206 modules corresponding to spatio-temporal patterns identified by WGCNA with 
its functional interpretation and result of gene ontology analysis performed by DAVID 
algorithm; list of intra-modular genes and their intra-modular connectivity; and list of 
modules with region-specific enrichment in V1C and MFC. 
 
Table S6. List of primers used for qRT-PCR 
List of human and macaque monkey primers used in this study. RPL32 was used as the 
housekeeping gene. 
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7. Supplementary Figures 
 
Figure S1 | Principle component analysis. 
Principle component analysis, with samples colored by period, shows separation in three 
distinct clusters: early fetal to late mid-fetal (periods 3-6), late fetal (period 7) and 
postnatal (periods 8-15). 
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Figure S2 | PCA clustering of the samples with RIN as the confounding variable.  
The first four principal components were plotted against RNA Index Number (RIN). 
Samples were colored by periods. Negligible correlation with the confounder was 
observed.
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Figure S3 | PCA clustering of the samples PMI as the confounding variable.  
The first four principal components were plotted against PMI. Samples were colored by 
periods. Negligible correlation with the confounder was observed. 
 144
 
 
Figure S4 | PCA clustering of the samples pH as the confounding variable.  
The first four principal components were plotted against pH. Samples were colored by 
periods. Negligible correlation with the confounder was observed.
 145 
 
 
Figure S5 | Number of expressed and inter-areal (IA) DEX genes per period. 
Analysis of DEX genes (red line) per period shows the hourglass shaped pattern, with the 
highest number of DEX genes during prenatal period, a lower number of DEX during 
infancy and childhood, and a reappearance of DEX from adolescence on. Number of 
expressed genes (blue line) stays stable throughout the fetal development and postnatal 
lifespan.  
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Figure S6 | Trajectories of genes associated with neurodevelopmental processes 
(cell proliferation related genes, doublecortin, axon development related genes).  
Genes associated with cell proliferation markers (RRM1, HES1, NES, and MKI67) are 
showing higher expression levels (A) and higher variability (B) during prenatal periods 
than after the birth. Doublecortin (DCX), a gene previously associated with neuronal 
migration and immature neuronal states, shows high expression (C) values during 
prenatal periods and a big decrease in expression levels during postnatal periods with 
little deviation from average trajectory (D). Axon development marker (CNTN2) is showing 
triphasic trajectory (E) with higher expression during early and mid-fetal and postnatal 
periods but with decrease in expression levels around the birth. Deviation from average 
trajectory is present but relatively low in both prenatal and postnatal periods (F).
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Figure S7 | Trajectories of genes associated with neurodevelopmental processes 
(dendrite development, synapse development and myelination related genes). 
Dendrite development genes (MAP1A, MAPT, and CAMK2A) show gradual increases in 
expression until they reach the plateau at period 10 (A). At prenatal periods, areas show 
higher deviation from average trajectory than postnatal periods (B). Synapse development 
markers (SYP, SYPL1, SYPL2, and SYN1) show increased expression until postnatal 
periods when they reach a plateau (C). Deviation from the average trajectory, while 
present during prenatal periods, virtually disappears after birth (D). Myelination genes 
(MBP, PLP1, MOG, C11orf9, and MAG) show similar trajectories to previous the two 
processes with steady increase during prenatal periods and reaching the plateau in 
periods 9 and 10 (E), but deviation from the average trajectory is present in both prenatal 
periods (F). 
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Figure S8 | Trajectories of genes associated with cortical glutamatergic neurons. 
Genetic makers for layer II-IV glutamatergic neurons (CUX1 and UNC5D) show slow 
increases in expression levels during development (A). Exceptions to this are the frontal 
areas where in early fetal periods expression is higher than in late mid-fetal period. 
Variability from the average trajectory is present in both prenatal and postnatal periods, 
with highest deviation in postnatal V1C (B). Markers for layer V glutamatergic neurons 
(FEZF2, BCL11B, OTX1, and ETV1) show an opposite trajectory with the highest 
expression levels during prenatal periods and reach the lowest point during childhood (C). 
Deviations among the areas are larger during prenatal periods (D). Markers of subplate 
glutamatergic neurons (CTGF and UNC5C) show increased expression during prenatal 
periods reaching a maximum after birth and a gradual decrease during postnatal periods 
(E). Variation from average trajectory is larger during prenatal periods compared to 
postnatal periods (F). 
 149 
 
 
Figure S9 | Trajectories of genes associated with cortical GABAergic interneurons.  
Calretinin (CALB2) shows increased expression until birth, when expression levels reach 
their maximum (A). After birth, expression levels start to decrease until period 10 when 
they reach their lowest values and then are followed by a small increase. All areas have 
high deviation from the average trajectory (B). Calbindin (CALB1) shows a highly dynamic 
trajectory, with an increase in expression during prenatal periods, with frontal regions 
increasing faster compared to others, especially V1C (C). Deviation from the average 
trajectory is present in both prenatal and postnatal periods, but much more accentuated 
prenatally (D). Parvalbumin (PVALB) expression levels gradually increase and reach their 
maximum at period 11 (E). Prenatal expression is low, while during postnatal periods 
expression levels are high with large deviations from the average trajectory (F).
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Figure S10 | Trajectories of genes associated with glial cells.  
Astrocyte associated genes (GFAP, S100B, and ALDOC) gradually increase in 
expression and reach a plateau after birth (A). Prenatal MFC shows the highest deviation 
from average the trajectory (B). A mature oligodendrocyte genetic marker (CNP) shows a 
similar trajectory with lower deviation from the average trajectory prenatally (C, D). 
Microglial genes (CFH, FCER1G, and TNIP2) show less pronounced increased 
expression through development (E, F). 
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Figure S11 | Trajectories of genes associated with neurotransmitter receptors 
(acetylcholine and serotonin receptor genes).  
Nicotinic receptor β subunit genes (CHRNB1, CHRNB2, CHRNB3, and CHRNB4) show a 
progressive increase in expression levels (A) with higher deviation from average trajectory 
during prenatal periods (B). Muscarinic M3 receptor gene (CHRM3) shows a sharper 
increase in expression levels prenatally reaching the maximum expression levels after 
birth (C). The deviation from average trajectory is higher during prenatal periods (D). 
Serotonin 5-HT3 receptor genes (HTR3A, HTR3B, HTR3C, HTR3D, and HTR3E) show 
expression levels that do not change drastically during the lifespan (E, F). 
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Figure S12 | Trajectories of genes associated with neurotransmitter receptors 
(glutamate and dopamine).  
Kainate receptor genes (GRIK1, GRIK2, GRIK3, GRIK4, and GRIK5) show a sharp 
decrease in expression levels during prenatal periods (A) with higher deviation from 
average trajectory also prenatally (B). mGluR group 2 receptor genes (GRM2 and GRM3) 
show a slower decrease in expression levels (C), with V1C in postnatal periods having the 
largest decrease in expression levels and the highest deviation from the average 
trajectory (D). D1-like receptor genes (DRD1 and DRD5) show a slow increase of 
expression through the whole lifespan (E) with small but present deviations from the 
average trajectory (F). 
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Figure S13 | Select prenatal WGCNA modules.  
(A) Heat map showing module 91 (M91) with a frontal-cortex enriched gradient in periods 
3-6 (top hub genes: CYP26A1, HSPA12A, CNIH3, C8orf34, PDE4D, MANBA, ASAM, 
TSEN15, DPP7, and HS6ST3). (B) M13 shows a temporal lobe enriched gradient in 
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period 5 (top hub genes: LRRC4C, GABRB1, SLC24A3, KLHL4, SLC2A13, RIT2, GRM7, 
CSPG5, SV2B, and GDA).(C) M105 contains genes with expression enriched in occipito-
temporal areas in periods 3 and 4 (top hub genes: SHISA6, KCNK12, DOCK10, PCK2, 
TMPRSS13, MAS1, STK10, and PPARG), (D) M100 genes exhibit expression with a 
medio-lateral gradient in periods 4 and 5 (top hub genes: APPL2, CTDSP2, HDAC1, 
ZNF43, NECAP2, and HEATR5A), (E) M2 genes are enriched with posterior perisylvian 
and temporal expression levels in periods 3-5 (top hub genes: PCDH9, CAMK4, OSTN, 
NCAM2, MDGA2, PLEKHH2, and COX7A1), (F) M80 genes exhibit expression with 
frontally enriched expression levels (top hub genes: YPEL2, DPF3, ZNF385A, GADL1, 
SLIT3, C13orf38, GNG7, TCERG1L, RCAN3, and FAM5B), (G) M5 genes exhibit co-
expression patterns in temporo-parieto-occipital areas in periods 3- 5 (top hub genes: 
STARD13, PAPPA2, VRK2, SORCS1, NXPH3, KLHL32, CABP7, WNT7B, OCA2, and 
GPR126), and (H) M118 genes exhibit expression highest in frontal areas in period 6 (top 
hub genes: GDF10, ACHE, CYB561, PDE4A, ADAMTS8, and TMEM151A). 
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 Figure S14 | Prenatal qRT-PCR validation.  
Radar charts showing expression levels in all areas in prenatal periods 3-4 (early) and 5-6 
(mid). Pearson’s correlation coefficient r is printed bold when there is positive correlation 
between human and monkey patterns of expression. The expression pattern is shown 
with lines and points in blue color for humans and red color for macaque. ASAM (A, B) 
shows a different pattern of expression in human and in macaque telencephalon. In 
human cortex, ASAM shows a frontooccipital gradient during early fetal periods (A) which 
disappears in midfetal periods (B). C13orf38 (C, D) shows a fronto-temporal gradient in 
human braun in both early and midfetal periods (C, D, respectively), while in macaque 
NCX the fronto-temporal gradient is not existent; moreover, it is anti-correlated in the early 
fetal period (C). WNT7B (E, F) shows the same gradient in human and monkey brains and 
in both early and mid-fetal periods. NR2F2 (G, H) shows a temporal gradient in both 
species and in all prenatal periods. KCNK12 (I, J) shows an occipito-frontal gradient in 
both periods in humans, while in macaque it is only during the early fetal period. 
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WBSCR17 (K, L) shows a correlated fronto-occipital gradient in both species during mid-
fetal periods, which is not evident during the earlier periods. 
-ΔCT 
 157 
 
 
Figure S15 | Select adolescence and adulthood periods WGCNA modules. 
Heat map of M215 (A) shows genes enriched postnatally in MFC (top genes: GABRQ, 
SLN, CCBE1, SCN9A, C2orf85, ARHGAP6, CCDC109B, GRID2, SYT10, and HTR7). 
M214 (B) genes are enriched postnatally in V1C (top genes: TRPC3, ITGA11, KCNAB3, 
VAV3, SYT6, DPP4, EYA4, PTGS1, EEPD1, and SH3RF2). M269 (C) genes are enriched 
in primary areas (top genes: SYT2, SCN1B, SCN1A, HAPLN4, VAMP1, ANKRD29, 
SCN4B, RAB37, KCNS1, and STAC2). M183 (D) genes are enriched in associative areas 
(top genes: ANO3, PRKCG, SLIT1, SCN3B, RAB27B, FAM65B, SYT17, PRKCD, 
PCDH20, and PPP4R4). M239 (E) genes are enriched in MFC and ITC (top genes: 
ADAMTS19, CCDC148, DPYD, GHR, ARMC2, C2orf60, ANKRD7, KLHL1, COCH, and 
PPM1M).
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Figure S16 | Select adolescent and adult qRT-PCR validations.  
Radar charts show the expression levels in all areas in adolescent and adult human and 
monkey brains. GABRQ exhibits enrichment in MFC in both adolescence and adulthood in 
human, but only in adulthood of the monkey (A, B). TRPC3 shows enrichment in V1C in 
both adolescence and adulthood (C, D). BAIAP3 shows enrichment in associative areas 
(E, F), and VAV3 shows enrichment in primary sensory areas (I, J). Pearson’s correlation 
coefficient r is printed bold when there is positive correlation between human and monkey 
pattern of expression. Human expression pattern is shown with blue lines and points while 
red is used for macaque. 
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3.1. Abstract 
Different brain regions possess distinct transcriptional profiles, and it has long been 
hypothesized that changes in transcriptome profiles have contributed to the evolution of 
the distinct phenotypical differences, including differences in cognitive and motor abilities, 
that exist between humans and non-human primates (NHPs). Here we report the RNA 
sequencing and analysis of 16 adult brain regions, including 11 neocortical areas, from six 
humans, five chimpanzees and five rhesus macaques. We found 6,389 genes were 
differentially expressed (DEX) among species, with 3,154 specifically up- or 
downregulated in humans. Furthermore, a multi-regional approach allowed us to examine 
intra-species DEX genes among all regions and compare how the transcriptional 
relatedness of areas differs among species. In addition, we found region-specific gene co-
expression modules that are conserved across all three species, as well as species-
specific transcription network modules, including one module that specifically 
discriminates human cortical areas. Several genes involved in the dopamine synthesis 
pathway were upregulated in humans, especially in the striatum. Finally, we analyzed the 
co-expression patterns of neurotransmitter receptors systems. Glutamatergic and 
GABAergic systems receptors were the most conserved among species, while 
serotoninergic and cholinergic systems were the least conserved. This study provides a 
comprehensive data set on the human and NHPs brain transcriptomes and insights into 
inter-primate and human-specific gene expression patterns. 
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3.2. Introduction 
Comparisons of human and NHP genomes have yielded lists of coding (Enard, Khaitovich 
et al. 2002, Stedman, Kozyak et al. 2004, Wang and Su 2004, Vargha-Khadem, Gadian et 
al. 2005) and non-coding (Bejerano, Haussler et al. 2004, Pollard, Salama et al. 2006, 
Prabhakar, Noonan et al. 2006, Visel, Prabhakar et al. 2008) changes that may have 
been important in human brain evolution. Beyond genome level analyses, several studies 
have searched for expression differences between human and NHP brains (Somel, Franz 
et al. 2009, Babbitt, Fedrigo et al. 2010, Liu, Somel et al. 2012) an approach rooted in the 
idea that the evolution of regulatory elements, along with coding sequences, underlies 
many phenotypic differences between humans and NHPs (King and Wilson 1975). These 
previous studies provide useful information about expression differences in the human 
and NHP brain but also have several limitations. Most of the studies have used 
microarrays, reducing the comparison to identical probes among species and thus 
decreasing the number of genes compared. Furthermore, all studies have been restricted 
to small sample sizes comprising only a few brain regions due to difficulties in obtaining 
high-quality post-mortem human and NHP brain tissue. By expanding the focus to many 
regions, a more comprehensive understanding can be gained, as the brain consists of 
functionally divided and complexly interconnected regions and circuits.  Studies on global 
transcription patterns in the human brain (Johnson, Kawasawa et al. 2009, Colantuoni, 
Lipska et al. 2011, Kang, Kawasawa et al. 2011) have revealed dynamic spatial regulation 
of transcription across different brain regions, including neocortical areas, further 
emphasizing the importance of analysing a wide range of brain regions. To better 
understand the evolution of the human brain, it is important to extend these multi-regional 
transcriptome studies to distinguish between features that conserved among primates and 
those that are specific to humans. 
 
3.3. Results 
Study design 
We performed a comparative analysis of gene expression in 16 brain regions (Table 1) 
sampled from six human (Homo sapiens; H), five chimpanzee (Pan troglodytes; P), and 
five rhesus macaque (Macaca mulatta; M) adult specimens. RNA sequencing was carried 
out on a total of 247 samples (Supplementary Table 1), resulting in 4.6 billion uniquely 
mapped reads that were used to assess gene expression. Consistent and stringent quality 
control measures were applied at the level of tissue acquisition and dissection, sample 
preparation, and data processing (see the Supplementary Information for a detailed 
description). Briefly, samples were filtered by RIN number, sequencing error, and the 
number of uniquely mapped reads. A hierarchical clustering of all samples separated 
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samples from two macaque brains, which were prepared by different RNA extraction 
methods, from all others. This batch effect was corrected using ComBat (Supplementary 
Information, and Supplementary Fig. 1).  
The macaque, which last shared a common ancestor with chimpanzees and humans 
around 25 million years ago (Ma; Sequencing, Consortium et al. 2007) served as an 
outgroup, enabling the inference of evolutionary species-specific differences between 
human and chimpanzees, which diverged approximately 6 Ma (Mikkelsen, Hillier et al. 
2005). To infer the genetic distances among individuals and verify that samples are not 
more closely related than expected (for reasons such as inbreeding while in captivity), 
RNA-Seq reads were used to call SNPs and build neighbor-joining trees (Supplementary 
Information and Supplementary Fig. 2). Clustering reliably captured evolutionary 
relationships. As expected, humans had the lowest variation and macaques had the 
greatest.  
 In order to examine the contributions of different factors to transcriptional 
differences, we applied principal component analysis (PCA). The species to which each 
sample belonged (Figure 1a), rather than the region (Figure 1b), accounted for the most 
variance, indicating that inter-species differences are more pronounced than intra-species 
inter-regional differences in gene expression. Furthermore, the PC1, which accounts for 
19.3% of the variability, separated macaque from human and chimpanzee samples, while 
the PC2, which explained 11.5% of the variance, separated human from chimpanzee 
samples (Figure 1). 
 
Interspecies differential expression 
We first focused on genes that had expression differences among species for each of the 
16 brain regions. To avoid biases due to the quality of gene annotation for the three 
species, we generated a common annotation set by overlapping reciprocal mapping of 
human annotation onto the chimpanzee and macaque genomes (Supplementary 
Information) and considered only 1:1:1 species orthologs for all downstream analyses. For 
each region, DEX genes were calculated by comparing generalized linear models (GLM), 
with species as a main factor and batch as a co-factor.  
 We found 6,389 genes that were differentially expressed between at least two 
species in one or more regions. Based on post hoc comparisons (Supplementary Table 
2), DEX genes were classified by the relationship among species, such as human and 
chimpanzee expression levels similar to each other and greater than macaque levels: H = 
P > M (Figure 2a). As expected, based on evolutionary relationships, the two most 
frequent patterns of differential expression had similar levels in human and chimpanzee 
 165 
samples, which together differed from the expression levels in macaque samples (H = P > 
M and H = P < M).  
 Within all the different species relationships, regions had substantial differences in 
the number of DEX genes, highlighting the importance of a multi-regional analysis. For 
genes with human-specific up- or downregulation (H > P = M or H < P = M), STR showed 
an excess of DEX genes, indicating that this region may have played an important role in 
human brain evolution (Figure 2b). There has been conflicting evidence of a human-
specific increase in gene upregulation (Caceres, Lachuer et al. 2003, Gu and Gu 2003, 
Khaitovich, Muetzel et al. 2004, Uddin, Wildman et al. 2004). In our study, 15 of the 16 
regions showed a greater number of genes with human-specific upregulation than genes 
with human-specific downregulation, with STR being the only region with more human-
specific downregulation. In contrast, chimpanzee brain regions were as likely to have a 
higher number of downregulated genes as upregulated, while only 2 macaque regions – 
HIP and STR – had more upregulated genes, with 14 showing more downregulated 
genes. 
Among the genes with human-specific up- or downregulation (Supplementary 
Table 3), we found 31 genes that were DEX in all regions. Only 3 genes were significantly 
DEX (H > P = M or H < P = M) exclusively in the eleven neocortical areas: TWIST1 
(Figure 2c), RP11-364P22.1, and CTB-78F1.1. There were also several genes that show 
human-specific DEX in only one brain region. Among those, we found that ZP2, a gene 
that was previously reported to be highly expressed in the postnatal human cerebellar 
cortex (Kang, Kawasawa et al. 2011) is not expressed, at our detection level, in any 
area/region of the chimpanzee and macaque brains (Figure 2d). 
 To gain some knowledge on which functional groups are more represented in our 
DEX gene list we performed gene ontology (GO) enrichment analysis. GO analysis on the 
species-specific DEX genes did not reveal any clear enrichment of functional categories, 
as most of the genes did not have distinctive functional annotation.  
 
Intraspecies differential expression 
In addition to species differences at the level of individual regions, we investigated how 
the regional transcriptional architecture differs among species. For each species, we 
calculated the number of intra-species DEX genes for all regions (Figure 3a) and for NCX 
areas only (Figure 3b). We found a smaller number of DEX genes in human brains 
regions, with macaque showing the highest number (Figure 3a). This pattern was 
especially pronounced in NXC areas (Figure 3b), indicating that the human NCX areas 
are very similar in terms of gene expression, when compared to chimpanzee or macaque. 
We also calculated pairwise correlation matrices of DEX genes and performed 
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hierarchical clustering of all regions to reveal the transcriptional relatedness of brain 
regions (Figure 3c-e). As expected (Lockhart and Barlow 2001, Roth, Hevezi et al. 2006), 
the CBC was the most divergent area of the brain in all species, followed by the STR and 
the MD (though in macaque the MD is more divergent from the cortical areas than the 
STR), thus clearly separating cortical areas from non-cortical ones. As mentioned above, 
NCX areas were more transcriptionally similar in humans than NCX areas were in either 
chimpanzees or macaques (Figure 3c-e). Among these areas, several intriguing species 
differences in clustering were present. Interestingly, the clearest difference in clustering 
was found in macaques, where all primary areas (M1C, S1C, A1C, and V1C) clustered 
together (figure 3e). Another noteworthy result was found in humans, which showed a 
clustering of IPC, STC, and VFC, a group of areas that comprise the perisylvian language 
areas of Broca and Wernicke (Broca 1861, Dax 1865, Wernicke 1874). This clustering 
was not present in the other two species. 
 
Weighted gene co-expression network analysis (WGCNA) 
As the DEX analysis focused on single genes and on a limited number of expression 
patterns, we next applied WGCNA to identify modules of highly co-expressed genes by 
searching for genes with similar patterns of variation across samples (Zhang and Horvath 
2005). We identified 229 modules of co-expressed genes (Supplementary Table 4), many 
with distinct regional and/or species expression patterns (Figure 4a). Modules with 
patterns that are shared across all three species include M33, a module that is enriched in 
NCX areas (Supplementary Figure 3). Genes in this module are enriched in the categories 
“Homeobox, conserved site” (Bonferroni-adjusted P = 0.02) and “transcription factor" 
(Bonferroni-adjusted P = 0.02). Hub genes in this module include a handful of genes that 
have been linked to neocortical development, including TBR1 (Hevner, Shi et al. 2001, 
Han, Kwan et al. 2011, McKenna, Betancourt et al. 2011), and SATB2 (Britanova, de 
Juan Romero et al. 2008), two genes that have previously been shown to be co-regulated 
(Srinivasan, Leone et al. 2012). Species also shared several spatially restricted modules, 
such as M16 enriched in CBC (Supplementary Figure 4). Genes in M16 are associated 
with “transcription factor activity” (Bonferroni-adjusted P = 2.9E-4), “DNA-binding” 
(Bonferroni-adjusted P = 3.9E-4) and “developmental protein” (Bonferroni-adjusted P = 
8.5E-4).  
 In contrast to these shared modules, other modules were distinguished by species 
differences. Among human-specific modules, M81, 162, 192, 229, were upregulated in all 
human regions (Supplementary Figures 5-8). Similarly, M215 is selectively increased in 
human cortical regions (Figure 4b). Genes in M81 were associated with “TSPN” 
(Bonferroni-adjusted P = 0.02), in M192 with “oxidative phosphorylation” (Bonferroni-
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adjusted P = 0.03), and in M229 with “ribosome” (Bonferroni-adjusted P = 1.2E-3), 
“ribosomal subunit” (Bonferroni-adjusted P = 0.01), and “large ribosomal subunit” 
(Bonferroni-adjusted P = 0.02). No significant pathways were identified for M162 or M215 
after Bonferroni adjustment. There were modules that show human-specific decreases in 
all regions, such as M69, and M173 (Supplementary Figures 9 and 10). No significant 
pathways were identified for M69 and M173 after Bonferroni adjustment. 
 Interestingly, some modules revealed species differences in only a small subset of 
regions. M130 is composed of genes that were upregulated in human AMY, HIP, and 
STR, which is the region with the most interspecies DEX genes (Figure 4d). Intriguingly, 2 
hub genes in this module are involved in the synthesis of dopamine: TH and DDC in M130 
(Figure 4e). One of the hub-genes in the M215 (Figure 4c), PAH, may also be part of the 
dopamine biosynthesis pathway. Due to this finding, we carried out a more detailed 
analysis of genes involved in dopamine metabolism. 
  
Human-specific expression of genes involved in dopamine synthesis  
Dopamine is a monoamine neurotransmitter that belongs to the catecholamine family, and 
it is the precursor of epinephrine and norepinephrine. Dopamine is synthetized from either 
L-phenylalanine or L-tyrosine by three enzymes in consecutive steps: phenylalanine 
hydroxylase (PAH) converts L-phenylalanine into L-tyrosine; tyrosine hydroxylase (TH) 
converts L-tyrosine into L-dihydroxyphenylalanine (L-DOPA); finally, DOPA decarboxylase 
(DDC) converts L-DOPA into dopamine (Figure 5a). We revealed that PAH exhibited 
higher expression levels in the human neocortical areas, when compared to chimpanzee 
and macaque (Figure 5b). More importantly, we found that TH and DDC showed higher 
expression levels in the STR of humans (Figures 5d and 5f). Furthermore, the genes 
coding for two of the enzymes involved in dopamine degradation, COMT and MAOA, did 
not show any significant differences, in expression, between species (Supplementary 
Figure 11). All these findings were validated using droplet digital PCR (ddPCR; Figure 5c, 
5e, and 5g). Together, this indicates that humans may have higher levels of dopamine in 
STR, because humans are producing more dopamine, which is then presumably 
degraded at the same level as in the other species. To determine if these differences were 
reflected at the protein level, we performed protein immunoblotting of STR lysates from 
human, chimpanzee, and macaque samples. Remarkably, both TH and DDC showed 
higher levels in human STR than in the other species (Supplementary Figure 12). The 
difference was more pronounced in TH, which is the enzyme that catalyzes the rate-
limiting step in the biosynthesis of dopamine.  
 We also analyzed dopamine receptors expression patterns to verify if the 
upregulation of dopamine production is accompanied by an upregulation of dopamine 
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receptors. Surprisingly, we found 3 genes that encode dopamine receptors – DRD1, 
DRD2, and DRD3 – were downregulated in the human STR (Supplementary Figure 13), 
which may have a balancing effect on the overproduction of dopamine in the human STR. 
 These differences in dopamine biosynthesis and neuroreceptors encouraged us to 
extend our analyses to other neurotransmitter systems. 
 
Neurotransmitter receptors networks 
Although differences in neurotransmitter biosynthesis may alter physiological properties of 
neural circuits because the levels of neurotransmitters will affect synaptic transmission, 
the composition of receptors is also relevant.  We generated co-expression networks 
between neuroreceptor subunits and measured the conservation of these networks 
among the three species. A statistic Z was calculated to evaluate the preservation of the 
network compared with randomly selected sets containing the same number of genes  
(Langfelder et al, 2011). We limited the analysis to four systems that involved enough 
genes to provide reliable comparisons: glutamatergic, GABAergic, serotoninergic, and 
cholinergic (Figure 6). The major excitatory and inhibitory systems in the brain, i.e. the 
glutamatergic and the GABAergic systems (Figure 6a and 6b, respectively), have similar 
correlation networks among species (Supplementary Figure 14). This conservation is 
unsurprising given that these two systems are ubiquitous and have a vital role in brain 
function. On the other hand, the two neuromodulatory systems analyzed, i.e. the 
cholinergic and the serotoninergic systems, have significantly different networks: human 
and chimpanzee serotoninergic networks are different from macaque (Figure 6c and 
Supplementary Figure 14); and chimpanzee have a significantly different cholinergic 
network when compared to human and macaque (Figure 6d and Supplementary Figure 
14).  
 
3.4. Conclusion 
Our study uncovers several human-specific features at the level of gene expression, 
allowing a better understanding of some aspects of human brain evolution. We show that 
some areas of the brain, like the striatum, show more differences between species than 
others. Species also exhibit different transcriptional architectures between brain regions. 
Additionally, all species show specific network modules of co-expressed genes, including 
two specific modules with human-specific expression of genes in cortical areas. We also 
found remarkable differences in the dopamine synthesis pathway, with several important 
genes being upregulated in humans. Moreover, we show differences among 
neurotransmitter receptors and reveal that some of them have a more conserved 
expression pattern than others. This data set (available at 
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www.humanbraintranscriptome.com) provides a basis for further functional studies on 
genes that might be of high relevance for human-specific traits and also for future 
comparisons with other transcriptome data sets. 
 Our study expands the knowledge of spatial differences in gene expression that 
distinguish the human brain from other NHPs, but uncovering how these regional 
differences vary throughout time, especially during prenatal and postnatal development, 
will be essential for a better understanding of human brain development and evolution.  
 
3.5. Methods summary 
Supplementary Information provides a full description of tissue acquisition and processing, 
data generation, validation and analyses. 
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3.7. Tables 
 
Table	  1	  |	  Specimens	  list	  
	   	   	   	  
	   	   	   	   	   	  Number Species Sex Age (years) Hemisphere 
	  HSB 123 Homo sapiens Male 37 Right 
	  HSB 126 Homo sapiens Female 30 Right 
	  HSB 130 Homo sapiens Female 21 Left 
	  HSB 135 Homo sapiens Female 40 Right 
	  HSB 136 Homo sapiens Male 23 Right 
	  HSB 145 Homo sapiens Male 36 Right 
	  PTB 162 Pan troglodytes Female 23 Left 
	  PTB 164 Pan troglodytes Female 31 Right 
	  PTB 165 Pan troglodytes Male 31 Right 
	  PTB 166 Pan troglodytes Male 27 Right 
	  PTB 167 Pan troglodytes Male 30 Right 
	  RMB 160 Macaca mulatta Female 11 Left 
	  RMB 161 Macaca mulatta Male 11 Left 
	  RMB 196 Macaca mulatta Female 11 Right 
	  RMB 218 Macaca mulatta Male 7 Left 
	  RMB 219 Macaca mulatta Male 7 Left 
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3.8. Figures 
 
 
Figure 1. Principal component analysis 
Three-dimensional plot of PCA of all samples. Each point represents one sample. 
Samples are colored by species (a) or by region (b). The percentage of variation that is 
explained by each Principal Component is shown. 
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Figure 2. Interspecies differential expression 
a, Heat map showing the number of genes differentially expressed, according to post hoc 
comparisons explained in supplementary table 2. b, Number of human-specific genes that 
are up- (h>p=m; red) or downregulated (h<p=m; blue) across the 16 brain regions. c, 
Expression [log2 (RPKM+1)] pattern of TWIST1. Significant differences are labeled with an 
asterisk. d, Expression pattern of ZP2. Significant differences are labeled with an asterisk. 
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Figure 3. Intraspecies differential expression 
a, Bar plot showing the number of intra-species DEX genes across all regions in human 
(red), chimpanzee (blue), and macaque (green). b, Bar plot showing the number of intra-
species DEX genes across the neocortical areas in human (red), chimpanzee (blue), and 
macaque (green). c, d, e, Heat maps of the unsupervised clustering of all regions in 
human, chimpanzee, and macaque, respectively. 
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Figure 4. Global co-expression networks and gene modules 
a, Figure showing the gene co-expression network analysis of all samples. Modules 
labeled as human-specific (red), chimpanzee-specific (blue), macaque-specific (green). 
Modules with a conserved expression (orange) and in a gradient pattern (violet) among 
species are labeled. Modules represented by a square include genes that are co-
expressed in all regions. Modules with a hexagon include genes that are co-expressed in 
only one region. b, Bar plot showing the spatial expression pattern of module 130. c, 
M130 genes. d, Bar plot showing the spatial expression pattern of module 215. e, Module 
215 genes. 
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Figure 5. Dopamine biosynthesis pathway 
a, Schematic figure of the dopamine biosynthesis pathway. b, Expression [log2 (RPKM+1)] 
pattern of PAH. This gene is significantly upregulated in several human neocortical áreas 
and the MD. c, ddPCR validation of PAH expression normalized to the housekeeping 
gene TBP. d, Expression pattern of TH. This gene is significantly upregulated in human 
striatum and amygdala. e, ddPCR validation of TH expression normalized to the 
housekeeping gene TBP. f, Expression pattern of DDC. This gene is significantly 
upregulated in the human striatum. g, ddPCR validation of DDC expression normalized to 
the housekeeping gene TBP.  
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Figure 6. Neurotransmitter receptor systems 
Network of co-expression of genes encoding glutamatergic system (a), GABAergic (b), 
cholinergic (c), and serotoninergic (d) receptor subunits. Positive correlation (red) and 
negative correlation (blue) between genes are shown. 
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1. Introduction 
 
In this Supplementary Information we provide further information regarding the study 
design, materials and methods, and additional data. The materials and methods section 
provide detailed description of the collection, dissection methods, and quality control 
assessments of human, chimpanzee and macaque postmortem tissue used in this study. 
We provide technical descriptions of data generation and analyses using different 
platforms. We also make available additional data and supplementary figures and tables 
that were discussed in the main manuscript. Some information for the human samples 
and procedures is shared with our previous study (Kang, Kawasawa et al. 2011) and is 
reproduced for completeness. 
 
2. Ontology and anatomical definition of sampled brain regions and NCX areas 
 
In the present study, we analysed the same 16 brain regions as in our previous 
study (Kang, Kawasawa et al. 2011). All brains were dissected using the same 
protocol used for human specimens. Chimpanzee and macaque brain regions 
were sampled according to DeLucchi (de Lucchi, Dennis et al. 1965) and Saleem 
and Logothetis (Saleem and Logothetis 2007) reference atlases, respectively. 
 
3. Tissue Procurement and Sampling 
3.1 Tissue procurement 
Postmortem human brain specimens were obtained from tissue collections at the 
Department of Neurobiology at Yale University School of Medicine and the Clinical Brain 
Disorders Branch of the National Institute of Mental Health [human paper ref?]. Tissue 
was collected after obtaining parental or next of kin consent and with approval by the 
institutional review boards at the Yale University School of Medicine, the National 
Institutes of Health, and at each institution from which tissue specimens were obtained. 
Tissue was handled in accordance with ethical guidelines and regulations for the research 
use of human brain tissue set forth by the NIH 
(http://bioethics.od.nih.gov/humantissue.html) and the WMA Declaration of Helsinki 
(http://www.wma.net/en/30publications/10policies/b3/index.html). Appropriate informed 
consent was obtained and all available non-identifying information was recorded for each 
specimen. Specimens range in age from 21 to 40 years. The postmortem interval (PMI) 
was defined as hours between time of death and time when tissue samples were frozen. 
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All experiments using nonhuman primates were carried out in accordance with a protocol 
approved by Yale University’s Committee on Animal Research and NIH guidelines. 
 
3.2 Neuropathological evaluation 
All clinical histories, tissue specimens, and histological sections were evaluated to assess 
for hypoxia, cerebrovascular incidents, tumours, microbial infections, neurodegeneration, 
demyelination, and metabolic disease. To prepare tissue sections for microscopic 
neuropathological examination, small samples (usually the dorsal parietal cortex, striatum 
with ependymal layer and subependymal zone, hippocampus, and the cerebellar cortex) 
were dissected and fixed in 4% paraformaldehyde and processed for histology and 
immunohistochemistry as described below. 
 
3.3 Selection criteria for brain specimens 
To better ensure consistency between samples and decrease potential variation due to 
ante- and postmortem conditions, specific selection criteria were arbitrarily established. 
The aim was to collect tissue specimens from clinically unremarkable donors. The 
following selection criteria were strictly adhered to when deciding whether to exclude or 
include each brain specimen:  
• Only brains free of obvious malformations or lesions were collected. Disqualifying 
characteristics included prominent intraparenchymal haemorrhage and ischemia, 
infection, periventricular leukomalacia, abnormal meninges, dysplasia, hypoplasia, 
alterations in the pial or ventricular surface, and extensive white matter lesions. 
• Samples were excluded if microscopic analysis revealed extensive neuronal loss, 
neuronal swelling, glioneuronal heterotopias, or dysmorphic neurons and neurites. 
• Samples that tested positive for Hepatitis B, Hepatitis C, or HIV were excluded. 
• Human specimens were excluded if excessive drug or alcohol abuse was 
reported. All specimens with any known neurological or psychiatric disorders, or 
any prolonged agonal conditions (coma, prolonged pyrexia, hypoxia, seizures, 
prolonged dehydration, hypoglycaemia, and multiple organ failure) were not 
included in this study. Other excluding factors included ingestion of neurotoxic 
substances at the time of death, suicide (within humans), severe head injury, 
significant haemorrhages, widespread vascular abnormalities, ischemia, tumours, 
stroke, congenital neural abnormalities, and signs of neurodegeneration 
(spongiosis, amyloid plaques, neurofibrillary tangles, Lewy bodies, and amyloid 
angiopathy). 
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3.4 Tissue dissection 
Different dissection procedures were used for each specimen depending on whether the 
samples were frozen (human and chimpanzee specimens) or fresh (macaque 
specimens). 
 
3.4.1 Regional sampling from fresh brain specimens 
Brains were chilled on ice for 15–30 minutes prior to sectioning. Brains were placed 
ventral side up onto a chilled aluminium plate (1 cm thick) on ice. The brainstem and 
cerebellum were removed from the cerebrum by making a transverse cut at the 
junction between the diencephalon and midbrain. Next, they were sectioned to obtain 
1 cm (period 5–15 specimens) or 0.5 cm (periods 3 and 4 specimens) thick serial, 
coronal sections. The tissue slabs were snap frozen in isopentane (J.T. Baker)/dry ice 
at -30 to -40 ºC and stored at -80 ºC.   
 
3.4.2 Regional sampling from frozen brain specimens   
All previously frozen periods 3–15 specimens and tissue slabs were microscopically 
inspected and the desired region was demarcated, then dissected using a dental drill 
(AnyXing, 300D) and a Lindemann Bone Cutter H162A.11.016 or diamond disk saw 
(Dental Burs USA; r=11 mm) on a 1 cm thick aluminium plate over dry ice. Dissected 
tissue samples were stored at -80 ºC prior to further processing. 
 
3.5 Histological verification of tissue sampling 
To verify that the region or NCX area of interest is properly and consistently sampled, we 
also collected small tissue blocks, adjacent to the tissue sample dissected for the RNA 
extraction. We have done this for the majority of M1C, S1C, IPC, A1C and V1C samples, 
which in our experience were hard to match across different specimens but can be 
histologically verified using Nissl method in postnatal specimens due to cytoarchitectonic 
differences. This method was also occasionally used for other regions or NCX areas. 
These tissue blocks were then fixed in 4% paraformaldehyde for 48 h, sectioned at 50 µm 
thickness using a vibratome, and Nissl stained to verify the identities of dissected adjacent 
tissue (data not shown).  
 
3.6 Tissue pulverization 
To ensure proper representation of the region of interest, frozen tissue samples were 
pulverized in liquid nitrogen using a ceramic mortar and pestle (Fisher Scientific, cat# 12-
961C and 12-961-5C). Pulverized samples were transferred to chilled wide-mouth 
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cryogenic vials (Nalgene, cat# 03-337-7B) and stored at -80 ºC until used for RNA 
extraction. 
 
4. RNA Isolation, Library Preparation, Sequencing, and Quality Assessment 
4.1 RNA extraction 
A bead mill homogenizer (Bullet Blender, Next Advance) was used to lyse the pulverized 
tissue. Each pulverized tissue sample was transferred to a chilled safe-lock 
microcentrifuge tube (Eppendorf). A mass of chilled stainless steel beads (Next Advance, 
cat# SSB14B) equal to the mass of the tissue was added to the tube. Two volumes of 
lysis buffer were added to the tissue and beads. Samples were mixed in the Bullet 
Blender for 1 min at a speed of six. Samples were visually inspected to confirm desired 
homogenization and then incubated at 37 °C for 5 min. The lysis buffer was added up to 
0.6 ml, and samples were mixed in the Bullet Blender for 1 min. Total RNA was extracted 
using RNeasy Plus Mini Kit (Qiagen) for mRNA-sequencing and using mirVana kit 
(Ambion) for small RNA-sequencing. Total RNAs from two macaques (RMB 218 and RMB 
219) were also extracted using mirVana kit. Each sample was subjected to a DNase 
treatment (TURBO DNase, Ambion) as per manufacturer’s instructions. 
Optical density values of extracted RNA were measured using NanoDrop (Thermo 
Scientific) to confirm an A260:A280 ratio above 1.9. RIN was determined for each sample 
using Bioanalyzer RNA 6000 Nano Kit (Agilent), depending upon the total amount of RNA. 
 
4.2 Library preparation for mRNA-sequencing 
cDNA libraries were prepared using the mRNA-Seq Sample Kit (Illumina) as per the 
manufacturer’s instructions with some modifications. Briefly, polyA RNA was purified from 
1 to 5 µg of total RNA using (dT) beads. Quaint-IT RiboGreen RNA Assay Kit (Invitrogen) 
was used to quantitate purified mRNA with the NanoDrop 3300. Following mRNA 
quantitation, 2.5 µl spike-in master mixes, containing five different types of RNA 
molecules at varying amount (2.5 × 10-7 to 2.5 × 10-14 mol), were added per 100 ng of 
mRNA (Jiang et al., 2011). The spike-in RNAs were synthesized by External RNA Control 
Consortium (ERCC) consortium by in vitro transcription of de novo DNA sequences or of 
DNA derived from the B. subtilis or the deep-sea vent microbe M. jannaschii genomes 
and were a generous gift of Dr. Mark Salit at The National Institute of Standards and 
Technology (NIST). These were used both to track the brain regions and to normalize 
expression levels across experiments. Each sample was tagged by adding a pair of spike-
in RNAs unique to the region from which the sample was taken. Also, an additional three 
common spike-ins were added for controlling sequencing error rates, which is not 
influenced by SNP existence (Supplementary Table 5). The mixture of mRNA and spike-in 
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RNAs were subjected to fragmentation, reverse transcription, end repair, 3’– end 
adenylation, and adapter ligation to generate libraries of short cDNA molecules. The 
libraries were size selected at 200 – 250 bp by gel excision, followed by PCR amplification 
and column purification. For RMB 218 and 219, we used TruSeq RNA Sample Prep Kit to 
generate cDNA libraries as per the manufacturer’s instructions with the similar 
modification of adding spike-in RNAs before the mRNA fragmentation. The TruSeq Kit 
allows addition of 12 different types of index, thus the multiplexing of samples when they 
are sequenced. The final product was assessed for its size distribution and concentration 
using Bioanalyzer DNA 1000 Kit. 
 
4.3 Library preparation for small RNA-sequencing 
The TruSeq Small RNA Sample Kit (Illumina) was used to prepare cDNA libraries per 
manufacturer instructions. Briefly, 1 µg of total RNA was ligated with 3’- and then 5’- 
adapters, followed by reverse transcription and PCR amplification. The PCR utilizes 48 
different types of primer that will add 48 different index sequences to the adapters. Each 
library was assessed for the presence of desired micro RNA population by Bioanalyzer 
High Sensitivity DNA Kit. We pooled 21 samples (16 samples from one brain and 5 
technical replicates) with distinct indexes, which allow subsequent retrieval of each 
sample from multiplexed sequencing runs. Each pooled library was size selected by gel 
excision. The final product was assessed for its size distribution and concentration using 
Bioanalyzer DNA 1000 Kit. 
 
4.4 Sequencing 
We used Illumina Genome Analyzer IIx (GAIIx) for mRNA-sequencing by loading one 
sample per lane. But for RMB 218 and 219, we used HiSeq 2000 by loading 4 samples 
per lane. For small RNA-sequencing, we used Illumina HiSeq 2000 by loading 21 samples 
per lane. 
For GAIIx sequencing, the library was diluted to 10 nM in EB buffer and then denatured 
using the Illumina protocol. The denatured libraries were diluted to 12 pM, followed by 
cluster generation on a single-end Genome Analyzer IIx (GAIIx) flow cell (v4) using an 
Illumina cBOT, according to the manufacturer's instructions. The Illumina GAIIx flow cell 
was run for 75 cycles using a single-read recipe (v4 sequencing kits) according to the 
manufacturer's instructions. 
For HiSeq 2000 sequencing, the library was diluted to 10 nM in EB buffer and then 
denatured using the Illumina protocol. The denatured libraries were diluted to 15 pM, 
followed by cluster generation on a single-end HiSeq flow cell (v1.5) using an Illumina 
cBOT, according to the manufacturer's instructions. The HiSeq flow cell was run for 75 
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cycles for RMB218 and 219 mRNA-sequencing, and for 50 cycles for small RNA-
sequencing using a single-read recipe (v2 sequencing kit) according to the manufacturer's 
instructions. 
 
5. mRNA Sequencing Data Analysis 
5.1 mRNA sequencing alignment, annotation, and expression quantification  
5.1.1 Reference genomes and read alignment 
The exporter files generated from Illumina's CASAVA pipeline were converted to fastq 
file. Reads were then filtered by quality score and mapped to the human (Homo 
sapiens, Feb. 2009 hg19), chimpanzee (Pan troglodytes, Oct. 2010 panTro3), and 
rhesus macaque genomes (Macaca mulatta, Jan. 2006 rheMac2), as appropriate, 
using TopHat without providing junction annotation.    
 
5.1.2 Generation of inter-species annotation 
To calculate the gene expression, we first created a composite gene model, 
using RSEQtools (Habegger et al., 2010), based on human Gencode v10 
(Harrow et al., 2012). In the composite model, the overlapped exons in the 
same gene were merged to one to avoid double counting.  
To find the non-human primate orthologous sequences for human exons, 
we mapped the human composite exons using liftOver (Hinrichs et al., 2006) 
followed by multiple filtering steps using BLAT (Kent 2002). 
LiftOver: The coordinates of exons on the human genome were converted 
to those on the chimpanzee and the rhesus macaque genomes, according to 
the instructions provided in liftOver. The parameter –minMatch was set to 0.98 
for chimpanzee and 0.913 for macaque, respectively, based on exon sequence 
similarity simulation (data not shown). The resulting coordinates were then 
converted back to the human genome, with the same –minMatch setting. The 
exons that did not map to the same human genomic location and the genes 
with exons mapping to different chromosomes or different strands were 
excluded from further analysis.  
BLAT: As liftOver is based on alignments of big stretches, we performed 
multiple steps of filtering with BLAT to obtain an accurate conversion. 
• Exons with low identity score (ID) and low percentage of mapped length (PL) 
were excluded. IDs were set to 0.95 and 0.9 for human-chimp and human-
macaque exon conversion, respectively. PL was set to 90%. 
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• To avoid the difficulties in estimating multi-mapped reads, we further filtered 
the exons (ID > 0.95 for human-chimp and ID > 0.9 for human-macaque, PL 
> 90%) and genes (ID > 95%, PL > 80%) with highly similar duplicated 
sequences. 
• To ensure the remaining sequences represent the original gene model, we 
kept only genes with length > 500bps or with at least 1/3 of the original 
length. Besides, we compared the rpkm of human genes using the 
converted model with that using original Gencode v10 annotation and 
filtered out genes with mean absolute difference greater than 1.  
 
5.1.3 Expression quantification 
After the reads were mapped to the reference sequences, the expression level of 
genes and exons were quantified by count number and RPKM (reads per kilobase of 
exon model per million mapped reads) (Mortazavi, Williams et al. 2008), using 
RSEQtools. Only genes with count number greater than 10 and maximum regional 
mean RPKM greater than 1 were included in further analysis. 
 
5.2 Quality control assessment and detection of outliers 
Several quality control measures were implemented throughout sample preparation and 
transcriptome data generation steps as described in Kang et al. 2011.  Samples that failed 
to pass the quality control measures were reprocessed or removed from the downstream 
analyses.  
5.2.1 Number of uniquely mapped reads 
The number and the percentage of uniquely mapped reads were calculated for each 
sample. Samples with less than 5 million reads or low percentage of uniquely mapped 
reads were excluded or re-sequenced. 
 
5.2.2 Uniformity of reads’ coverage along the annotated genes 
All genes were evenly divided into 100 segments from 5’ to 3’ end. We calculated the 
number of nucleotides mapped to each segment. Only genes with more than 1000 
nucleotides mapped were used.  The percentage of nucleotides (PN) mapped to each 
segment was calculated as the number of nucleotides in each segment divided by the 
total number of nucleotides mapped to the whole gene. The median of segmental PN 
for all genes was calculated to represent segmental PN of a specific sample. The 
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quartiles of sample segmental PN were then plotted, with solid and dash lines 
representing median, upper, and lower quartiles, respectively. 
 
5.2.3 Hierarchical clustering and batch effect correction 
All analyses were performed using R (R Development Core Team, 2008). 
Hierarchical clustering was performed using function hclust, with 1-correlation as 
distance. Hierarchical clustering of log2-RPKM clearly separated samples by species, 
as well as RNA extraction protocols (Supplementary fig. 1a). To normalize the 
expression values, we performed quantile normalization to log2-RPKM values  
(Hansen, Irizarry et al. 2012), and eliminated batch effects using R package ComBat 
(Johnson et al., 2007). We then built a hierarchical clustering with the normalized 
data, which resulted in a clustering by species and regions (Supplementary fig 1b). 
 
5.2.4 Principal component analysis 
We performed a PCA for all samples included in the study, and for samples belonging 
to each species separately, using the function prcomp. The first three components 
were plotted using the R package rgl (Adler and Murdoch, 2010).. The percentage 
of variance explained by each component was also plotted (Figure 1).  
 
5.2.5 Effects of RIN and PMI on mRNA expression 
To investigate the effects of main factors and confounders on the data, we drew the 
first three principle components against factors, including species, region, RIN, and 
PMI.  
The number of genes with RPKM > 1 and RPKM > 10 were plotted against RIN and 
PMI, respectively. The upper quartile, median, and lower quartile of gene RPKM were 
plotted against RIN and PMI. No correlation was found in all these plots. As 
chimpanzee PMI were not available and all macaque samples were processed within 
one hour after death, only human sample were used in PMI plots.  
 
5.3 Identification of DEX genes 
DEX genes were computed with the R package DESeq (Anders and Huber, 2010). In 
this package, the count data were modeled with a negative binomial distribution to 
address the problem of overdispersion.  
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5.3.1 Identification of inter-species DEX genes 
Inter-species DEX genes were computed for each brain region. Five generalized linear 
model of the negative binomial family with log link were fitted for each gene. The fitted 
models were listed as follows: 
• Model A: count ~ species + batch (3 levels of species: human, chimpanzee, 
macaque) 
• Model H: count ~ species + batch (2 levels of species: human, 
chimpanzee/macaque) 
• Model P: count ~ species + batch (2 levels of species: chimpanzee, 
human/macaque) 
• Model M: count ~ species + batch (2 levels of species: macaque, 
human/chimpanzee) 
• Model 0: count ~ batch 
P values were calculated by a χ2 likelihood ratio test comparing Model A with 
Model 0 and inter-species DEX genes were called at a false discovery rate (FDR; 
Benjamini and Hochberg, 1995) of 0.01.  
Eleven inter-species gene expression patterns were investigated per region. The 
genes were called at false discovery rate 0.01 for significant differential expression 
and 0.1 for non-significance. The models used were listed in Supplementary Table 3. 
 
5.3.2 Identification of intra-species DEX genes 
P values of likelihood ratio test were computed by comparing the alternative model 
(count ~ region + batch) with the null model (count ~ batch). Intra-species DEX genes 
were called at a false discovery rate (FDR) of 0.01.  
 
 
5.4 Weighted gene co-expression network analysis (WGCNA) 
Signed co-expression networks were built using the WGCNA package in R (Langfelder 
and Horvath, 2008). To reduce noise, only inter- and intraspecies DEX genes were 
included in the analysis. For all genes included, a pair-wise correlation matrix was 
computed, and an adjacency matrix was calculated by raising the correlation matrix to a 
power. The power was set to 15 according to a scale-free topology criterion. For each pair 
of genes, a robust measure of network interconnectedness (topological overlap measure) 
was calculated based on the adjacency matrix. The topological overlap based dissimilarity 
was then used as input for average linkage hierarchical clustering. Modules were 
generated by hybrid dynamic tree-cutting. To obtain rare expression patterns, we set the 
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minimum module size to 5 genes, deepSplit to 4, and the minimum height for merging 
modules to 0.15.   
Each module was summarized by an eigengene, which is the first principal component 
of the scaled module expression. Thus, the module eigengene explained the maximum 
amount of variation of the module expression levels. The module membership (also 
known as module eigengene based connectivity kME) is defined as the correlation 
between gene expression values and the module eigengene. To obtain modules with 
clear clustering of expression patterns, we iteratively reassigned genes to the module with 
largest kME and genes with maximum kME < 0.5 were assigned to the M0.   
 
5.5 Conservation of neurotransmission systems 
We compared networks of neurotransmitter receptors across species. Networks were 
constructed based on pairwise correlation of receptors’ subunits genes from the same 
neurotransmission system. The preservation of the networks was evaluated with the 
statistics computed by modulePreservation function in WGCNA R package. 
6. Functional enrichment analysis 
Functional enrichment was assessed using DAVID Bioinformatics Resources 
(http://david.abcc.ncifcrf.gov; Huang et al., 2009). 
 
7. Determination of the genetic relationships among samples 
We used the DFC samples from each individual (expect for HSB 136, for which OFC was 
used, as the DFC sample was filtered out in the process of quality control) to study the 
relationships between species, under the assumption that one sample should represent 
the true phylogeny of the species. 
 
7.1 Mapping 
All DFC samples were mapped against the human reference genome by GEM (Marco-
Sola et al., 2012), allowing mismatches based on different divergence of the species. 
Human samples were mapped at edit distance 1. Unmapped reads were trimmed at 50 bp 
and mapped at edit distance 1. Chimps were mapped at edit distance 2. Unmapped reads 
were then mapped at edit distance 3. If still unmapped, reads were then trimmed at 50 bp 
and mapped at edit distance 2. Macaque samples were mapped at edit distance 2; 
unmapped reads were then mapped at the edit distance 4, and 6, sequentially. If still 
unmapped, reads were trimmed at 50 bp and mapped at edit distance 2, 4 and 6, 
sequentially.  
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7.2 Identification of single nucleotide variants 
Regions with more than 20X coverage in all the samples were selected for the SNP 
calling. This threshold was selected because only one sample is used for this analysis.  In 
total, 3,373 Kbps were used. SNP calling was performed using standard SAMtools 
methods (Li, Ruotti et al. 2010) and SNPs with more than two variants were filtered out.  
 
7.3 Construction of phylogentic tree 
PLINK (Purcell, Neale et al. 2007) was used to calculate a distance matrix between the 
samples. The distance is defined as the average number of positions in which the two 
individuals have a different base over the total number of variable sites.  MEGA software 
(Tamura, Peterson et al. 2011) was used to build a neighbor-joining tree from the distance 
matrix. 
 
8. Validation of dopamine synthesis genes 
8.1 Digital PCR 
We employed Droplet Digital PCR (ddPCR) to reliably quantitate gene expression. An 
aliquot of the total RNA that was previously extracted from each brain sample was used for 
secondary validation through ddPCR analysis. One µg of total RNA was used for cDNA 
synthesis using SuperScript III First-strand synthesis Supermix (Invitrogen) and subsequently 
diluted with nuclease-free water. Custom gene-specific primers and probe for each gene of 
interest were designed using NCBI/Primer-BLAST (http://www.ncbi.nlm.nih.gov/tools/primer-
blast/) and PrimerQuest tool (IDT). ddPCR (Hindson et al. 2011) was carried out using the Bio-
Rad QX100 system. After each PCR reaction mixture consisting of ddPCR master mix and 
custom primers/probe set was partitioned into 15,000–20,000 droplets, parallel PCR 
amplification was carried out. Endpoint PCR signals were quantified and Poisson statistics 
was applied to yield target copy number quantification of the sample. Two-color PCR reaction 
was utilized for the normalization of gene expression by the housekeeping gene TBP. Table 6 
provides sequences of primers and probes used for the validation.  
 
8.2 Immunoblotting 
We used 20 µg of proteins for immunoblotting. Blots were blocked using 5% fat-free milk 
in TBST for 1h, and then exposed to corresponding primary antibodies for 1h. After 
extensive washings, blotted protein was exposed to appropriate horseradish peroxidase–
conjugated secondary antibodies and visualized with chemi-luminescence systems 
(Chemiglow). 
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9. Supplementary Tables 
 
Supplementary Table1 | Tissue sample metadata 
This table summarizes quality control data for individual tissue samples, including RNA 
integrity number (RIN) and RNA extracting kit used. 
 
Supplementary Table2 | Models used to categorize interspecies DEX genes  
List of post hoc comparisons used to categorize species-specific differential expressed 
genes. 
 
Supplementary Table 3 | Human-specific DEX genes 
List of DEX genes that are up- or downregulated in humans, when compared to 
chimpanzee and macaque.  
 
Supplementary Table 4 | Weighted co-expression network modules 
List of 229 modules corresponding to regional patterns identified by weighted gene co-
expression network analysis (WGCNA); list of intra-modular genes and their intra-modular 
connectivity; list of up- and downregulated patterns and the species where they are found. 
 
Supplementary Table 5 | List of spike-in RNAs  
List of spike-in RNAs used in this study and the Barcode scheme used for identification of 
each brain region. 
 
Supplementary Table 6 | List of primers used for ddPCR validation 
List of primers and fluorescent oligo probes used in this study for validation of results 
using ddPCR. TBP was used as the housekeeping gene. 
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10. Supplementary Figures 
 
 
 
a b 
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Supplementary Figure 1.  Unsupervised sample clustering 
Diagram showing the unsupervised hierarchical clustering of all samples used in this 
study before (a) and after batch effect correction using ComBat (b). 
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Supplementary Figure 2. Species neighbor-joining tree from variant calling 
Clustering of DFCs from each specimen based on genetic distances. All samples from 
each species clustered together. The distance is corresponds to the average number of 
positions in which two individuals have a different base over the total number of variable 
sites.   
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Supplementary Figure 3. WGCNA Module 33 
The bar plot shows the regional pattern of the module. M33 was associated with an 
upregulation in the NCX areas of all species. 
 197 
 
 
 
Supplementary Figure 4. WGCNA Module 16 
The bar plot shows the regional pattern of the module. M16 was associated with an 
upregulation in the CBC areas of all species. 
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Supplementary Figure 5. WGCNA Module 81 
The bar plot shows the regional pattern of the module. M81 was associated with an 
upregulation in all regions of the human brain. 
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Supplementary Figure 6. WGCNA Module 162 
The bar plot shows the regional pattern of the module. M162 was associated with an 
upregulation in all regions of the human brain. 
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Supplementary Figure 7. WGCNA Module 192 
The bar plot shows the regional pattern of the module. M192 was associated with an 
upregulation in all regions of the human brain. 
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Supplementary Figure 8. WGCNA Module 229 
The bar plot shows the regional pattern of the module. M229 was associated with an 
upregulation in all regions of the human brain. 
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Supplementary Figure 9. WGCNA Module 69 
The bar plot shows the regional pattern of the module. M69 was associated with a 
downregulation in all regions of the human brain. 
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Supplementary Figure 10. WGCNA Module 173 
The bar plot shows the regional pattern of the module. M173 was associated with a 
downregulation in all regions of the human brain. 
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Supplementary Figure 11. Expression pattern of genes involved in dopamine 
degradation 
a,  Expression [log2 (RPKM+1)] pattern of MAOA. b, ddPCR validation of COMT 
expression normalized to housekeeping gene TBP. c, Expression pattern of COMT. 
Although human expression values of both genes are lower than in other species no 
significant difference was observed. d, ddPCR validation of MAOA expression normalized 
to housekeeping gene TBP. 
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Supplementary Figure 12. Immunoblots of TH and DDC in STR and DFC of human, 
chimpanzee and macaque brains. 
 
TH and DDC protein levels in STR and DFC of human (H), chimpanzee  (C) and macaque  
(M) brains. TH is significantly more expressed in the human STR compared to the STR of 
chimpanzee and macaque. Similarly, DDC show lower levels in STR of macaques and 
higher levels in human STR. 
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Supplementary Figure 13. Expression pattern of genes coding dopamine receptors 
Expression [log2 (RPKM+1)] pattern of a,  DRD1, b, DRD2, c, DRD3, and d, DRD4. 
All genes, except DRD4, are significantly downregulated in the human STR. 
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Supplementary Figure 14. Neurotransmitter networks conservation 
Figure showing Z statistics of Maximum Adjacency Ratio (MAR; Langfelder et al., 2011) 
and corresponding P values of neurotransmitter receptors networks. Cholinergic and 
serotoninergic systems are less conserved, whereas glutamatergic and GABAergic are 
highly conserved. 
   
 
 
 
 
 
 
 
 
 
 208
3.10. References 
 
Anders S, Huber W. (2010). “Differential expression analysis for sequence count data”. 
Genome Biology 11(10):R106.  
 
Babbitt, C. C., O. Fedrigo, A. D. Pfefferle, A. P. Boyle, J. E. Horvath, T. S. Furey and G. A. 
Wray (2010). "Both Noncoding and Protein-Coding RNAs Contribute to Gene Expression 
Evolution in the Primate Brain." Genome Biology and Evolution 2: 67-79. 
 
Bejerano, G., D. Haussler and M. Blanchette (2004). "Into the heart of darkness: large-
scale clustering of human non-coding DNA." Bioinformatics 20: 40-48. 
 
Britanova, O., C. de Juan Romero, A. Cheung, K. Y. Kwan, M. Schwark, A. Gyorgy, T. 
Vogel, S. Akopov, M. Mitkovski, D. Agoston, N. Sestan, Z. Molnar and V. Tarabykin 
(2008). "Satb2 is a postmitotic determinant for upper-layer neuron specification in the 
neocortex." Neuron 57(3): 378-392. 
 
Broca, P. (1861). "Perte de la parole, ramollissement chronique et destruction partielle du 
lobe antérieur gauche." Bulletin de la Société d'Anthropologie 2: 235–238. 
 
Caceres, M., J. Lachuer, M. A. Zapala, J. C. Redmond, L. Kudo, D. H. Geschwind, D. J. 
Lockhart, T. M. Preuss and C. Barlow (2003). "Elevated gene expression levels 
distinguish human from non-human primate brains." Proceedings of the National 
Academy of Sciences of the United States of America 100(22): 13030-13035. 
 
Colantuoni, C., B. K. Lipska, T. Z. Ye, T. M. Hyde, R. Tao, J. T. Leek, E. A. Colantuoni, A. 
G. Elkahloun, M. M. Herman, D. R. Weinberger and J. E. Kleinman (2011). "Temporal 
dynamics and genetic control of transcription in the human prefrontal cortex." Nature 
478(7370): 519-U117. 
 
Daniel Adler and Duncan Murdoch (2010). “rgl: 3D visualization device system 
(OpenGL)”. R package, version 0.92.794. http://CRAN.R-project.org/package=rgl 
 
Dax, M. (1865). "Lésions de la moitié gauche de l'encéphale coincidant avec l'oubli des 
signes de la pensée (lu au Congrés méridional tenu à Montpellier en 1836)." Gaz Heb 
Méd Chi. 
 
 209 
de Lucchi, R., M., B. J. Dennis and W. R. Adey (1965). Stereotaxic Atlas of the 
Chimpanzee Brain (Pan satyrus). , University of California Press. 
 
Enard, W., P. Khaitovich, J. Klose, S. Zollner, F. Heissig, P. Giavalisco, K. Nieselt-Struwe, 
E. Muchmore, A. Varki, R. Ravid, G. M. Doxiadis, R. E. Bontrop and S. Paabo (2002). 
"Intra- and interspecific variation in primate gene expression patterns." Science 
296(5566): 340-343. 
 
Gu, J. Y. and X. Gu (2003). "Induced gene expression in human brain after the split from 
chimpanzee." Trends in Genetics 19(2): 63-65. 
 
Habegger, L., A. Sboner, T. A. Gianoulis, J. Rozowsky, A. Agarwal, M. Snyder and M. 
Gerstein (2011). "RSEQtools: a modular framework to analyze RNA-Seq data using 
compact, anonymized data summaries." Bioinformatics 27(2): 281-283. 
 
Han, W., K. Y. Kwan, S. Shim, M. M. Lam, Y. Shin, X. Xu, Y. Zhu, M. Li and N. Sestan 
(2011). "TBR1 directly represses Fezf2 to control the laminar origin and development of 
the corticospinal tract." Proceedings of the National Academy of Sciences of the United 
States of America 108(7): 3041-3046. 
 
Hansen, K. D., R. A. Irizarry and Z. J. Wu (2012). "Removing technical variability in RNA-
seq data using conditional quantile normalization." Biostatistics 13(2): 204-216. 
 
Harrow J, Frankish A, Gonzalez JM, Tapanari E, Diekhans M, Kokocinski F, Aken BL, 
Barrell D, Zadissa A, Searle S, Barnes I, Bignell A, Boychenko V, Hunt T, Kay M, 
Mukherjee G, Rajan J, Despacio-Reyes G, Saunders G, Steward C, Harte R, Lin M, 
Howald C, Tanzer A, Derrien T, Chrast J, Walters N, Balasubramanian S, Pei B, Tress M, 
Rodriguez JM, Ezkurdia I, van Baren J, Brent M, Haussler D, Kellis M, Valencia A, 
Reymond A, Gerstein M, Guigó R, Hubbard TJ. (2012). “GENCODE: the reference human 
genome annotation for The ENCODE Project”. Genome Research 22(9):1760-1774. 
 
Hevner, R., L. Shi, N. Justice, Y. Hsueh, M. Sheng, S. Smiga, A. Bulfone, A. Goffinet, A. 
Campagnoni and J. Rubenstein (2001). "Tbr1 regulates differentiation of the preplate and 
layer 6." Neuron 29(2): 353-366. 
 
 210
Hindson BJ, Ness, KD, Masquelier, DA, Belgrader, P, Heredia, NJ, Makarewicz, AJ, 
Bright, IJ, Lucero, MY, Hiddesen, AL, Legler, TC, Kitano, TK, Hodel, MR, Petersen, JF, 
Wyatt, PW, Steenblock, ER, Shah, PH, Bousse, LJ, Troup, CB, Mellen, JC, Wittman, DK, 
Erndt, NG, Cauley, TH, Koehler, RT, So, AP, Dube, S, Rose, KA, Montesclaros, L, Wang, 
S, Stumbo, DP, Hodges, SP, Romine, S, Milanovich, FP, White, HE, Regan, JF, Karlin-
Neuman, GA, Hindson, CM, Saxonov, S, Colston, BW. (2011). High-throughput droplet 
digital PCR system for absolute quantitation of DNA copy number. Analytical Chemistry 
83(22): 8604–8610. 
 
Hinrichs AS, Karolchik D, Baertsch R, Barber GP, Bejerano G, Clawson H, Diekhans M, 
Furey TS, Harte RA, Hsu F, Hillman-Jackson J, Kuhn RM, Pedersen JS, Pohl A, Raney 
BJ, Rosenbloom KR, Siepel A, Smith KE, Sugnet CW, Sultan-Qurraie A, Thomas DJ, 
Trumbower H, Weber RJ, Weirauch M, Zweig AS, Haussler D, Kent WJ.  (2006). “The 
UCSC Genome Browser Database: update 2006”. Nucleic Acids Res 34: D590–D598.  
 
Huang, D. W., B. T. Sherman and R. A. Lempicki (2009). "Systematic and integrative 
analysis of large gene lists using DAVID bioinformatics resources." Nature Protocols 4(1): 
44-57. 
 
Johnson, M. B., Y. I. Kawasawa, C. E. Mason, Z. Krsnik, G. Coppola, D. Bogdanovic, D. 
H. Geschwind, S. M. Mane, M. W. State and N. Sestan (2009). "Functional and 
evolutionary insights into human brain development through global transcriptome 
analysis." Neuron 62(4): 494-509. 
 
Johnson, WE, Rabinovic, A, and Li, C (2007). Adjusting batch effects in microarray 
expression data using Empirical Bayes methods. Biostatistics 8(1):118-127. 
 
Kang, H. J., Y. I. Kawasawa, F. Cheng, Y. Zhu, X. Xu, M. Li, A. M. Sousa, M. Pletikos, K. 
A. Meyer, G. Sedmak, T. Guennel, Y. Shin, M. B. Johnson, Z. Krsnik, S. Mayer, S. 
Fertuzinhos, S. Umlauf, S. N. Lisgo, A. Vortmeyer, D. R. Weinberger, S. Mane, T. M. 
Hyde, A. Huttner, M. Reimers, J. E. Kleinman and N. Sestan (2011). "Spatio-temporal 
transcriptome of the human brain." Nature 478(7370): 483-489. 
 
Kent WJ. (2002). “BLAT--the BLAST-like alignment tool”. Genome Research: 12(4):656-
64. 
 
 211 
Khaitovich, P., B. Muetzel, X. W. She, M. Lachmann, I. Hellmann, J. Dietzsch, S. Steigele, 
H. H. Do, G. Weiss, W. Enard, F. Heissig, T. Arendt, K. Nieselt-Struwe, E. E. Eichler and 
S. Paabo (2004). "Regional patterns of gene expression in human and chimpanzee 
brains." Genome Research 14(8): 1462-1473. 
 
King, M. and A. Wilson (1975). "Evolution at two levels in humans and chimpanzees." 
Science 188(4184): 107-116. 
 
Langfelder, P. and S. Horvath (2008). "WGCNA: an R package for weighted correlation 
network analysis." BMC Bioinformatics 9: 559. 
 
Langfelder, P., Luo, R., Oldham, M. D., and S. Horvath (2011). "Is my network module 
preserved and reproducible?" PLoS Computational Biology 7: e1001057. 
 
Li, B., V. Ruotti, R. M. Stewart, J. A. Thomson and C. N. Dewey (2010). "RNA-Seq gene 
expression estimation with read mapping uncertainty." Bioinformatics 26(4): 493-500. 
 
Liu, X. L., M. Somel, L. Tang, Z. Yan, X. Jiang, S. Guo, Y. Yuan, L. He, A. Oleksiak, Y. 
Zhang, N. Li, Y. H. Hu, W. Chen, Z. L. Qiu, S. Paabo and P. Khaitovich (2012). "Extension 
of cortical synaptic development distinguishes humans from chimpanzees and 
macaques." Genome Research 22(4): 611-622. 
 
Lockhart, D. J. and C. Barlow (2001). "Expressing what's on your mind: DNA arrays and 
the brain." Nature Reviews Neuroscience 2(1): 63-68. 
 
Marco-Sola, S, Sammeth, M, Guigó, R, Ribeca, P. (2012). “The GEM mapper: fast, 
accurate and versatile alignment by filtration”. Nature Methods 9: 1185–1188.  
 
McKenna, W. L., J. Betancourt, K. A. Larkin, B. Abrams, C. Guo, J. L. Rubenstein and B. 
Chen (2011). "Tbr1 and Fezf2 regulate alternate corticofugal neuronal identities during 
neocortical development." J Neurosci 31(2): 549-564. 
 
Mikkelsen, T. S., L. W. Hillier, E. E. Eichler, M. C. Zody, D. B. Jaffe, S. P. Yang, W. Enard, 
I. Hellmann, K. Lindblad-Toh, T. K. Altheide, N. Archidiacono, P. Bork, J. Butler, J. L. 
Chang, Z. Cheng, A. T. Chinwalla, P. deJong, K. D. Delehaunty, C. C. Fronick, L. L. 
Fulton, Y. Gilad, G. Glusman, S. Gnerre, T. A. Graves, T. Hayakawa, K. E. Hayden, X. Q. 
Huang, H. K. Ji, W. J. Kent, M. C. King, E. J. Kulbokas, M. K. Lee, G. Liu, C. Lopez-Otin, 
 212
K. D. Makova, O. Man, E. R. Mardis, E. Mauceli, T. L. Miner, W. E. Nash, J. O. Nelson, S. 
Paabo, N. J. Patterson, C. S. Pohl, K. S. Pollard, K. Prufer, X. S. Puente, D. Reich, M. 
Rocchi, K. Rosenbloom, M. Ruvolo, D. J. Richter, S. F. Schaffner, A. F. A. Smit, S. M.  
Mortazavi, A., B. A. Williams, K. Mccue, L. Schaeffer and B. Wold (2008). "Mapping and 
quantifying mammalian transcriptomes by RNA-Seq." Nature Methods 5(7): 621-628. 
 
Smith, M. Suyama, J. Taylor, D. Torrents, E. Tuzun, A. Varki, G. Velasco, M. Ventura, J. 
W. Wallis, M. C. Wendl, R. K. Wilson, E. S. Lander, R. H. Waterston and C. S. A. 
Consortium (2005). "Initial sequence of the chimpanzee genome and comparison with the 
human genome." Nature 437(7055): 69-87. 
 
Pollard, K. S., S. R. Salama, B. King, A. D. Kern, T. Dreszer, S. Katzman, A. Siepel, J. S. 
Pedersen, G. Bejerano, R. Baertsch, K. R. Rosenbloom, J. Kent and D. Haussler (2006). 
"Forces shaping the fastest evolving regions in the human genome." Plos Genetics 2(10): 
1599-1611. 
 
Prabhakar, S., J. P. Noonan, S. Paabo and E. M. Rubin (2006). "Accelerated evolution of 
conserved noncoding sequences in humans." Science 314(5800): 786-786. 
Roth, R. B., P. Hevezi, J. Lee, D. Willhite, S. M. Lechner, A. C. Foster and A. Zlotnik 
(2006). "Gene expression analyses reveal molecular relationships among 20 regions of 
the human CNS." Neurogenetics 7(2): 67-80. 
 
Purcell, S., B. Neale, K. Todd-Brown, L. Thomas, M. A. R. Ferreira, D. Bender, J. Maller, 
P. Sklar, P. I. W. de Bakker, M. J. Daly and P. C. Sham (2007). "PLINK: A tool set for 
whole-genome association and population-based linkage analyses." American Journal of 
Human Genetics 81(3): 559-575. 
 
R Development Core Team (2009). “R: A language and environment for statistical 
computing”. Vienna, R Foundation for Statistical Computing. 
 
Saleem, K. S. and N. Logothetis (2007). A combined MRI and histology atlas of the 
rhesus monkey brain in stereotaxic coordinates. London ; Burlington, MA, Academic. 
 
Sequencing, R. M. G., A. Consortium, et al., (2007). "Evolutionary and Biomedical Insights 
from the Rhesus Macaque Genome." Science 316(5822): 222-234. 
 
 213 
Somel, M., H. Franz, Z. Yan, A. Lorenc, S. Guo, T. Giger, J. Kelso, B. Nickel, M. 
Dannemann, S. Bahn, M. J. Webster, C. S. Weickert, M. Lachmann, S. Paabo and P. 
Khaitovich (2009). "Transcriptional neoteny in the human brain." Proceedings of the 
National Academy of Sciences of the United States of America 106(14): 5743-5748. 
 
Srinivasan, K., D. P. Leone, R. K. Bateson, G. Dobreva, Y. Kohwi, T. Kohwi-Shigematsu, 
R. Grosschedl and S. K. McConnell (2012). "A network of genetic repression and 
derepression specifies projection fates in the developing neocortex." Proceedings of the 
National Academy of Sciences of the United States of America 109(47): 19071-19078. 
 
Stedman, H. H., B. W. Kozyak, A. Nelson, D. M. Thesier, L. T. Su, D. W. Low, C. R. 
Bridges, J. B. Shrager, N. Minugh-Purvis and M. A. Mitchell (2004). "Myosin gene 
mutation correlates with anatomical changes in the human lineage." Nature 428(6981): 
415-418. 
 
Tamura, K., D. Peterson, N. Peterson, G. Stecher, M. Nei and S. Kumar (2011). "MEGA5: 
Molecular Evolutionary Genetics Analysis Using Maximum Likelihood, Evolutionary 
Distance, and Maximum Parsimony Methods." Molecular Biology and Evolution 28(10): 
2731-2739. 
 
Uddin, M., D. E. Wildman, G. Z. Liu, W. B. Xu, R. M. Johnson, P. R. Hof, G. Kapatos, L. I. 
Grossman and M. Goodman (2004). "Sister grouping of chimpanzees and humans as 
revealed by genome-wide phylogenetic analysis of brain gene expression profiles." 
Proceedings of the National Academy of Sciences of the United States of America 101(9): 
2957-2962. 
 
Vargha-Khadem, F., D. G. Gadian, A. Copp and M. Mishkin (2005). "FOXP2 and the 
neuroanatomy of speech and language." Nature Reviews Neuroscience 6(2): 131-138. 
 
Visel, A., S. Prabhakar, J. A. Akiyama, M. Shoukry, K. D. Lewis, A. Holt, I. Plajzer-Frick, 
V. Afzal, E. M. Rubin and L. A. Pennacchio (2008). "Ultraconservation identifies a small 
subset of extremely constrained developmental enhancers." Nature Genetics 40(2): 158-
160. 
 
Wang, Y. Q. and B. Su (2004). "Molecular evolution of microcephalin, a gene determining 
human brain size." Human Molecular Genetics 13(11): 1131-1137. 
 
 214
Wernicke, C. (1874). Der Aphasische Symptomenkomplex: Eine Psychologische Studie 
auf Anatomischer Basis. Breslau, Max Cohn & Weigert. 
 
Zhang, B. and S. Horvath (2005). "A general framework for weighted gene co-expression 
network analysis." Stat Appl Genet Mol Biol 4: Article17. 
 
 
 
 
 
 
 
 
  
 
 
 
 
 
 
 
CHAPTER III
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GENERAL DISCUSSION, CONCLUSIONS AND FUTURE 
DIRECTIONS 
 
The generation and genome-wide exon-level analysis of a comprehensive 
transcriptome and genotyping dataset covering multiple brain regions and NCX areas 
across all periods of human brain development and adulthood expands the current 
knowledge of the transcriptional processes that govern human brain development and 
provides immediate opportunities for a variety of further investigations. Also, the 
comparative analyses of human with chimpanzee and rhesus macaque brain 
transcriptomes increase our knowledge about human-specific changes that may have 
contributed to human distinctive features, such as language and cognition. Data from these 
studies are publicly available via multiple avenues, including a searchable database 
(www.humanbraintranscriptome.org). These data will also provide opportunities for 
comparison with other existing and forthcoming large-scale gene expression and 
transcriptome datasets, including some generated from different human conditions and 
model organisms (Zapala et al., 2005; Semeralul et al., 2006; Mirnics et al., 2000; Ryan et 
al., 2006). 
Our initial analyses revealed several important aspects of the spatio-temporal 
dynamics and functional organization of the human brain transcriptome and provided 
insights into human neurobiological processes. These findings build substantially on 
previous finding that gene transcription and exon usage have complex and dynamically 
regulated patterns across space and time in the brain (Chikaraishi, 1979; Sutcliffe, 1988). 
We showed that global transcriptome dynamics and organization are age-dependent and 
differ across human brain regions. These transcriptional differences are far more prominent 
than those that exist between sexes, ethnicities, or individuals, in spite of their underlying 
genomic differences. We found that approximately 86% of genes are expressed in the 
sampled regions, and over 90% of these are differentially regulated, predominantly in the 
form of gene- and exon-level temporal regulation.  
We found that there is a progressive increase in correlation of the transcriptome 
between anatomically and functionally related structures (e.g., NCX, HIP, AMY) during 
development. Furthermore, our analysis of co-expressed gene networks identified large 
modules comprised of genes that exhibit opposite trajectories and a reversal in gene 
expression across multiple regions just before birth (late fetal period). We speculate that 
these findings likely reflect several underlying phenomena and features of human brain 
development and structure. One such feature is a general trend of pronounced 
transcriptional differences during embryonic and fetal development, when specific neural 
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circuits are being established, followed by an increased correlation between functionally 
related regions and NCX areas in the postnatal and adult brain. Furthermore, perinatal 
reversals in expression of a large number of genes may reflect intrinsic changes in 
developmental processes between fetal and postnatal development as well as effects of 
early experience and environment on brain development. We also showed that the 
identified network modules are related to specific biological pathways and contain hub 
genes that encode transcriptional regulators, modulators of chromatin state, and signal 
transduction proteins, all of which likely play an important role in driving the module 
expression pattern. 
We also demonstrated how this dataset can be used to identify novel spatial and 
temporal patterns of alternative exon usage. Specifically, we showed that an alternative 
isoform of ANKRD32 forms a transient graded expression pattern in the PFC and motor 
cortex during midfetal development. Since the anterior-posterior gradient of ANKRD32b 
expression in human period 6 frontal cortex was not detected in mice of the equivalent 
developmental period, it is possible that this isoform is involved in the development and 
evolution of species differences in the frontal cortex. The great majority of genes and 
putative alternative isoforms identified in this study have not previously been characterized, 
emphasizing how little is known about genetic mechanisms in the developing human brain.  
The accuracy and usefulness of the data was illustrated by profiling spatial 
differences and developmental trajectories of genes related to specific neurobiological 
processes and brain disorders, many of which would not likely be evident in transcriptome 
data generated from model organisms. Specifically, the examples presented here 
demonstrate how these transcriptome data can be used to assess the onset and the 
spatiotemporal trajectories of major neurodevelopmental processes, cell types, and 
neurotransmitter systems in the human brain. Notable regional differences were observed 
between developing brain regions for the three major categories of neurobiological 
processes. For example, we observed specific transcriptional changes, including peaking of 
PVALB and UTS2D expression, in the NCX and AMY, during adolescence, a 
developmental period during which the symptoms of schizophrenia and other 
neuropsychiatric disorders typically arise (Insel, 2010; State, 2010; Crow, 2008; Meyer-
Lindenberg and Weinberger, 2006; Lewis and Levitt, 2002). This is consistent with previous 
observations of alterations in PVALB-immunopositive interneurons in patients with 
schizophrenia and seizures (Lewis and Levitt, 2002).  
Our analysis confirmed and expanded on previous findings on sexually dimorphic 
gene expression in the human brain. Overall, more sex-specific DEX genes were found in 
males and during prenatal and, to a lesser extent, postnatal development than adult life. 
Many sex-specific genes also showed significant regional differences and are associated 
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with specific biological processes and major disorders. We featured two examples: 
PCDH11Y, a gene previously associated with cerebral asymmetry (Priddle and Crow, 
2003), and IGF2, an imprinted gene implicated in embryonic growth and cognitive function 
(Lehtinen et al., 2011; Chen et al., 2011). The imprinting pattern of IGF2 undergoes 
complex regulation in the developing mouse brain (Gregg et al., 2010), and the dramatic 
changes we observed may reflect underlying epigenetic regulation.  
From the genes displaying DEU between males and females, we highlighted 
NLGN4X, a gene encoding a protein involved in synapse formation and function (Sudhof et 
al., 2008), which is expressed at comparable levels in male and female brain but displays 
sex-specific DEU pattern. Consistent with its role in synapse formation, NLGN4X is 
upregulated during the second half of the prenatal NCX development that coincides with an 
increase in genes associated with synapse and dendrite development. Mutations in 
NLGN4X have previously been associated with ASD (Jamain et al., 2003), which are more 
prevalent in males. Many of the ASD associated risk SNPs and deletions are present in 
NLGN4X’s exons 5, 6, and 7, which display male-specific bias in DEU. While we do not yet 
understand the full functional implications of the findings of sex-specific gene expression 
and exon usage, they offer possible transcriptional mechanisms underlying the sex 
differences in the incidence, prevalence, and severity of many neurological and psychiatric 
disorders. 
In addition, our data reveal previously unknown spatio-temporal expression patterns 
for many genes previously associated with ASD, schizophrenia, and other major disorders. 
Coupled with analysis of co-expressed genes in the dataset, these provide information 
about when and where these disease-associated genes are expressed in the developing 
and adult brain, which can be used to help to infer their function. Moreover, genome-wide 
association or linkage studies of complex multigenic disorders frequently implicate large 
genomic intervals that encompass dozens of relatively unknown candidate genes. Our data 
can enhance such results by narrowing the focus to those genes that are specifically 
expressed during development or restricted to a specific region known to be preferentially 
affected.  
We show associations between specific SNPs and expression levels at both gene 
and exon level in different regions of the developing human brain, indicating that genetic 
variations contribute to inter-individual transcriptome variability across regions and 
development. While the current number of specimens in our dataset restricted our power to 
detect eQTLs, the cis-eQTLs that we were able to detect may provide insights into how 
SNPs may affect the regulation of gene expression. 
In our second analyses of the human brain transcriptome, we focused on the 
following prominent features of the human neocortex: it is parcelated into many 
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functionally distinct areas; some of its cognitive and motor functions are lateralized 
between the two cerebral hemispheres; and its development is very protracted over 
prenatal and postnatal development. These three aspects of the human neocortical 
development remained poorly understood, mainly because until now it has been difficult to 
directly study them in the developing human brain.  
The main finding of this analysis is the three main phases that the human 
neocortical transcriptome undergoes during the lifespan. The first phase corresponds to 
the intrauterine period, when the foundations of neocortex are being built. During that 
period, transcriptional differences between the areas are pronounced and may be related 
with areal specification (O’Leary & Sahara, 2008; O’Leary et al., 2007; Rakic, 1988). The 
next period lasts from birth to adolescence. At the very beginning of the period, the 
transcriptome abruptly becomes nearly homogenous across neocortical areas. While the 
foundation for the structure and connectivity are established during prenatal periods, the 
fine-tuning of cortical connectivity occurs postnatally (Stiles et al., 2011; Johnson et al., 
2001). For that, the interaction with the outside world is of the outmost importance, and 
the first years of life are the first opportunity for that to happen. The increased similarity of 
areas during infancy and childhood represents a major finding that can influence multiple 
fields of medicine and psychology. Those periods are critical in cognitive development 
and learning (Knudsen, 2004; Jolles and Crone, 2012; Johnson et al., 2001), and the 
profile of the transcriptome could be an important factor in these complex processes. 
Moreover, during these periods of homogeneity of the transcriptome the human neocortex 
is more highly plastic, more prone to circumvent the functional defects due to the lesion 
than the adult neocortex (Anderson et al., 2011; Staudt, 2010). This described 
homogeneity of the transcriptome between different areas lasts until the next key point of 
the development: the adolescence, when we see the transition to the adult-like highly 
specialized profile of the neocortical areas.  
In addition to discovering changes in the landscape of the transcriptome during 
development, we report another surprising finding. Our data shows that on the level of the 
transcriptome, interhemispherical differences are absent. This is perhaps the most 
unexpected finding. Despite our intense interest and efforts to identify asymmetry in gene 
expression in human brain, no differences were found, in contrast to a previously study 
that had fewer samples (Sun et al. 2005). This finding indicates that brain lateralization 
may be driven by stochastic, hormonal, epigenetic, functional connectivity-based, and/or 
activity-dependent mechanisms that are not reflected in gene expression. Furthermore, in 
accordance to our findings, a recent large-scale MRI study also failed to detect robust 
asymmetries on the population level (Chen et al, 2012). 
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Finally, the comparative analysis of adult human, chimpanzee, and macaque 
brains revealed several differences among species, including some that are human-
specific. We found that several genes are differentially expressed among species. 
Focusing our analysis on human-specific DEX, we found that the striatum is the region 
where the highest number of genes is differentially expressed. Interestingly, most of the 
DEX genes in humans exhibited upregulation, a pattern not seen in chimpanzee or 
macaques. This result corroborates previous findings that show an enrichment of 
upregulated gene expression in the human brain (Cáceres et al., 2003; Gu and Gu, 2003; 
Khaitovich et al., 2004). Among the human-specific genes, we found three to be 
exclusively DEX in the human neocortex: TWIST1, RP11-364P22.1, and CTB-78F1.1. 
TWIST1 is a transcription factor that inhibits trans-activation by MEF2 (Hamamori et al., 
1997). According to a recent study (Liu et al., 2012), MEF2A, a member of the MEF2 
family, is likely the regulator of a module of co-expressed genes involved in 
synaptogenesis. This study was done in the developing postnatal brain and thus it is hard 
to integrate the findings with ours, but the downregulation of TWIST1 in adulthood might 
allow an easier synaptic reorganization in humans. Intraspecies clustering of regions 
based on DEX genes revealed that there is a human-specific clustering of perisylvian 
regions involved in speech and language. Interestingly, the human neocortex appears to 
be more transcriptionally similar than the neocortices from chimpanzees and macaques.  
We also found several human-specific modules of co-expressed genes, including 
two that had genes coding for dopamine biosynthesis pathway as hub genes. The 
upregulation of these genes in the human striatum was confirmed with ddPCR. 
Immunobloting confirmed that protein levels for these genes corresponded to the gene 
expression levels. Since the genes involved in the anabolic pathway were upregulated 
and the genes involved in the catabolic pathway did not show any statistically different 
expression, we hypothesize that humans may have higher levels of dopamine than the 
other species analyzed. It has been reported that dopamine is involved in several 
cognitive processes, especially working memory, reasoning, and overall intelligence 
(Goldman-Rakic, 1998; Nieoullon, 2002. The putative higher levels of dopamine 
production we report may give some hints on the evolution of human cognition. However, 
we also observed an increase in dopamine production that was accompanied by a 
downregulation of genes coding the dopamine receptors D1, D2, and D3. It will be 
important to analyze the protein levels of these receptors to confirm that humans have 
lower amounts of these receptors in the STR. If confirmed, this downregulation of 
dopamine receptors might balance the upregulation of dopamine biosynthesis. 
Nevertheless, further studies on this balance between neurotransmitter and their 
receptors will be needed. 
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  We extended our study to other neurotransmitters through the analysis of 
neurotransmitter receptor systems network correlations. We found that both the 
glutamatergic and the GABAergic systems were well conserved among species, whereas 
the serotoninergic and cholinergic systems were not. The role of serotonin in cognition 
(Meneses and Hong, 1995; Steckler and Sahgal, 1995) and its involvement in some 
neurological diseases, such as schizophrenia (Roth et al., 2004; Naughton et al., 2000) 
are well reported. Similarly, acetylcholine has been implicated in the processes of learning 
and memory (Harder et al., 1998; Sarter and Parikh, 2005) and neurodegenerative 
diseases (Mega, 2000). We reveal that the organization of the correlation networks for 
these neuromodulators show some differences among humans, chimpanzees, and 
macaques. Interestingly, two recent studies (Raghanti et al., 2008a; Raghanti et al., 
2008b) showed that there are differences at the level of prefrontal cortex innervation 
among these species, reinforcing that these two neuromodulatory systems might be 
relevant to species differences in cognition.      
 
Together, these data highlight the complexity of spatio-temporal gene expression 
and exon usage, as well as the species-differences that may have been crucial for some 
aspects of human-specific brain function. However, there are several potential limitations in 
our data that warrant discussion. Foremost, we used stringent criteria in order to faithfully 
characterized general transcriptional patterns and minimize false positives, rather than to 
capture all the changes that we think may in fact occur. We also analyzed dissected tissue 
samples that contain multiple cell types, thus diluting the contribution and dynamic range of 
genes expressed in a more cell type specific manner. Current limitations prevent us from 
using cell type-specific approaches in systematically analyzing the transcriptome across 
multiple regions and all developmental periods. Also, all of these analyses were performed 
in postmortem tissue. Even though some studies showed that there is no correlation of PMI 
with RNA degradation (Barton et al., 1993; Heinrich et al., 2007), others suggested that 
there is a PMI-related RNA degradation that might cause a significant impact on the RNA 
population structure (Catts et al., 2005).  Furthermore, the number of brains and regions 
analyzed so far is not sufficient to fully investigate the whole magnitude of changes in gene 
expression and exon usage or the full range of eQTLs. Although the application of RNA 
sequencing technology allowed more in-depth analysis of the transcriptome, including some 
low-expressing transcripts and their associated spatiotemporal patterns, it also carried 
some problems. The hardest one to circumvent was related to the differences at the 
genome annotation level. Since the genome of these species have are not annotated with a 
similar level of detail, it is difficult to accurately calculate differential expression among 
them. Finally, while specific patterns of expression are often linked to equally specialized 
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biological processes, it is important to notice that the relationship between mRNA and 
protein levels is not always linear or translated into apparent phenotypic differences. As 
these concerns are addressed in the future, it will be possible to uncover additional insights 
into the transcriptional foundations of human brain development and evolution.  
The findings presented in this thesis open the door to several future research 
directions. Since the mRNA levels during development are so dynamically regulated, it will 
be interesting to study the expression of noncoding RNAs and try to correlate their 
expression and putative regulation of some of the co-expression networks that were found. 
It will be also interesting to analyze if the human-specific patterns can be explained by 
differences in miRNA or lncRNA expression. The extending of the interspecies comparison 
to developmental stages will be of the utmost relevance because it will likely reveal several 
human-specific patterns of expression that shape human-specific features of brain 
development. 
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Brain development and function depend on the precise regulation of gene expression.However, our understanding of the
complexity and dynamics of the transcriptome of the human brain is incomplete. Here we report the generation and
analysis of exon-level transcriptome and associated genotyping data, representing males and females of different
ethnicities, from multiple brain regions and neocortical areas of developing and adult post-mortem human brains. We
found that 86 per cent of the genes analysedwere expressed, and that 90 per cent of thesewere differentially regulated at
the whole-transcript or exon level across brain regions and/or time. The majority of these spatio-temporal differences
weredetectedbeforebirth,with subsequent increases in the similarity amongregional transcriptomes.The transcriptome
is organized intodistinct co-expressionnetworks, andshows sex-biasedgeneexpressionandexonusage.Wealsoprofiled
trajectories of genes associated with neurobiological categories and diseases, and identified associations between single
nucleotide polymorphisms and gene expression. This study provides a comprehensive data set on the human brain
transcriptome and insights into the transcriptional foundations of human neurodevelopment.
Human neurodevelopment is a complex and precisely regulated pro-
cess that occurs over a protracted period of time1–3. Human-specific
features of this process are likely to be important factors in the evolu-
tion of human specializations2–5. However, in addition to giving us
remarkable cognitive andmotor abilities, the formation ofmolecularly
distinct and intricate neural circuits may have also increased our sus-
ceptibility to certain psychiatric and neurological disorders4–9.
Furthermore, sex differences are important in brain development
and function, and are a risk factor for conditions such as autism spec-
trumdisorders (ASDs) and depression9–13. Research and progress in all
these areas could be enhanced by a comprehensive analysis of the
spatio-temporal dynamics of gene expression and transcript variants
in the human brain.
Previous transcriptome studies of the developing human brain
have used relatively small numbers of samples and predominantly
focused on only a few regions or developmental time points14–18. In
this Article, we explore the transcriptomes of 16 regions comprising
the cerebellar cortex, mediodorsal nucleus of the thalamus, striatum,
amygdala, hippocampus and 11 areas of the neocortex. The data set
was generated from 1,340 tissue samples collected from 57 developing
and adult post-mortem brains of clinically unremarkable donors
representing males and females of multiple ethnicities.
Study design, data generation and quality control
To investigate the spatio-temporal dynamics of the human brain
transcriptome, we created a 15-period system spanning the periods
from embryonic development to late adulthood (Table 1 and Sup-
plementary Information, section 2.1). We sampled transient prenatal
structures and immature and mature forms of 16 brain regions,
including 11 neocortex (NCX) areas, from multiple specimens per
period (Table 2; Supplementary Information, section 2.2; Sup-
plementary Figs 1–3; and Supplementary Table 1). The 11 NCX areas
are collectively referred to hereafter as the region NCX. We also
genotyped donor DNA using an Illumina 2.5-million single nucleotide
polymorphism (SNP) chip (Supplementary Fig. 4 and Supplementary
Table 2). Only brains fromclinically unremarkable donorswith no signs
of large-scale genomic abnormalitieswere included in the study (N5 57,
including 39 with both hemispheres; age, 5.7 weeks post-conception
*These authors contributed equally to this work.
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Table 1 | Periods of human development and adulthood as defined
in this study
Period Description Age
1 Embryonic 4PCW#Age,8PCW
2 Early fetal 8 PCW#Age,10PCW
3 Early fetal 10PCW#Age,13PCW
4 Early mid-fetal 13PCW#Age,16PCW
5 Early mid-fetal 16PCW#Age,19PCW
6 Late mid-fetal 19PCW#Age,24PCW
7 Late fetal 24PCW#Age,38PCW
8 Neonatal and early infancy 0M (birth)#Age,6M
9 Late infancy 6M#Age,12M
10 Early childhood 1Y#Age,6Y
11 Middle and late childhood 6Y#Age,12Y
12 Adolescence 12Y#Age,20Y
13 Young adulthood 20Y#Age,40Y
14 Middle adulthood 40Y#Age,60Y
15 Late adulthood 60Y#Age
M, postnatal months; PCW, post-conceptional weeks; Y, postnatal years.
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(PCW) to 82 years; sex, 31 males and 26 females; post-mortem interval,
12.116 8.63 (mean6 s.d.) hours; pH, 6.456 0.34 (mean6 s.d.)).
Transcriptome profiling was performed using total RNA extracted
from a total of 1,340 dissected tissue samples (RNA integrity number,
8.836 0.93 (mean6 s.d.); Supplementary Tables 3 and 4).We used the
Affymetrix GeneChip Human Exon 1.0 ST Array platform, which fea-
tures comprehensive coverage of the human genome, with 1.4 million
probe sets that assay expression across the entire transcript or indi-
vidual exon, thereby providing redundancy and increased confidence
in estimates of gene-level differential expression (DEX, differentially
expressed) and differential exon usage (DEU). Descriptions of tissue
sampling and quality control measures implemented throughout tran-
scriptome data generation steps are provided in Supplementary
Information, sections 2–5, and Supplementary Figs 5–8.
Global transcriptome dynamics
Spatio-temporal gene expression
After quality control assessments and quantile normalization, we
summarized core and unique probe sets, representing 17,565 mainly
protein-coding genes, into gene-level information. Using stringent
criteria (log2-transformed signal intensity of$6 in at least one sample
and mean detection-above-background P value of ,0.01 in at least
one region of at least one period) to define an ‘expressed’ gene, we
found that 15,132 (86.1%) of 17,565 genes surveyed were expressed in
at least one brain region during at least one period, and that 14,375
(81.8%) were expressed in at least one NCX area (Fig. 1a, Supplemen-
tary Information 6.1 and Supplementary Fig. 9). To investigate the
contributions of different factors to the global transcriptome
dynamics, we applied multidimensional scaling and principal-
component analysis, which revealed that region and age (that is,
spatio-temporal dynamics) contribute more to the global differences
in gene expression than do other tested variables: sex, ethnicity and
inter-individual variation (Fig. 1b; Supplementary Information,
sections 6.2 and 6.3; and Supplementary Figs 10 and 11).
To identify genes thatwere spatially or temporally regulated,weused
a conservative threshold (false-discovery-rate Q value of ,0.01 and
$2-fold log2-transformed signal intensity difference), included post-
mortem interval and RNA integrity number as technical covariates
within all of our analysis-of-variance models of differential expression,
considered the influence of dissection variation and applied a fivefold
jackknife procedure (Supplementary Information, section 6.4, and
Supplementary Figs 12 and 13). We found that 70.9% of expressed
genes were spatially DEX between any two regions within at least
one period, and that 24.1% were spatially DEX between any two
NCX areas (Fig. 1a). By contrast, 89.9% of expressed genes were tem-
porally DEX between any two periods across regions, and 85.3% were
temporallyDEXbetween any twoperiods acrossNCXareas.Moreover,
70.0% and 23.9% of expressed geneswere both spatially and temporally
DEXwithin brain regions andwithinNCXareas, respectively. The bulk
of spatio-temporal regulation occurred during prenatal development.
For instance, 57.7% of NCX-expressed genes were temporally DEX
across fetal development (periods 3–7), whereas 9.1% were during
postnatal development (periods 8–12) and0.7%were during adulthood
(periods 13–15). Together, these data indicate that the majority of
brain-expressed protein-coding genes are temporally and, to a lesser
extent, spatially regulated, and that this regulation occurs predomi-
nately during prenatal development.
Transcriptional architecture of the human brain
To assess transcriptional relatedness between brain regions/NCX
areas, we calculated correlation matrices of pairwise comparisons
Table 2 | Ontology and nomenclature of analysed brain regions and
NCX areas
Periods 1 and 2 Periods 3–15
FC, frontal cerebral wall OFC, orbital prefrontal cortex
DFC, dorsolateral prefrontal cortex
VFC, ventrolateral prefrontal cortex
MFC, medial prefrontal cortex
M1C, primary motor (M1) cortex
PC, parietal cerebral wall S1C, primary somatosensory (S1) cortex
IPC, posterior inferior parietal cortex
TC, temporal cerebral wall A1C, primary auditory (A1) cortex
STC, superior temporal cortex
ITC, inferior temporal cortex
OC, occipital cerebral wall V1C, primary visual (V1) cortex
HIP, hippocampal anlage HIP, hippocampus
— AMY, amygdala
VF, ventral forebrain STR, striatum
MGE, medial ganglionic eminence
LGE, lateral ganglionic eminence
CGE, caudal ganglionic eminence
DIE, diencephalon MD, mediodorsal nucleus of the thalamus
DTH, dorsal thalamus —
URL, upper (rostral) rhombic lip CBC, cerebellar cortex
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Figure 1 | Global spatio-temporal dynamics of gene expression. a, Venn
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(Fig. 1c) and performed unsupervised hierarchical clustering across
periods 3–15, an interval during which all analysed regions/areas can
be consistently followed across time. Among regions, this analysis
showed distinct and developmentally regulated clustering of NCX
(combination of 11 areas), HIP and AMY, with CBC having the most
distinctive transcriptional profile. At the level of NCX areas, cluster-
ing formed the following groups during fetal periods: OFC, DFC and
MFC; VFC and primary somatomotor cortex (S1C and M1C); and
parietal–temporal perisylvian areas (IPC, A1C and STC). V1Chad the
most distinctive transcriptional profile of NCX areas throughout
development and adulthood. The increased correlations between
NCX, HIP, AMY and the majority of non-V1C NCX areas with age
indicate that transcriptional differences are particularly pronounced
during development.
Consistent with the clustering observed, CBC showed the greatest
number of region-restricted or region-enriched DEX genes, with 516
(4.8%) of 10,729 genes spatially DEX (Supplementary Information,
section 6.4, and Supplementary Table 5). By contrast, the numbers of
genes highly enriched in the other regions were lower: NCX, 46
(0.43%); HIP, 48 (0.45%); AMY, 4 (0.04%); STR, 137 (1.28%); MD,
216 (2.01%). The majority of these spatially enriched genes were also
temporally regulated, and some, such as those in Supplementary Figs
14 and 15 (NCX: FLJ32063, KCNS1; HIP: CDC20B,METTL7B; AMY:
TFAP2D, UTS2D; STR: C10orf11, PTPN7; MD: CEACAM21,
SLC24A5; CBC: ESRRB, ZP2), were transiently enriched during a
narrow time window. These clustering and region-enrichment results
reveal that regional transcriptomes are developmentally regulated and
reflect anatomical differences.
Spatio-temporal differential exon usage
Alternative exon usage is an important mechanism for generating
transcript diversity19,20. Using a splicing analysis of variance and a
splicing index algorithm with conservative criteria (Q, 0.01 with a
minimum twofold splice index difference between at least two
regions/areas or periods; Supplementary Information, section 6.5),
we found that 13,647 (90.2%) of 15,132 expressed genes showed
DEU across sampled regions (0.1%), periods (19.5%) or both
(70.6%). Of 14,375 NCX genes, 88.7% showed DEU across sampled
areas (,0.01%), periods (59.8%) or both (28.9%). The regulation of
DEU also varied in time, with themajority of expressed genes (83.0%)
showing temporal DEU across fetal development, whereas only 0.9%
and 1.4% were temporally regulated across postnatal development
and adulthood, respectively.
Focusing onANKRD32, a gene we have previously shown to express
an alternative variant in the late mid-fetal frontal cortex16, we
confirmed and extendedour findings onDEUby showing thatwhereas
the longer isoform (ANKRD32a) was equally expressed across fetal
NCX areas, the shorter isoform (ANKRD32b), comprising the last
three exons, exhibited dynamic areal patterns. ANKRD32b was tran-
siently expressed in a gradient along the anterior–posterior axis of the
mid-fetal frontal cortex, with the highest expression in OFC and the
lowest in M1C. Before this, ANKRD32b was most highly enriched in
the ITCand, to a lesser extent, the STC. These spatio-temporal patterns
disappeared after birth, when only ANKRD32a was expressed, and
were not observed in the mouse NCX of equivalent ages (Sup-
plementary Fig. 16 and Supplementary Table 6). These findings illus-
trate the complexity of DEU in the human brain and demonstrate
how specific alternative transcripts can be spatially restricted during
a narrow developmental window and with interspecies differences.
Sex differences in the transcriptome
Sex-biased gene expression
Previous studies have identified sexually dimorphic gene expression
in the developing and adult human brain11–13. Analysis of our data set
using a sliding-window algorithm and t-test model (Q, 0.01 with
.2-fold difference in log2-transformed signal intensity; Supplemen-
tary Information, section 6.6) identified 159 genes, including a number
of previously reported and newly uncovered genes withmale or female
bias in expression located on the Y (13 genes), X (9 genes) and
autosomal (137 genes) chromosomes. A large fraction (76.7%) had
male-biased expression (Fig. 2a and Supplementary Table 7). Notable
spatial differences were observed, and more genes had sex-biased
expression during prenatal development than during postnatal life,
with the adult brain characterized by having the fewest.
Consistent with previous findings12,13, we found that the largest differ-
ences were attributable to Y-chromosome genes, especially PCDH11Y,
RPS4Y1, USP9Y, DDX3Y, NLGN4Y, UTY, EIF1AY and ZFY, which
showed constant expression across regions and periods, with the excep-
tion of PCDH11Y downregulation in the postnatal CBC (Fig. 2b).
Notably, the functional homologues of these genes on the X chro-
mosome, barring ZFX during fetal development (PCDH11X, RPS4X,
USP9X, DDX3X, NLGN4X, UTX and EIF1AX), were not upregulated
in a compensatory manner in female brains (Supplementary Fig. 17).
We also found other X-linked and autosomal genes with sex-biased
expression and distinct spatio-temporal patterns, including functionally
uncharacterized transcripts (LOC554203, C3orf62, FLJ35409 (also
known asMIR137HG) andDKFZP586I1420), S100A10 (whichhas been
linked to depression21) and IGF2 (an imprinted autosomal gene previ-
ously implicated in embryonic growth and cognitive function22,23), that
showed population-level male-biased expression (Fig. 2c).
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Sex-biased exon usage
We next explored sex-biased DEU using a sliding-window algorithm
with a splicing t-test model (Q, 0.01 and splicing index .2; Sup-
plementary Information, section 6.6). We identified 155 genes (145
autosomal) that showed sex-biased expression of probe sets encoding
one or a subset of exons (Supplementary Table 8) in one or multiple
regions/NCX areas. These included several members of the collagen
family of genes (COL1A1,COL1A2,COL3A1,COL5A2 andCOL6A3),
C3, KCNH2 (a gene associated with schizophrenia24), NOTCH3 (a
gene mutated in a common form of hereditary stroke disorder25),
ELN (a gene located within the Williams syndrome critical region26)
and NLGN4X (an X-chromosome gene implicated in synapse func-
tion and associated with ASD and moderate X-linked intellectual
disability10,27). Although comparably expressed in males and females
at the population and gene levels (Supplementary Fig. 17), NLGN4X
had a significantmale bias in expressionof exon7 and, to a lesser extent,
exons 1, 5 and 6 in a developmentally regulated manner (Fig. 3).
Together, these findings show that developmentally and spatially regu-
lated differences in gene- and exon-level expression exist betweenmale
and female brains.
Gene co-expression networks
To extract additional biological information embedded in the multi-
dimensional transcriptome data set, we performed weighted gene co-
expression network analysis28, which allowed us to identify modules
of co-expressed genes. We identified 29 modules associated with
distinct spatio-temporal expression patterns and biological processes
(Fig. 4a; Supplementary Information, section 6.7; Supplementary
Tables 9–11; and Supplementary Figs 18–20). Among modules cor-
responding to specific spatio-temporal patterns, M8 consisted of 24
genes with a common developmental trend that showed the highest
expression levels in early fetal NCX and HIP (period 3), followed by a
progressive decline in expression levels with age until infancy (period
9) (Fig. 4b). By contrast,M15 contained 310 genes showing changes in
the opposite direction (relative to those inM8) in theNCX,HIP, AMY
and STR (Fig. 4c). Gene ontology enrichment analysis showed that
genes in M8 were enriched for gene ontology categories related to
neuronal differentiation (Bonferroni-adjusted P5 7.73 1023) and
transcription factors (P5 5.23 1023) (Supplementary Information,
section 6.8, and Supplementary Table 9). Conversely, M15 gene onto-
logy categories included ionic channels (P5 8.03 1028) and neuro-
active ligand–receptor interaction (P5 4.03 10214).
Genes with the highest degree of connectivity within a module are
termed hub genes and are expected to be functionally important within
themodule.M8hub genes included transcription factorsTBR1, FEZF2,
FOXG1, SATB2, NEUROD6 and EMX1 (Fig. 4b), which have been
functionally implicated in the development ofNCX andHIP projection
neurons29–38. Furthermore, FOXG1 variants have been linked to Rett
syndrome and intellectual disability34. Sequence variants in M15 hub
genes (Fig. 4c) have been linked to major depression39 (GDA) and to
schizophrenia and affective disorders6,40 (NRGN and RGS4).
We also identified two large-scale, temporally regulated modules
(M20 and M2) with opposite developmental trajectories of genes co-
expressed across regions: expression in M20 gradually decreased with
age and expression inM2 gradually increased (Supplementary Figs 21
and 22). M20 was enriched for gene ontology categories related to
zinc-finger proteins (P5 7.33 10248) and transcription factors
(P5 4.83 10250), including many ZNF and SOX family members.
M2 was enriched for gene ontology categories related to membrane
proteins (P5 1.83 10221), calcium signalling (P5 8.13 10210),
synaptic transmission (P5 1.63 1026) and neuroactive ligand–
receptor interaction (P5 4.13 1024), reflecting processes important
in postnatal brain maturation. Their hub genes encoded transcrip-
tional factors, modulators of chromatin state and signal transduction
proteins, all of which are likely to be involved in driving the co-
expression networks. Drastic expression shifts in M20 and M2 in
the opposite direction just before birth indicate that this period is
associated with global transcriptional changes that probably reflect
environmental influences on brain development and intrinsic
changes in cellular composition and functional processes.
Expression trajectories of neurodevelopment
One important use for the generated data set is to gain insight into
normal and abnormal human neurodevelopment by analysing
trajectories of individual genes or groups of genes associated with a
particular neurobiological category or disease. To test this strategy, we
compared our expression data forDCX (a gene expressed in neuronal
progenitor cells and immaturemigrating neurons), as well as for genes
associated with dendrite (MAP1A, MAPT, CAMK2A) and synapse
(SYP,SYPL1,SYPL2,SYN1) development,with independently generated,
non-transcriptome human data sets. TheDCX expression trajectory was
remarkably reminiscent of the reported changes in the density of DCX-
immunopositive cells in the postnatal human HIP36,40 (r5 0.946,
Pearson correlation; Fig. 5a). In our transcriptome data set,DCX expres-
sion increased until early mid-fetal development (period 5) and then
gradually declined with age until early childhood (period 10). Likewise,
expression trajectories of dendrite and synapse development gene
groups closely paralleled the growth of basal dendrites ofDFCpyramidal
neurons41 (r5 0.810 for layer 3 and r5 0.700 for layer 5; Fig. 5b) and
DFC synaptogenesis42 (r5 0.940; Fig. 5c), respectively. Steep increases in
both processes occurred between the late mid-fetal period and late
infancy, indicating that a considerable portion of these two processes
occurs before birth and reaches a plateau around late infancy.
After demonstrating the accuracy and viability of using the data set
to profile human neurodevelopment, we manually curated lists of
genes associated with over 80 categories, including various neuro-
developmental processes, neural cell types and neurotransmitter
systems (Supplementary Information 6.9 and Supplementary Table
12). Notable trajectories and differences in their onset times, rates of
increase and decrease, and shapes were observed within and between
brain regions for categories including major neurodevelopmental
processes (neural cell proliferation and migration, dendrite and
synapse development, and myelination; Fig. 5d), cortical GABAergic
inhibitory interneurons (CALB1,CALB2,NOS1, PVALB andVIP) and
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glutamate receptors (Supplementary Figs 23 and 24). Two expected
patterns were observed in neurodevelopmental trajectories: changes in
expression of cell proliferation genes preceded the increase in expres-
sion of DCX, and expression of each decreased during perinatal
development whereas synapse development, dendrite development
and myelination trajectories increased. Notably, the NCX trajectory
for synapse development did not drastically decline during late child-
hood or adolescence (Fig. 5c, d) as previously reported for synapse
density42.We also identified co-expression networkmodules and addi-
tional genes that are highly correlated with the categories
(SupplementaryTables 10, 13 and 14). For example,M20 andM2were
strongly correlatedwithneuronmigration (r5 0.894) andmyelination
(r5 0.972), respectively.
In addition, our data set enabled us to generate expression trajectories
of genes commonly associatedwithASDand schizophrenia.We inves-
tigated a number of genes previously linked to these disorders (Sup-
plementary Information, section 6.10) and observed distinct and
dynamic expression patterns, especially among NCX areas (Sup-
plementary Fig. 25 shows examples for CNTNAP2, MET, NLGN4X
andNRGN). To gain insight into potential biological functions ofASD-
and schizophrenia-associated genes in human neurodevelopment, we
identified other genes with significantly correlated spatio-temporal
expression profiles and performed gene ontology enrichment analysis
(Supplementary Tables 15 and 16). These findings reveal associated
spatio-temporal differences in these expression trajectories and pro-
vide additional co-expressed genes that can be interrogated for their
role in the respective processes or disorders.
Expression quantitative trait loci
Previous studies have identified expression quantitative trait loci
(eQTLs) in the adult human brain, primarily in the cerebral cortex43–47.
Our multiregional developmental data set enabled us to search for
association between SNP genotypes and spatio-temporal gene expres-
sion. We tested only for cis-eQTLs, restricting the search to SNPs
within 10 kilobases of either a transcription start site or a transcription
end site, as opposed to trans-eQTLs, which would require much larger
sample sizes.
Implementing a conservative strategy (gene-wide Bonferroni cor-
rection followed by genome-wide Q, 0.1; Supplementary Informa-
tion, section 9), we identified 39 NCX, eight HIP, four AMY, two STR,
sixMDand five CBCgenes (Supplementary Table 17)with evidence of
cis-eQTL, including two previously reported genes45,47 (ITGB3BP and
ANKRD27). Consistent with previous studies48, associated SNPs were
enriched near transcription start and termination sites (Fig. 6a, b).
An example of a significant association in NCX, MD and CBC is
that between SNP rs10785190 andGLIPR1L2, amember of the glioma
pathogenesis-related 1 family of genes49. The expression differences
were observed at the level of the whole transcript and exons 1 and 2,
the only exons we observed to be expressed at appreciable levels in the
NCX (Fig. 6c, d). The NCX probably had more cis-eQTLs than other
regions owing to its smaller variation in gene expression resulting
from the averaged expression of 11 areas. Many eQTLs identified as
significant in NCX also have similar associations in other regions,
although they were not statistically significant after the conservative
genome-wide correction (Supplementary Table 17). Thus, we have
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identified polymorphic regulators of transcription in different regions
across development, potentially providing insights into inter-
individual differences and genetic control of the brain transcriptome.
Discussion
Our analysis reveals several features of the human brain transcriptome,
and increases our knowledge of the transcriptional events in human
neurodevelopment.We show that gene expression and exon usage have
complex and dynamically regulated patterns, some ofwhichmay not be
evident in the transcriptomes of commonly studied model organisms.
Moreover, these patterns differmore prominently across time and space
than they do between sexes, ethnicities or individuals, despite their
underlying genetic differences. Transcriptome differences between
males and females also included several disease-related genes, offering
possible mechanisms underlying the sex differences in the incidence,
prevalence and severity of some brain disorders. We also found that
some of the inter-individual variations in the regional and develop-
mental transcriptomes were associated with specific SNP genotypes,
which may have altered expression-regulating elements. Thus, the pre-
sent data set (available at http://www.humanbraintranscriptome.org),
along with an accompanying study50, provides a basis for a variety of
further investigations and comparisons with other transcriptome-
related data sets of both healthy and diseased states.
Although our study has uncovered many intricacies in gene expres-
sion and exon usage in the human brain, there are potential limitations
of our study that warrant discussion. Foremost, we used stringent
criteria to minimize false positives and faithfully characterize general
transcriptional patterns, rather than to capture all the changes thatmay
occur. Also, we analysed dissected tissue that contained multiple cell
types, thus diluting the transcriptional contribution and dynamic
range of expression of any one specific cell type. Current limitations
prevent us from using cell-type-specific approaches in systematically
analysing the spatio-temporal transcriptome. Furthermore, the num-
ber of brains and regions analysed so far is not sufficient to investigate
the full magnitude of transcriptional changes or the full range of
eQTLs.Application of sequencing technologywill allowmore in-depth
analyses of the transcriptome, and aid in discovery of novel or
low-expressing transcripts. Finally, although specific patterns of
expression are often linked to specialized biological processes, it is
important to remember that the relationship between messenger
RNA and protein levels is not always linear nor translated into appar-
ent phenotypic differences. As these concerns are addressed in future
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Figure 6 | Association between SNPs and gene expression. a, b, SNP
distribution around transcription start sites (TSS; a) and transcription end sites
(TES; b) of the associated genes, based on several Wald test P-value cut-offs
after gene-wide Bonferroni correction. c, GLIPR1L2 expression association
with rs10785190 genotype, a SNP located in exon 1. The solid and dashed
curves, calculated from locally weighted scatter-plot smoothing (LOWESS),
show the developmental trends of gene expression and exon-1 and exon-2
expression, respectively. d, qRT–PCR validation of exon-1 and exon-2
expression in NCX for each genotype (N5 14 GG, 14 AG, 8 AA), plotted
relative to the LOWESS curve in c to facilitate comparison across
developmental periods. P values were calculated by unpaired t-test. Whiskers
indicate fifth and ninety-fifth percentiles, respectively.
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with more samples and new data sets from human and non-human
primate brains, it will be possible to uncover deeper insights into the
transcriptional foundations of human brain development and evolu-
tion.
METHODS SUMMARY
Supplementary Information, sections 3–9, provides a full description of tissue
acquisition and processing, data generation, validation and analyses.
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